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Abstract 
Cerebral palsy (CP) is the largest single cause of childhood physical disability. While the 
brain lesion responsible for CP is static, there is a cascade of secondary musculoskeletal 
adaptations including reduced muscle size, reduced joint range of motion, increased joint 
stiffness, and muscle weakness. These secondary alterations progress with age and 
contribute to a gradual loss of functional capacity into adulthood. Strength training has 
been used to increase muscle strength in individuals with CP, however it may not be an 
effective intervention for improving gross mobility-related measures, such as walking 
performance. It is also unknown whether skeletal muscle in young adults with CP can 
undergo hypertrophy or architectural adaptations in response to different exercise modes. 
The general aim of this thesis was to examine the effect of combined functional anaerobic 
and strength training (FAST) on muscle properties, functional capacity, and gait in 
adolescents and young adults with CP.  
 
A systematic review was undertaken (Chapter 2) to determine the effects of muscle 
strengthening interventions on skeletal muscle morphology and architecture in children 
and adolescents with CP. The analysis revealed preliminary evidence that strength training 
leads to increased muscle size in children and adolescents with CP, accompanied by an 
increase in muscle strength. Muscle hypertrophy findings may, however, be confounded 
by factors such as natural growth and concurrent therapies. The findings of this review 
informed the design of the FAST program and outcome measures used in the following 
studies to better understand the muscular responses to exercise training in this population. 
The full study protocol for the FAST intervention is described in Chapter 3. There have 
been no previous exercise trials conducted in young adults with CP using training 
parameters that meet established guidelines, that have measured muscle morphology and 
architecture outcomes. Details of the functional anaerobic and resistance training 
parameters and progressions according to established guidelines are set out, as well as 
establishing a-priori outcome measures and the data analysis plan for implementation of 
the intervention. 
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A cross-sectional study was undertaken (Chapter 4) to investigate the relationships 
between muscle strength, stiffness, and functional capacity in a larger sample of adults 
with CP. The results of this study demonstrated that maximum isometric plantar flexion 
strength independently explained 50 – 61% of variance in functional capacity outcome 
measures. Passive medial gastrocnemius muscle fascicle stiffness and ankle joint stiffness 
were not related to functional capacity measures. These findings suggest lower isometric 
muscle strength of the plantar flexor muscles contributes to the decline in functional 
capacity in adults with CP.  
 
Chapter 5 investigated the impact of the FAST intervention on lower limb muscle volumes, 
joint and muscle stiffness, muscle strength, and functional capacity in a sample of 17 
young adults with CP. Participants were randomised to 12 weeks, 3 sessions per week, of 
high intensity functional anaerobic and progressive resistance training of the lower limbs 
(n=8), or a waitlist control group (n=9). Pre- and post-training plantar flexor and tibialis 
anterior muscle volumes and composition, passive and active plantar flexor muscle 
properties, and functional capacity outcomes were assessed. The training group had 
higher values compared to the control group (adjusted mean difference) at 12-weeks for: 
more- and less-impaired total plantar flexor and tibialis anterior muscle volumes; maximum 
isometric plantar flexion strength; muscle power sprint test peak power; agility shuttle time; 
composite functional strength score; and six-minute walk test distance. The addition of 
anaerobic training to progressive resistance exercise likely contributed to the improved 
functional capacity.  
 
The final experimental study (Chapter 6) reports on the gait outcomes following the FAST 
intervention. Participants walked at a preferred walking speed on a force instrumented, 
tandem treadmill, while three-dimensional kinematics, kinetics were simultaneously 
acquired. There were no changes between the training group and control group for 
maximum ankle DF angle at foot contact or during stance; gait profile score; and peak 
ankle power during late stance. Within-group analysis revealed an increase in ankle power 
generation during late stance after training in the intervention group, in part due to a 
compensatory reduction in hip power generation, indicating a potential trade-off between 
the two joints post-training. Overground functional capacity improvements reported in 
Chapter 5 occurred in the absence of treadmill gait kinematic changes.  
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The collection of studies in this thesis provides new information on the relationships 
between muscle structure and function in adults with CP, and the influence of a combined 
FAST intervention on muscle properties, functional capacity, and gait. Skeletal muscle in 
high functioning young adults appears to be capable of undergoing a hypertrophic 
response to FAST. Undertaking specific anaerobic exercises in addition to resistance 
exercise may be important for improving functional capacity in these individuals. Taken 
together, these findings have important implications for the prescription of exercise in high 
functioning young adults with CP as a means of addressing the muscle and functional 
deficits that progress with age in this population. 
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1.1 Cerebral Palsy  
Cerebral palsy (CP) can be described as a group of motor impairment disorders caused by 
a non-progressive lesion in the developing child’s brain during pregnancy or shortly after 
birth.1 The economic cost of CP in Australia is estimated to be $1.47 billion per year.2 This 
is a large percentage of healthcare expenditure for this age group and demonstrates the 
enormity of this problem for not only the individuals involved, but also for the wider 
community.  
 
Individuals with spastic-type CP have reduced muscle growth which may result in the 
development of fixed contractures of the muscle-tendon unit.3 Fixed contractures 
compromise strength and function4 and may result in skeletal deformity5 requiring surgery. 
While the brain lesion responsible for CP is static, it results in secondary musculoskeletal 
problems such as reduced joint range of motion, increased joint stiffness, and muscle 
weakness.6-8 These secondary alterations progress with age9 and contribute to a gradual 
loss of functional capacity,10 characterised by deterioration in gait11,12 and reduced 
muscular strength13 throughout adolescence and young adulthood in individuals with CP. 
Conservative treatments aim to reduce the progressive secondary musculoskeletal 
problems and maintain independent mobility and walking into adolescence and adulthood. 
 
1.2 Musculoskeletal adaptations in cerebral palsy and relation to 
function 
Changes in muscle morphology and physical performance with CP have been well 
documented in isolation. The relationship between the decline in neuromuscular properties 
and the performance of functional tasks is however less well understood. Currently there is 
little information on the progression of the underlying muscle adaptations that influence 
walking ability during development from childhood to adulthood, which makes it difficult to 
ascertain the efficacy of lower limb treatment options for individuals with CP. Without this 
understanding, the impact of treatments such as resistance training, can only be 
speculation. 
 
The ability of a muscle to generate movement is dependent on the capacity to produce 
appropriate forces while changing length and the ability of the nervous system to 
appropriately control that movement. Whilst isolated skeletal muscle typically generates 
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force along a bell-shaped force-length curve,14 there are specific physiological properties 
of the musculoskeletal system which constrain the ability of muscles and the nervous 
system in vivo. 
 
The force-length relationship of a muscle in vivo is the combination of active (contractile 
process) and passive (cytoskeleton, connective tissue, and tendon) components.14 These 
active and passive components contribute to the mechanical properties of the muscle. 
Shorter muscle fibres have a narrower force-length relation and a slower maximum 
shortening velocity15 (Figure 1-1). A shorter optimal muscle fibre length may also result in 
reduced or enhanced force production depending on whether the muscle fibres are 
operating on the ascending or descending limbs of the force-length relation.16 Similarly, a 
muscle fibre with a reduced maximum shortening velocity will produce less force at any 
given shortening velocity. In vivo contraction and movement specific studies, as opposed 
to isolated or resting-state investigations, may provide greater insight into the decline in 
neuromuscular performance that is seen with CP. 
 
 
Figure 1-1. Schematic force-length (A) and force-velocity (B) relations of two muscles with 
different fibre lengths but identical physiological cross sectional area. Reprinted from 
Lieber and Friden15 with permission from Wolters Kluwer Health, Inc. 
 
The force a muscle can produce is directly proportional to the physiological cross-sectional 
area (PCSA) of the muscle. A muscle with a larger PCSA will therefore produce greater 
force at the same muscle length or velocity, assuming equivalent fibre length, pennation 
angle, fibre-type distribution and specific tension15 (Figure 1-2). Increasing muscle mass 
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by adding contractile tissue in a parallel arrangement would therefore be expected to 
increase the force generating capacity of the muscle.  
 
 
Figure 1-2. Schematic force-length (A) and force-velocity (B) relations of two identical 
muscles with different physiological cross-sectional areas. Reprinted from Lieber and 
Friden15 with permission from Wolters Kluwer Health, Inc. 
 
Architectural and morphological adaptations of the lower limb muscles in individuals with 
CP compared to typically developing (TD) individuals include: i) reduced muscle volume,17-
20 ii) increased muscle fascicle stiffness,21 iii) reduced22-24 or similar18,25 muscle fascicle 
lengths, iv) longer sarcomere lengths,26 v) increased intramuscular fat,27 and vi) increased 
Achilles tendon length.28 Alterations to muscle architecture in individuals with CP begin to 
occur within the first years of life17,29,30 which may progress into adulthood.28  
 
As muscle architecture is the primary determinant of muscle function,31 these specific 
musculotendinous adaptations in individuals with CP may contribute to a loss of muscle 
strength7,8,32 and motor performance.33 The decline in force generating capacity of the 
muscle has been directly attributed to a reduced muscle volume.28 Increased muscle 
fascicle stiffness21 may also result in the inability of the muscle fascicles to reach lengths 
favourable for high force production.31 A longer sarcomere length is indicative of less 
overlap between actin and myosin – the two basic proteins involved in generating muscle 
force. Force generation may therefore be reduced at very long sarcomere lengths 
according to the length-tension relationship.15 The optimum muscle length (where force 
generating capacity is maximum) may also be altered due to longer sarcomere lengths. A 
longer Achilles tendon in series with weaker muscles and more stiff muscle fascicles may 
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result in altered muscle function during walking.34 A higher intramuscular fat content 
translates to a reduced proportion of contractile tissue within the muscle27. This reduced 
muscle quality may therefore be a contributing factor to muscle weakness and have 
implications for functional performance in individuals with spastic CP.  
 
The alterations to the musculotendinous unit may also contribute to the reduced power 
generation during gait35 and diminished anaerobic performance36 in individuals with CP. 
Moderate to high correlations have also been reported between strength and walking 
speed (r=0.61)37 and between strength and activity limitations (r=0.70 – 0.83)4 suggesting 
muscle weakness plays a role in the mobility difficulties associated with CP. The link 
between altered muscle structure and reduced muscle function is also supported by 
emerging evidence that impaired gait function in adults with CP is associated with reduced 
rapid force generation and increased passive stiffness of ankle muscles,38 suggesting that 
interventions targeting these neuromuscular properties might be beneficial for improving 
gait. 
 
At a biological level, muscle in people with CP is also different to TD muscle. Several 
biological factors have been proposed that may contribute to the reduced muscle growth 
and development of muscle contractures in individuals with CP. These include a reduction 
in satellite cells,3 altered extracellular matrix,26,39,40 competing hypertrophic signalling 
pathways,41 altered neural activation,42 and the impact of tensional-homeostasis and 
mechano-transduction.42 These factors may not only impact on the neuromuscular 
interaction to generate movement, but also the ability of the muscle to adapt to stimuli 
such as resistance training.  
 
1.3 Exercise interventions for individuals with CP to enhance muscle  
Despite the correlations between strength and mobility in individuals with CP,4,37 evidence 
is scarce regarding the translation of strength improvements to gross functional and 
mobility-related measures such as walking performance.43-45 Resistance training 
interventions in individuals with CP have traditionally focused on enhancing muscle 
strength; hypothesising functional performance would improve as a consequence. There is 
consensus in the literature that PRT is effective in improving muscle strength in children 
with CP without negatively impacting on the level of spasticity.43,46-49 Several RCTs of 
resistance training in individuals with CP have demonstrated increases in muscular 
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strength but without a concurrent increase in functional performance43,50-52 leading to 
questions regarding the overall effectiveness of this intervention.53 Without examining the 
underlying neuromuscular properties that PRT can impact on in individuals with CP, these 
studies can only hypothesise as to the mechanisms underlying this incongruity.  
 
The National Strength and Conditioning Association (NSCA) provides guidelines on the 
prescription of resistance training in youth.54 The first exercise and physical activity 
recommendations for people with CP have also been published recently.55 The 
recommendations for resistance exercise propose single and multi-joint exercises; 1-3 sets 
of 6-15 repetitions per set, performed at 50-85% repetition maximum; undertaken 2-4 
times per week. The RCT’s conducted by Dodd et al,48 Liao et al,51 Lee et al,56 and 
Scholtes et al44 do not meet the NSCA guidelines outlining the type of exercises performed 
(single and multi-joint) and program duration (8-20 weeks).53 Similarly, a RCT carried out 
by Maeland et al52 only performed one exercise (seated leg press) in middle-aged adults 
with CP and found no effect on mobility. Studies by Liao et al,51 Lee et al,56 and Scholtes 
et al44 also included participants under the age of 7 years which is not in line with the 
NSCA’s guidelines.54 The mismatch between training program design in these studies and 
the resistance training guidelines provides a potential explanation for the ineffectiveness of 
these studies at influencing functional outcomes in youth with CP.53 A more recent RCT 
conducted by Taylor et al43 in young adults with CP (GMFCS level II – III) more closely 
matches the proposed CP and NSCA resistance training guidelines (participants aged 18 
years, trained twice weekly for 12 weeks, 3 sets of 10-12 repetitions per exercise) but 
participants performed different exercises depending on individually identified deficiencies 
from gait analysis, and no measures of neuromechanical properties were performed 
making it difficult to ascertain whether any muscle or neural parameters were altered by 
the intervention. Nonetheless, Taylor et al43 increased the strength of the targeted muscles 
by 27% (95% CI 8–46%) compared to the control group, but showed no transfer to 
improvements in measures of mobility.  
 
Recent prospective investigations have shown that muscle volume57 and cross-sectional 
area58 are increased following resistance training in this population, and that muscle 
architecture may change depending on the type of training performed.59 The lack of a 
control group and presence of confounding variables in these studies such as growth, age, 
and degree of skeletal maturity make the results less robust. This preliminary evidence 
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suggests muscle morphology and architecture adapts following PRT in children and 
adolescents with CP. Increases in muscle size may influence the mechanical properties of 
the musculotendinous unit and potentially slow the development of, or reduce muscle 
contracture. Changes in muscle morphology may also alter the interaction of the muscle 
and tendon during functional tasks such as walking. Specifically, the muscle may operate 
at more optimum fibre lengths and velocities for force production resulting in more efficient 
function during challenging tasks such as walking up and downhill. It is important to 
understand the underlying neuromuscular properties that may change with resistance 
training in individuals with CP because the interaction between these properties are likely 
to influence any transfer to improvements in functional performance.60  
 
Fundamental principles of exercise training should underpin the basic research question 
and objective of exercise interventions.61 The principle of specificity may underlie the 
translation of strength improvements to functional performance following resistance 
training in individuals with CP. Specificity relates to the training intervention being 
implemented in a context related to the functional tasks being performed. The principle of 
specificity predicts that the closer the training routine is to the requirements of the desired 
outcome (e.g. a specific performance task), the better the outcome will be.62 Previous PRT 
studies that have set out to improve motor performance have not trained in a context 
related to the outcome measures (e.g. gait function), nor included any exercises 
addressing the specific motor skills to be improved (i.e. walking).43  
 
From a motor control perspective, the degree of transfer from resistance training to other 
tasks is determined by the interaction of the various neuromuscular adaptations 
associated with training, and the characteristics of the transfer tasks.60 Positive transfer of 
resistance training gains to performance may occur if the process of learning the optimal 
patterns of muscle activity during resistance exercises strengthens excitatory neural 
connections between muscles that act as functional synergists in the context of the 
performance task.60 There may also be beneficial transfer if resistance training reinforces 
the optimum muscle-activation patterns that are required in the execution of the 
performance skill.60 Individuals with CP have difficulties with co-ordination and motor 
planning, therefore, providing resistance training in non-functional tasks may not enhance 
motor learning or translate to improvements of functional performance.63 Emerging 
evidence that intensive gait training improves gait kinematics as well as neural drive to the 
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ankle muscles in children with CP,64 supports the premise of training in a manner specific 
to the goal of the intervention. 
 
Extensive attention has been paid to evaluating the effects of resistance training using 
functional, performance, and gross motor outcome measures, without examining the 
muscle itself. The relationship of muscle architecture to muscle function suggests that the 
evaluation of key muscle parameters such as volume, activation level and muscle fascicle 
behaviour should occur following PRT as a means of examining whether the 
neuromuscular properties have been altered. RCTs provide the highest level of scientific 
evidence and no such studies exist regarding the effect of PRT on skeletal muscle 
structure in individuals with CP. In a well-designed and adequately powered RCT, Taylor 
et al43 measured no change in mobility outcomes following PRT in adolescents with CP 
using the 6-minute walk test, timed stairs test, gait kinematics, and Gross Motor Function 
Measure-66 dimensions D (standing) and E (walking, running, and jumping), even though 
strength increased by 27% (95% CI 8–46%) post-training compared to the control group. 
The question remains though as to what neuromuscular properties (parameters that 
influence muscle force generation), if any, were altered by the training intervention and the 
relationship of these properties to the mobility outcomes being assessed. Such 
neuromuscular adaptations that may occur in vivo cannot be measured from gross 
functional outcome measures. As methods of measurement and research design have 
become more sophisticated, we are increasingly able to measure the underlying 
adaptations that lead to improvements in strength and function in a variety of ways. 
 
1.4 Concurrent training  
Anaerobic muscle power refers to the ability of the neuromuscular system to perform 
maximum work within a short time period65 and is reduced in children with CP compared to 
their TD counterparts.36 Anaerobic power may be important to successfully performing 
daily activities in individuals with CP as most tasks such as walking short distances, 
avoiding obstacles, climbing stairs require short bursts of high intensity movement and as 
such, are anaerobic in nature.36 Anaerobic training in youth and adolescents with CP has 
led to improvements in muscle strength, anaerobic capacity, and agility,66,67 but the impact 
on muscle morphology and architecture remains unknown. Given the difficulty in improving 
functional outcomes following traditional resistance training interventions, the addition of 
anaerobic training may lead to increased mobility and agility. 
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The addition of lower limb strength training concurrent to sports training (anaerobic, speed, 
agility, endurance) in TD adolescents has been shown to significantly improve sprint 
performance by 5-10% compared to performing sports training only.68 Similarly, Christou et 
al69 found concurrent strength and sports training in adolescent males significantly 
improved vertical jump height and 30m speed compared to sports training only.69 These 
findings illustrate that there may be increases in motor performance when resistance 
training is added concurrently to a total training program that addresses other performance 
characteristics such as speed, agility and power. Although not measured in the above 
studies, it could be hypothesised that neuromuscular adaptations to the resistance training 
component may underpin the observed increase in motor performance.  
 
1.5 Thesis aim 
The overall effectiveness of PRT for individuals with CP remains unclear. There is a 
paucity of evidence about how PRT influences muscular properties in CP, making it 
difficult to interpret the impact of such interventions at a physiological level. This thesis 
aims to bridge this gap in the literature by employing a strong study design (RCT), utilising 
evidenced based exercise training principles, with objective measurements of muscular 
and functional outcomes. The specific research aims of this thesis are to:  
 Systematically review the literature to examine the effects of strength training on 
muscle morphology and architecture in individuals with CP; 
 Prospectively design and report a full study protocol to investigate the impact of a 
12-week functional anaerobic and strength training (FAST) program on lower limb 
neuromuscular properties, functional capacity, and gait function in adolescents and 
young adults with spastic type CP; 
 Investigate the relationships between muscle strength, stiffness, and functional 
capacity in adults with CP; 
 Examine the impact of the FAST program on muscle properties, strength and 
functional capacity; and 
 Examine the impact of the FAST program on gait kinematics, kinetics, and 
temporal-spatial outcomes.  
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1.6 Thesis structure  
This thesis is comprised of 7 chapters. They include this introduction; a systematic review 
of existing literature; the full study protocol of the FAST intervention; three experimental 
studies; and a discussion on the entire body of work with implications and practical 
recommendations. 
 
Chapter 2  
The objective of this chapter was to systematically review the literature to investigate the 
impact of PRT on skeletal muscle morphology in children and adolescents with CP. A 
paucity of studies exist that have measured morphological outcome measures resulting in 
preliminary evidence only. The findings of this review provided a fundamental basis for the 
design of forthcoming studies.  
 
Chapter 3 
Informed by the findings of the systematic review and a critical appraisal of previous 
exercise training interventions in individuals with CP, this chapter documents the full study 
protocol of the FAST intervention. The study protocol provides detailed anaerobic and 
resistance training programming variables, outcome measure selection, ethics and 
dissemination information, and data analysis plans.   
 
Chapter 4 
This chapter investigates how muscle strength and stiffness is related to functional 
capacity. The data reported in this study contains baseline data from the FAST study 
outlined in Chapter 3, as well as additional data collected in older adults with CP. Adults 
with CP have weaker and stiffer muscles than their TD counterparts. It is unknown, 
however, whether these factors play a role in reducing overall functional capacity. It is 
important to establish the limiting factors for functional capacity in individuals with CP in 
order to target these parameters using specific exercise programming. Using statistical 
regression analyses, it is possible to establish the relative importance of muscle strength 
and stiffness to functional capacity outcomes. 
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Chapter 5 
The impact of the FAST intervention on lower limb muscle volumes, joint and muscle 
stiffness, muscle strength, and functional capacity are reported in this chapter. The 
previous chapter determined the relationships between strength, stiffness and functional 
capacity in an associative study, and as such does not prove causal relationships between 
these variables. This study thereby sets out to investigate causal relationships between 
the FAST intervention and muscle structure, strength and functional capacity. This is the 
first study to report muscle hypertrophy following resistance training in young adults with 
CP.  
 
Chapter 6 
This chapter reports on the gait outcomes following the FAST intervention. Specifically, we 
use three-dimensional gait analysis methods to assess kinematics, kinetics, and temporal-
spatial variables to establish whether any increase in lower limb muscle size and strength 
following the FAST intervention is accompanied by changes in gait. 
 
Chapter 7 
The final chapter summarises the results from this program of research. The role of 
muscle in enhancing strength, functional capacity and musculoskeletal health is discussed 
in the context of all studies included in this thesis. The implications of this research is 
discussed; practical recommendations made; and future research opportunities identified.  
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The impact of strength training on muscle morphology and 
architecture in children and adolescents with cerebral palsy: A 
systematic review  
 
This chapter consists of a systematic review to gain an understanding of the specific 
muscular adaptations in response to strength training in individuals with CP, of which there 
have been no reviews previously published. The impact of strength training on muscle 
morphology and architecture is important, as any structural changes may influence the 
mechanical properties of the musculotendinous unit, alter muscle stiffness, improve 
musculoskeletal health, and alter the interaction of the muscle and tendon during 
functional tasks such as walking. 
 
 
 
 
 
 
 
Bibliographic details of published manuscript  
Gillett JG, Boyd RN, Carty CP, Barber LA. The impact of strength training on skeletal 
muscle morphology and architecture in individuals with spastic cerebral palsy: A 
systematic review. Res Dev Disabil 2016;56:183-96. 
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Abstract 
Aim: The aim of this study was to systematically review the current literature to determine 
the impact of strength training on skeletal muscle morphology and architecture in 
individuals aged 4 -20 years with spastic type cerebral palsy. Methods: A comprehensive 
search for randomised and non-randomised controlled trials, cohort studies and cross-
comparison trials was performed on five electronic databases. Included studies were 
graded according to level of evidence and assessed for methodological quality using the 
Downs and Black scale. Quantitative data was analysed using effect sizes. Results: Six of 
304 articles met the inclusion criteria. Methodological quality of the included papers ranged 
from 14 to 19 (out of 32). A large effect was found on muscle cross-sectional area 
following strength training, with small to moderate effects on muscle volume and thickness. 
Conclusion and implications: There is preliminary evidence that strength training leads 
to hypertrophy in children and adolescents with cerebral palsy. A paucity of studies exist 
measuring morphological and architectural parameters following strength training in these 
individuals. Overall low study methodological quality along with heterogeneous study 
design, dissimilar outcome measures, and lack of adequate control groups, indicated that 
care is needed when interpreting the results of these studies in isolation. 
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2.1 Introduction 
Muscle architecture is the primary determinant of muscle function.31 Morphological and 
architectural adaptations of muscles in individuals with CP compared to TD individuals 
include: i) reduced muscle volume,17-19 ii) reduced22-24 or similar18,25 muscle fascicle 
lengths, iii) increased intramuscular fat,27 and iv) increased Achilles tendon length.28 
Microscopically, sarcomeres are longer and extracellular matrix composition is different to 
TD muscle.26 These specific musculotendinous adaptations in individuals with CP begin to 
occur within the first five years of life17,29,30 and are likely to contribute to a loss of muscle 
strength and power compared to TD individuals7,8,32,70,71 and gradual decline in functional 
ability throughout adulthood.33 
 
Muscular strength and power, muscle volume, muscle fascicle architecture, and the force-
length properties of muscle are all responsive to strength training and have therefore been 
targeted in exercise-based interventions in TD individuals.72-77 Resistance training 
interventions in individuals with CP have traditionally focused on enhancing muscle 
strength and functional performance.43,50-52,78 For the purpose of this review, maximal 
muscular strength is defined as the maximum volitional force produced at a given velocity, 
for a specified movement,79 and is primarily governed by the size and structure of the 
muscle, and the ability of the nervous system to maximally activate the muscle.80 
 
Extensive attention has been paid to evaluating the effects of resistance training in 
individuals with CP using functional, performance, and gross motor outcome measures, 
without examining the muscle itself.43,50 A recent meta-analysis of 13 randomised 
controlled trials (RCT) on the effect of strengthening interventions in individuals with CP 
found a large overall effect on strength and physical performance (ES = 0.86).81,82 The 
review by Park and Kim,81 however, included studies that did not measure any 
morphological or architectural adaptations, making it difficult to ascertain the mechanisms 
underpinning these effects. There is a lack of understanding in the literature of how 
strength training influences skeletal muscle structure in individuals with CP and it remains 
largely unknown whether CP muscle adapts to strength training in a manner similar to that 
of TD individuals. The relationship of muscle structure to muscle function,31 suggests that 
the evaluation of key muscle morphological and architectural parameters such as volume, 
cross-sectional area (CSA), and fascicle length and angle, should occur following strength 
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training as a means of examining the mechanisms underpinning strength and functional 
improvements.  
 
A small number of recent investigations have focussed on the effects of strength training 
on morphological and architectural properties of muscle in individuals with CP,57-59,83-85 
however, no reviews have been published regarding these outcomes. The effects of 
strength training on muscle morphology and architecture is important, as any structural 
changes may influence the mechanical properties of the musculotendinous unit, reduce 
muscle stiffness, and alter the interaction of the muscle and tendon during functional tasks 
such as walking. 
 
The purpose of this study was to systematically review the current literature to determine 
the impact of strength training on skeletal muscle morphology and architecture in individuals 
aged 4 – 20 years with spastic type CP.  
 
2.2 Methods 
 Search Strategy  
A comprehensive search of the following online databases was performed in November 
2015: PubMed, Embase, CINAHL, PsychINFO, and the Cochrane Central Register of 
Controlled Trials (CENTRAL, The Cochrane Library). The search strategy was confined to 
studies written in English, but not limited by date, and comprised the following Medical 
Subject Headings (MeSH) or keywords: (1) child* or adolescent; (2) and cerebral palsy or 
spastic diplegia or spastic quadriplegia or spastic hemiplegia; (3) and resistance training or 
strength training or exercise therapy or strengthening or resistance exercise or weight 
training (4) and muscle (skeletal) or movement or function* or architectur* or structur* or 
fascicle or tendon or volume. A supplementary bibliographical search of the literature was 
conducted in an attempt to find articles missed by the electronic search. Title and abstract 
screening of the initial search yield was performed independently by two reviewers (JG 
and LB) to obtain relevant articles.  
 
 Inclusion Criteria 
Studies were assessed by two independent reviewers (JG and LB) according to the 
following selection criteria for inclusion: (1) randomised controlled trial (RCT), quasi-RCT, 
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or prospective cohort studies; (2) participants aged >4 and <20 years old, clinically 
diagnosed with spastic type CP, Gross Motor Function Classification System (GMFCS) 
levels I-III, not having undergone surgery within the last 12 months; (3) strength training 
intervention defined as any type of volitional exercise aimed at strengthening one or more 
muscles, with exercise progression as ability changed, performed at home, school, 
hospital, or in a community setting for a minimum of 6 weeks; (4) comparison between 
strength training versus nothing or other therapy, or pre-post cohort comparison; and (5) 
outcome assessed using one or more morphological or architectural parameters (volume, 
thickness, CSA, fascicle length, and/or fascicle angle). 
 
 Study collection and quality assessment 
Title and abstract screening of the initial search yield was performed independently by two 
reviewers (JG and LB) to obtain relevant articles after removing duplicates. Papers were 
included following agreement both raters, and any conflicting viewpoints were discussed 
with a third rater (RB). Full text articles were appraised independently by two authors (JG 
and LB) using a graded level of evidence system ranging from 1a (systematic review of 
randomised controlled trials) to 5 (expert opinion).86 Quality assessment of the included 
papers was also performed independently (JG and LB) using the Downs and Black rating 
scale.87 The 27 item scale can be used to assess the methodological quality of 
randomised and non-randomised trials, and consists of five subscales: (1) Reporting, (2) 
External validity, (3) Bias, (4) Confounding, and (5) Power. Each item is scored 0 or 1 (‘no’ 
or ‘yes’) with the exception of one item in the Reporting subscale which is scored from 0 to 
2 (‘no’, ‘partially’ or ‘yes’) and a single item on Power, which can be given a score from 0 to 
5 (based on sample size). The total possible score is 32. All conference abstracts were 
excluded. 
 
 Data extraction and synthesis  
Data extracted from each study included population demographics; intervention details 
including the type of training, muscle/s trained, duration, intensity, volume, frequency, 
progression, and location; and morphological, architectural, and strength outcomes.  
Where required, outcome data points were extracted manually by creating a digital image 
of the manuscript graph and locating data points from calibrated axes dimensions 
(GetData Graph Digitizer version 2.26.0.20). Correspondence with study authors by email 
was used to obtain and confirm raw data if sufficient data was unable to be extracted from 
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the publication. Effect sizes with 95% confidence intervals were calculated using outcome 
means, standard deviations (SD) and participant numbers extracted from publication 
(Meanpost – Meanpre)/SDwithin).88 An effect size of ≤ 0.20 was considered a small effect size, 
0.50 a moderate effect size, and ≥ 0.80 a large effect size.89 The p values reported were 
directly extracted from each included study according to the authors’ original statistical 
analyses and do not reflect the effect size or 95% confidence intervals calculated in this 
systematic review. 
 
2.3 Results 
 Search Results 
Our search retrieved 304 articles, with 23 remaining after removing duplicates and deletion 
by title and abstract. Six empirical articles were included in the review. Included articles 
and reasons for the exclusion of 17 of the 23 articles for which full text was obtained are 
outlined in Figure 2-1.  
 
 
Articles identified and 
screened by title and abstract 
(n=304) 
 
Full text articles obtained 
(n=23) 
Studies included (n=6) 
Prospective cohort (n=2) 
Prospective randomised cohort (n=2) 
Single-blind randomised trial (n=1) 
Prospective cross-comparison (n=1) 
Articles excluded (n=281)  
Total articles excluded (n=17) 
Didn't fulfill criteria (n=14) 
Case Reports (n=2) 
Conference abstracts (n=1) 
Figure 2-1. Flow diagram of literature search. 
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 Study Design 
One single-blind randomised controlled trial (RCT) was included investigating the effects of 
neurodevelopmental treatment and functional movement training on the lower limbs.83 The 
remaining five studies were all prospective designs, including two randomised cohort 
studies,59,85 two cohort follow-up studies,57,58 and one cross-comparison study.84 Of these 
five non-randomised controlled studies, three studies investigated predominantly home-
based lower limb strength training,57,84,85 one study evaluated the effects of isokinetic 
strength training in a tertiary setting,59 and one study utilised an upper limb strengthening 
intervention administered within a tertiary institution.58 
 
 Study Participants  
Of the 85 total participants in the included studies, 72 children with CP received strength 
training. Mean age of the participants ranged from 6 to 14 years. All participants were 
classified as GMFCS levels I-III, of whom 37 were children with diplegia, 23 with 
hemiplegia, 5 with quadriplegia, and the remaining 26 children having no cerebral palsy 
type reported. The study design and population characteristics are summarised in  
Table 2-1. 
20 
 
 
Table 2-1. Study design and population characteristics. 
Study Design Subjects (n) Sex (m/f) Mean age (SD) Cerebral Palsy type GMFCS Level 
   Exp Con Exp Con Exp Con Exp Con 
M. Lee et 
al83 
Single-blind 
Randomised 
trial 
26 (13 control) 8/5 5/8 6y1mo 
(2y8mo) 
6y11m 
(2y6mo) 
NR NR I-III (n NR) 
J.A. Lee et 
al58 
Prospective 
cohort 
10 
  
5/5 8y7mo (1y3mo)a 5 hemiplegia 
5 quadriplegia 
NR 
McNee et 
al57 
Prospective 
cohort 
13 
 
7/6 10y11m0 (3y0m) 5 hemiplegia 
8 diplegia 
I = 6;  
II = 5;  
III = 2 
   HV T HV T HV T HV T 
Moreau et 
al59 
Prospective 
randomised 
cohort 
16 (9 HV 
group; 7 T 
group) 
4/5 6/1 13y11mo 
(2y7mo) 
13y 8mo 
(4y3mo) 
5 hemiplegia 
4 diplegia 
3 hemiplegia 
4 diplegia 
I = 5;  
III = 4 
I = 4;  
II = 1;  
III = 2 
Stackhouse 
et al85 
Prospective 
randomised 
cohort 
5 3/2 10y5mo (2y4mo) 5 diplegia  II-III (n NR) 
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Williams et 
al84 
Cross-
comparison 
design 
15 10/5 8y5mo (1y10mo) 15 diplegia I-II (n NR) 
a = estimated SD from range; Exp = experimental group; Con = control group; f = female; GMFCS = Gross Motor Function Classification 
System; HV = high velocity training group performed training repetitions at movement velocities up to 120 deg.s-1; m = male; NR = not 
reported; T = traditional strength training group performed all training repetitions at movement velocity of 30 deg.s-1. 
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 Types of interventions 
A detailed description of all intervention characteristics of the included studies is shown in 
Table 2-2. Five out of the six included studies implemented lower limb strengthening 
interventions,57,59,83-85 and one study implemented an upper limb strengthening program.58 
None of the included studies had a pure control group that received no intervention. The 
study by Lee et al83 had a control group that underwent neurodevelopmental treatment, 
whereas Williams et al84 utilised a within-subject control period before participants received 
the training intervention. Participants in the study by Moreau et al59 were allocated to 
different modes of training to form comparison groups.
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Table 2-2. Description of interventions from included studies. 
Study  Intervention type Training 
location 
Muscle/s 
trained 
Mode of exercise Frequency, 
duration,   
total 
sessions  
Supervision  
& adherence 
Load Progression 
M. Lee et al83 Neurodevelopmental 
treatment and 
progressive 
functional training 
NR Proximal 
and distal 
lower leg 
muscles 
Neurodevelopmental 
treatment and 
functional movement 
training (sit-to-
stands, lateral step-
ups, half knee-rise) 
3 x week, 
6 weeks, 
18 sessions 
NR 5% of 
bodyweight 
loaded sit-
to-stands 
for 5 min, 
loaded 
lateral step-
up and half-
knee rise 
for 10 min, 
unloaded 
lateral step-
up and half 
knee-rise 
for 10 min 
Load 
increased 
based on 
repeated 
estimation of 
8 repetitions 
maximum 
(amount NR) 
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J. A. Lee et 
al58 
Upper limb strength 
training 
Tertiary 
centre 
Triceps 
Brachii, 
Extensor 
Carpi 
Radialis 
Weight-bearing 
closed kinetic chain 
treadmill arm 
stepping 
3 x week, 
10 weeks, 
30 sessions 
All sessions 
supervised by 
therapist, 
adherence NR 
60 minutes 
arm 
stepping at 
0.8 km/h 
NR 
McNee et al57 Lower limb strength 
training 
3 
sessions 
/ week at 
home 
1 session 
/ week at 
tertiary 
centre 
Plantar 
flexors 
Single-leg heel-
raises or seated 
Thera Band calf 
press with knee 
extended 
4 x week, 
10 weeks, 
40 sessions 
1 session per 
week 
supervised by 
therapist, 
70% adherence 
 
3-4 sets x 
6-12 
repetitions 
maximum 
Thera Band 
used if 
could not 
complete 
heel raises 
Weight 
added on 
completion 
of 12 
repetitions or 
use of 
heavier 
Thera Band 
(amount NR) 
Moreau et 
al59 
Lower limb 
progressive 
resistance training 
Tertiary 
centre 
Knee 
extensors 
High velocity 
concentric and 
traditional strength 
training using 
Biodex isokinetic 
dynamometer 
3 x week, 
8-10 
weeks, 
24 sessions 
Supervised, 
94% adherence 
(one participant 
23/24 sessions) 
 
6 sets x 5 
repetitions, 
80% of 
maximum 
torque 
output at 30 
deg/s 
Weekly to 
match 
highest 
torque value 
achieved in 
previous 
week 
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Stackhouse 
et al85 
Lower limb strength 
training 
Home,  
1 session 
at tertiary 
centre at 
6 weeks 
Knee 
extensors
, Plantar 
flexors 
Isometric strength 
training on custom 
build exercise board 
(hips 50 degrees 
flexion, knees 60 
degrees flexion, 
ankles neutral) 
3 x week, 
12 weeks 
Parent/guardian 
supervision,  
100% 
adherence 
 
1 set x 15 
MVICs 
lasting 15s 
each 
NR 
Williams et 
al84 
Lower limb strength 
training 
Home Proximal 
and distal 
lower leg 
muscles, 
other 
muscles 
NR 
Manual resistance, 
Thera Band 
resistance, ankle 
weights,  
specific exercises 
NR 
3 x week, 
10 weeks, 
30 sessions 
1 session per 
fortnight 
supervised by 
exercise 
physiologist, 
Adherence NR 
NR, 
exercises 
completed 
in sets of 
10 
Fortnightly 
increase in 
repetitions 
and load 
(amount NR) 
NR = not reported.   
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For all six studies, the length of intervention ranged from 6 to 12 weeks, with a frequency 
of 3 to 4 training sessions per week, totalling 18 to 40 sessions. Of the five lower limb 
interventions, training load was highly variable across studies, utilising a range of exercise 
modes that included maximum isometric contractions85; combined neurodevelopmental 
treatment and loaded functional movements such as sit-to-stands, lateral step-ups, and 
half-knee rises83; heel raises or Thera Band calf press57; isokinetic knee extension on a 
dynamometer59; and a mix of manual resistance, Thera Band exercises and ankle 
weights.84 The upper limb intervention58 targeted the proximal and distal arm musculature 
implementing 60 min of weight-bearing treadmill arm stepping in each session. The study 
by Williams et al84 combined strength training with the use of intramuscular Botulinum toxin 
type A (BoNT-A) injections. Participants in this study received the strength training 
intervention either before or after receiving BoNT-A, however, the specific strength training 
exercises performed in each session were not reported.    
 
 Adherence, Supervision and Adverse Events 
Adherence rates calculated by the proportion of enrolled participants completing baseline 
assessments, all training sessions, and post-intervention measures were not reported by 
three studies.58,83,84 The adherence rate was 70% for the study by McNee et al,57 94% for 
the randomised cohort study by Moreau et al,59 and 100% for the home-based intervention 
conducted by Stackhouse et al.85 Supervision of training sessions was not reported by one 
study.83 In the remaining five studies, supervision varied from having all sessions 
supervised by a therapist,58,59 to having one session per week57 or per fortnight84 
supervised, or all sessions supervised by a parent or guardian.85 Minor adverse events of 
Achilles tendon pain in one participant, and patella pain in another were reported by 
McNee et al.57 One participant in the study by Moreau et al59 reported end range knee 
pain. In both studies, the training load or range of movement was reduced for these 
participants so they could complete the intervention. Three of the included studies did not 
report on adverse events.58,83,84 
 
 Qualitative Assessment  
The methodological quality of included studies is presented in Table 2-3. The level of 
evidence for all studies was assessed as Level IIb (low quality RCT or individual cohort 
studies).86 Downs and Black scores ranged from 14 to 19 (maximum score: 32). The 
prospective cohort study57 investigating the impact of plantar flexor (PF) strength training 
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on muscle volume had the highest quality score of 19/32 on the Downs and Black scale, 
with the Reporting sub-scale scoring 91%, and External Validity, Confounders and Power 
scoring 50% or below.57 The remaining five studies scored between 14 and 17 on the 
Downs and Black scale, all rating 50% or below on the External Validity, Confounders and 
Power sub-scales.58,59,83-85 
 
Table 2-3. Methodological quality of included studies. 
  Downs and Black Scale 
Study  LOE Reporting 
/ 11 
External 
Validity 
/ 3 
Bias 
/ 7 
Confounders 
/ 6 
Power 
/ 5 
Total 
/ 32 
M. Lee et al83 2b 5 1 6 2 0 14 
J.A. Lee et al58 2b 8 0 5 2 0 15 
McNee et al57 2b 10 1 4 3 1 19 
Moreau et al59 2b 8 1 4 3 1 17 
Stackhouse et al85 2b 8 1 5 3 0 17 
Williams et al84 2b 7 1 5 3 1 17 
LOE = Level of evidence according to a graded level of evidence system.86 
 
 Outcome Measures 
Outcome measures for muscle morphological and architectural variables in each study are 
summarised in Table 2-4. Muscle volume was measured using three-dimensional 
ultrasound (3DUS)57 and magnetic resonance imaging (MRI).84 Cross-sectional area was 
measured from two-dimensional ultrasound (2DUS)58,59,83 and MRI,85 and muscle 
thickness,59,83 fascicle length,59 and fascicle angle59,83 were all measured using 2DUS.
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Table 2-4. Effect sizes for muscle morphology and architecture outcomes by subgroup. 
Outcome Study Unit of 
measure 
Measurement 
method 
Muscle/s 
(LL or UL) 
Intervention 
subgroup  
Mean 
difference 
Effect 
Size 
95% C.I. p value 
Muscle 
volume 
McNee et al57 ml/kg 3DUS MG (LL) - 0.30 0.46 -0.32 – 1.24 0.001 
    LG (LL) - 0.20 0.44 -0.34 – 1.22 0.006 
 Williams et al84 cm3/cm MRI  Hamstrings 
(LL) 
Pre-BoNT-A 0.68 0.42 -0.33 – 1.17 < 0.001 
    Hamstrings 
(LL) 
Post-BoNT-A 0.39 0.21 -0.53 – 0.96 < 0.002 
    Quadriceps 
(LL) 
Pre-BoNT-A 0.98 0.31 -0.44 – 1.05 0.001 
    Quadriceps 
(LL) 
Post-BoNT-A 0.83 0.27 -0.48 – 1.01 < 0.001 
    Plantar flexors 
(LL) 
Pre-BoNT-A 0.85 0.51 -0.25 – 1.26 < 0.001 
    Plantar flexors 
(LL) 
Post-BoNT-A 0.77 0.37 -0.37 – 1.12 < 0.001 
    TA (LL) Pre-BoNT-A 0.18 0.55 0.20 – 1.31 < 0.001 
    TA (LL) Post-BoNT-A 0.15 0.43 -0.31 – 1.19 < 0.001 
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Cross-
sectional 
area 
M. Lee et al83 cm2 2DUS RF (LL) - 0.50 0.82  0.02 – 1.62 < 0.01 
 J. A Lee et al58  2DUS ECR (impaired 
UL) 
- 0.69 1.71  0.69 – 2.74 0.009 
    ECR (less 
impaired UL) 
- 0.49 0.78 -0.13 – 1.69 0.010 
    TRI (impaired 
UL) 
- 0.55 0.27 -0.61 – 1.15 0.024 
    TRI (less 
impaired UL) 
- 0.24 0.16 -0.71 – 1.04 0.128 
 Moreau et al59  2DUS RF (LL) HV 0.26 0.12 -0.81 – 1.04 0.029 
    RF (LL) T  0.57 0.25 -0.81 – 1.30 0.009 
 Stackhouse et 
al85 
 MRI Quadriceps 
(LL) 
- 2.35 0.11 -1.13 – 1.35 > 0.05 
    Plantar flexors 
(LL) 
- 0.47 0.38 -0.88 – 1.63 > 0.05 
Muscle 
thickness  
M. Lee et al83 cm 2DUS QF (LL) - 0.20 0.78 -0.01 – 1.58 < 0.01 
    MG (LL) - 0.00 0.00 - - 
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 Moreau et al59  2DUS VL (LL) HV 0.08 0.24 -0.69 – 1.17 > 0.05 
    VL (LL) T  0.07 0.63 -0.44 – 1.71 0.011 
Fascicle 
length  
Moreau et al59 cm  2DUS RF (LL) HV 1.23 0.34 -0.59 – 1.37 0.044 
    RF (LL) T  -0.76 -0.19 -1.24 – 0.86 0.049 
    VL (LL) HV -0.64 -0.44 -1.37 – 0.50 > 0.05 
    VL (LL) T  -0.26 -0.26 -1.31 – 0.80 > 0.05 
Fascicle 
angle 
J. A. Lee et al58  degrees 2DUS MG (LL) - 2.30 0.67 -0.12 – 1.46 < 0.05 
 Moreau et al59  2DUS RF (LL) HV -1.44 -0.46 -1.39 – 0.48 > 0.05 
    RF (LL) T 0.42 0.13 -0.92 – 1.18 > 0.05 
    VL (LL) HV 1.03 0.42 -0.64 – 1.48 > 0.05 
    VL (LL) T 1.03 0.38 -0.68 – 1.44 > 0.05 
Abbreviations not listed in thesis: ECR = Extensor carpi radialis; HV = high velocity training group performed training repetitions at 
movement velocities up to 120 deg.s-1; LL = lower limb; Pre-BoNT-A = trained prior to receiving intramuscular botulinum toxin type-A; 
Post-BoNT-A = trained following intramuscular botulinum toxin type-A injection; RF = rectus femoris; T = traditional strength training 
group performed all training repetitions at movement velocity of 30 deg.s-1; TRI = triceps brachii; UL = upper limb; VL = vastus lateralis. 
p values reported were directly extracted from each included study according to the authors’ original statistical analyses.
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Muscle strength outcome measures are described in Table 2-5. One study did not include 
any measure of muscle strength.83 Isometric strength was assessed using handheld 
dynamometry (HHD),58,84 and isokinetic dynamometry.59,84,85 Isokinetic strength and power 
were measured using isokinetic dynamometry.59,84 Maximum number of completed heel-
raises was used by one study as the muscle strength outcome.57
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Table 2-5. Effect sizes for muscle strength outcomes by subgroup. 
Outcome Study Unit of 
measure 
Measurement 
instrumentation  
Movement Intervention 
Subgroup 
Mean 
difference 
Effect 
Size 
95% C.I. p value 
Isometric 
strength 
J. A. Lee et 
al58 
N HHD Elbow 
extension 
Impaired limb 14.91 0.73  -0.18 – 1.63 0.003 
     Less impaired limb 16.18 0.90  -0.02 – 1.81 < 0.05 
    Wrist extension  Impaired limb 14.54 0.88  -0.04 – 1.80 0.009 
     Less impaired limb 10.25 0.56  -0.33 – 1.46 < 0.05 
 Moreau et al59 Nm/Kg  Isokinetic 
dynamometer 
Knee extension HV 0.22 0.40 -0.53 – 1.33 > 0.05 
     T  0.58 1.03 -0.09 – 2.14 0.007 
 Stackhouse et 
al85 
Nm/Kg Isokinetic 
dynamometer 
Knee extension  - 0.51 0.49 -0.77 – 1.75 > 0.05 
    Plantar flexion - -0.28 -0.44 -1.70 – 0.81 > 0.05 
 Williams et 
al84 
Nm/Kg Isokinetic 
Dynamometer 
Knee extension  Pre-BoNT-A  0.29 0.43 -0.32 – 1.17 0.210 
     Post-BoNT-A  0.18 0.16 -0.54 – 0.85 0.102 
    Knee flexion  Pre-BoNT-A  0.20 0.58 -0.17 – 1.34 0.233 
     Post-BoNT-A  0.17 0.40  -0.30 – 1.10 0.010 
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  Kg HHD Plantar flexion  Pre-BoNT-A  2.46 0.30  -0.44 – 1.05 0.204 
     Post-BoNT-A  5.74 0.81 0.09 – 1.54 0.004 
    Dorsiflexion  Pre-BoNT-A  2.46 0.90 0.12 – 1.68 0.010 
     Post-BoNT-A  1.78 0.68 -0.04 – 1.39 0.085 
Isokinetic 
strength  
Moreau et al59 Nm/Kg Isokinetic 
dynamometer 
Knee extension 
30 deg/s  
HV 0.72 1.15  0.16 – 2.15 < 0.05 
     T 0.86 1.20  0.06 – 2.33 < 0.05 
    Knee extension 
60 deg/s 
HV 0.63 1.00  0.02 – 1.98 < 0.05 
     T 0.68 1.56  0.36 – 2.75 < 0.05 
    Knee extension 
90 deg/s 
HV 0.60 1.04  0.56 – 2.02 < 0.05 
     T 0.65 1.51 0.33 – 2.70 < 0.05 
    Knee extension 
120 deg/s 
HV 0.71 1.47  0.43 – 2.51 < 0.05 
     T 0.58 1.01 -0.11 – 2.12 < 0.05 
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 Williams et 
al84 
Nm/Kg Isokinetic 
dynamometer 
Knee extension 
60 deg/s 
Pre-BoNT-A 0.27 0.52 -0.23 – 1.27 0.114 
     Post-BoNT-A 0.21 0.28 -0.41 – 0.98 0.033 
   Isokinetic 
dynamometer 
Knee Flexion  
60 deg/s 
Pre-BoNT-A 0.18 0.68 -0.08 – 1.44 0.053 
     Post-BoNT-A 0.04 0.13 -0.56 – 0.82 0.076 
Muscle 
Power   
Moreau et al59 Watts/kg Isokinetic 
dynamometer 
Knee extension  HV 1.34 0.46  -0.48 – 1.40 0.023 
     T 0.56 0.19  -0.86 – 1.24 > 0.05 
 Williams et 
al84 
Watts Isokinetic 
dynamometer 
Knee extension 
60 deg/s 
Pre-BoNT-A  3.44 0.61 -0.15 – 1.36 0.164 
     Post-BoNT-A 4.49 0.41 -0.34 – 1.16 0.033 
   Isokinetic 
dynamometer 
Knee flexion  
60 deg/s 
Pre-BoNT-A  4.19 1.06 0.27 – 1.85 0.004 
     Post-BoNT-A  2.59 0.38 -0.37 – 1.3 0.002 
Heel 
raises 
McNee et al57 Count  - Plantar flexion - 9.00 0.80  0.0 – 1.59 < 0.001 
HHD = hand held dynamometer; HV = high velocity training group performed training repetitions at movement velocities up to 120 deg.s-
1; Pre-BoNT-A = trained prior to receiving intramuscular botulinum toxin type-A; Post-BoNT-A = trained following intramuscular botulinum 
toxin type-A injection; T = traditional strength training group performed all training repetitions at movement velocity of 30 deg.s-1. p values 
reported were directly extracted from each included study according to the authors’ original statistical analyses. 
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 Quantitative Assessment  
Effects sizes for muscle morphology and architecture are summarised in Table 2-4. A 
meta-analysis was not possible due to the heterogeneity of interventions, varied outcome 
measures, different muscles assessed, and dissimilar measurement methods used across 
all six studies.  
 
The large effect sizes for muscle morphology and architecture were on rectus femoris CSA 
(ES = 0.82) following functional progressive strength training,83 and extensor carpi radialis 
CSA in the impaired limb (ES = 1.71) after upper limb strengthening.58 There was a 
greater effect on the more impaired than the less impaired upper limb CSA.58 The 
associated 95% confidence intervals for each of these outcomes were also large (Table 2-
4).  
 
Two studies reported on muscle volume, following isolated PF strength training,57 and 
combined lower limb strengthening exercises with BoTN-A,84 and showed small to 
moderate effects across distal (ES = 0.37 – 0.51) and proximal leg muscles (ES = 0.21 – 
0.42). A moderate effect was found on quadriceps femoris (ES = 0.78)83 and vastus 
lateralis muscle thickness (ES = 0.63).59 
 
Fascicle length was measured in one study59 for two comparison groups (traditional 
isokinetic strength training v high velocity isokinetic strength training). High velocity 
isokinetic strength training had a small to moderate positive effect on rectus femoris 
fascicle length (ES = 0.34), indicating an increase in fascicle length. There was a small 
negative effect on rectus femoris fascicle length following traditional isokinetic strength 
training (ES = -0.19).59 Of the two studies that measured fascicle angle,59,83 a moderate 
positive effect was found for medial gastrocnemius following lower limb strength training 
(ES = 0.67), indicating an increase in fascicle angle following training.83 
 
Effects sizes for muscle strength outcomes are summarised in Table 2-5. Meta-analysis of 
strength data was not performed due to the heterogeneity of interventions, diverse 
measurement instrumentation, and different muscles assessed.  
 
Large effects were on upper limb58 and lower limb isometric strength,59,84 lower limb 
isokinetic strength following traditional and high velocity isokinetic strength training,59 
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muscle power following lower limb strength training,84 and on the number of heel raises 
performed after isolated PF strengthening.57 
 
2.4 Discussion  
The purpose of this systematic review was to determine the impact of strength training on 
skeletal muscle morphology and architecture in individuals aged 4 – 20 years with spastic 
type CP. Six studies were included in the review and demonstrated preliminary evidence 
for a positive effect on muscle morphology and architecture following strength training. 
One prospective cohort study investigated upper limb strengthening on muscle CSA,58 and 
the remaining five studies evaluated the impact of lower limb strength training programs on 
muscle size and architecture.57,59,83-85 Overall, low study methodological quality along with 
heterogeneous training program design, dissimilar outcome measures, and lack of 
adequate control groups, indicated that care is needed when interpreting the results of 
these studies in isolation. 
 
 Muscle morphology and architecture outcomes 
Upper and lower limb strength training programs effectively increased muscle size in five 
of the six included studies, however, the size of effect varied between muscles and 
interventions.57-59,83-85 
 
Rectus femoris CSA increased (ES = 0.82) following lower limb functional PRT in the study 
conducted by M. Lee et al83 comprised of loaded sit-to-stands, loaded step-ups, and half-
knee rises. The number of training sets, repetitions and intensity of each session were not 
reported.  It was somewhat unexpected that a significant increase in CSA was found 
following the six week intervention by M. Lee et al83 considering the adaptation to PRT in 
TD individuals is thought to occur primarily via neurological factors during the initial phase 
of a training program, followed by muscle hypertrophy as the predominant long-term 
adaptation.90 The mechanisms for muscle morphology adaptation following strength 
training in individuals with CP remains unclear, indicating the importance of morphological 
and architectural measures post-intervention.  
 
It is perhaps unsurprising that Stackhouse et al85 found no effect on quadriceps or PF CSA 
considering their intervention comprised only one set of 15 maximum voluntary isometric 
contractions per training session, in a small sample of five individuals. This may have been 
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a sufficient starting point for strength training in these participants, however, progressive 
overload and a greater training volume may be required to achieve increases in muscle 
size.54 
 
In the only study that trained the upper limb, J.A. Lee et al58 used a repetitive hand 
treadmill stepping program, and the largest effect was found on extensor carpi radialis 
muscle CSA in the more impaired upper limb (ES = 1.71). The large effect shown on upper 
limb muscle size is consistent with the greater increases found in upper limb muscle 
thickness compared to the lower limb, after upper and lower limb strength training in TD 
individuals.91,92 Variations in muscle morphology and architecture between muscles; 
muscle fibre type composition; specificity of the movement during training; individual 
genetic differences; and training background may all play a role in the differential upper 
and lower limb hypertrophic adaptations to strength training. There was a greater effect on 
the more impaired upper limb than the less impaired upper limb, potentially indicating a 
greater starting deficit and larger capacity for improvement in the more impaired limb.8 
This study has demonstrated that there are other potential muscle strengthening 
interventions that differ from traditional strength training methods, to increase muscle size 
in individuals with CP.    
 
The two studies that measured muscle volume showed objective evidence that muscle in 
individuals with CP can grow in response to a strength training stimulus.57,84 The 
prospective follow-up study by McNee et al57 showed that PF muscle training for 10 weeks 
in children with CP resulted in moderate medial (ES 0.46) and lateral gastrocnemius (ES 
0.44) muscle volume increases of 23.1 and 23.6% respectively. This finding provides the 
first published evidence of muscle growth following resistance training in individuals with 
CP. The lack of a control group, however, makes it difficult to ascertain how much muscle 
volume change was due to natural growth as opposed to the training intervention. It is 
plausible given the wide age range of the sample (6 to 16 years), that general muscle 
growth may have accounted for some of the increase seen in muscle volume, considering 
the muscle growth reported over 10 weeks (23-24%) was larger than the muscle volume 
change reported for TD individuals following strength training of between 8 – 12%.74,93 
 
The larger than typical muscle growth following strength training reported by McNee et al57 
may also be explained by a greater initial deficit in muscle volume, resulting in a larger 
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absolute improvement (muscle growth) than in TD individuals. Muscle in individuals with 
CP may also respond differently to strength training compared to TD muscle, resulting in 
different hypertrophic adaptation. At a microscopic level, muscle in individuals with CP has 
altered protein transcription processes,41 as well as a different extracellular matrix 
composition compared to TD muscle.26 As the mechanisms for hypertrophy following 
strength training in individuals with CP remain unknown, these genetic alterations may 
give rise to different pathways for muscle growth compared to TD individuals.  
 
The muscle volume findings of Williams et al84 are in line with those presented by McNee 
et al.57 Small effects were found on proximal leg musculature (ES 0.21 – 0.42), and 
moderate effects on the plantar and dorsiflexor (DF) muscles (0.37 – 0.55) following a 
home-based 10 week strength training program. There was also a greater effect on 
muscle volume seen in the Pre-BoNT-A group (who commenced the training program 
three months after intramuscular BoNT-A injection) compared to the Post-BoNT-A group 
(who trained with the BoNT-A active in their system) immediately post-training, suggesting 
that muscle morphology adaptation may have been confounded by the timing of the 
adjunct BoNT-A therapy. Intramuscular BoNT-A injections cause chemo-denervation of 
skeletal muscle which may have compromised the hypertrophic response of contractile 
tissue in the Post-BoNT-A group.  
 
Caution is needed when considering the effectiveness of strength training on muscle 
fascicle length, primarily because there is only one study available that measured this 
outcome.59 Secondly, baseline fascicle lengths varied between the training groups by a 
larger amount than the change in fascicle length reported following the intervention. The 
small sample randomised trial conducted by Moreau et al59 investigated the impact of high 
velocity training versus traditional lower limb strength training in individuals with CP. 
Rectus femoris fascicle length increased following training in the high velocity group by 
1.23cm (ES 0.34) and decreased post-training in the traditional training group by 0.76cm 
(ES -0.19), providing weak evidence of differential muscle adaptations to training stimulus 
in individuals with CP. The fascicle angle may also change following training depending on 
the type of training performed.59,83 In agreement with the findings by Moreau et al,59 high 
velocity concentric training in TD individuals for 13 weeks resulted in a fascicle length 
increase of 10% in vastus lateralis.94 Other studies in TD individuals have employed either 
concentric or eccentric training modalities and found different muscle fascicle 
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adaptations.74,95 Concentric training at slower velocities may lead to greater increases in 
fascicle angle with little change in fascicle length, whereas eccentric training may result in 
greater increases in fascicle length and smaller increases in fascicle angle.74,95,96 A 
combination of factors such as the range of motion, movement velocity, and contraction 
mode may all play a role in determining how muscle fascicles adapt following training. 
 
The decline in force generating capacity of the muscle has been directly attributed to a 
reduced muscle volume in individuals with CP, highlighting the importance of muscle size 
to muscle function in this population.28 Increases in muscle size following strength training 
may also influence the mechanical properties of the musculotendinous unit. Specific 
strength training modes lead to muscle growth patterns via preferential increases in 
muscle fascicle pennation angle (concentric load) versus muscle fascicle length (eccentric 
load) in TD adults,74 which may have implications for increasing joint range of motion 
and/or reducing contracture in individuals with CP.97,98 
 
 Strength outcomes  
Strength outcomes from the included studies in our review were reported as a secondary 
objective alongside the morphological and architectural outcomes to contextualise any 
muscle adaptation with changes in capacity. Strength outcomes reported in Table 5, 
therefore, do not reflect all of the available literature directly related to these outcomes.  
 
The study by M. Lee et al83 did not include any measure of strength post-intervention 
making it difficult to infer any mechanism of muscle adaptation to muscle function. In line 
with their finding of no change in quadriceps and PF muscle CSA post-intervention, 
Stackhouse et al85 also found no significant increase in knee extension or PF isometric 
strength.  
 
The remaining studies assessed strength using isometric,58,59,84 isokinetic,59,84 or functional 
capacity measures,57 alongside the muscle morphology and architecture outcomes. Of the 
studies that reported increases in muscle size, strength outcomes are in agreement with 
the overall large effect of strengthening interventions found by Park and Kim,81 for 
individuals with CP. The response to strength training in TD adolescents is similar to those 
reported here, with strength gains of 30–40% typically observed in untrained youth 
following participation in an introductory resistance training program.54 
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 Confounding variables and conflicts between papers  
Across the six included studies, there was inadequate description of critical training 
program characteristics such as frequency, volume, load, intensity and individual 
progression making it difficult to compare dosage between studies. Dissimilar study 
design, including upper and lower limb training programs, as well as adjunct therapies 
such as BoNT-A, make it difficult to compare results across the limited studies that do 
exist. There are no robust RCTs on the impact of PRT on muscle morphology and 
architecture in individuals with CP. There were differences between studies in the choice 
of measurement method which could also impact on the results. Imaging modalities 
including MRI, 2DUS, and 3DUS were used by different studies to assess muscle size and 
architecture, with a lack of reporting of reliability and minimal clinically important difference 
in the outcome measures used. Data extraction revealed a heterogeneous population 
within and between studies. The participant pool was made up of varying CP types and 
functional abilities. Some studies included both unilaterally and bilaterally involved 
participants, as well GMFCS levels I – III. This heterogeneous participant pool may lead to 
variability in response to resistance training due to the different levels of functional ability, 
range of motion, coordination and exercises that were able to be completed.   
  
 Potential limitations 
There are a number of considerations that should be taken into account when interpreting 
the results of this systematic review. Firstly, only papers written in English were included. 
There are no robust RCTs in existence meaning the methodological quality of included 
studies is not of the highest standard with inadequate control groups. Upper and lower 
limb interventions were included, which may contribute to the variability in results. Different 
muscle groups may have greater potential for adaptation following strength training, or 
undergo growth at different rates depending on age or gender. Caution should also be 
used when interpreting effect sizes from small samples as outliers in scores can skew the 
effect. 
 
 Consideration for future research 
Factors such as age, gender, impairment level and genetics play a role in overall muscle 
strength and function. Robust, randomised controlled trials are needed to assess the dose 
and intensity of intervention required to cause change in muscle morphology in individuals 
with CP following strength training and to assess whether any adaptation can be 
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maintained over time. Natural growth should be accounted for when measuring muscle 
size changes in developing children and adolescents. Strength training studies in skeletally 
mature individuals with CP are likely to eliminate natural growth as a confounding variable 
and assist in understanding the hypertrophic processes following strength training in this 
population.  
 
Recent imaging and methodological advancements allow us to measure several muscular 
and neural factors that underpin muscle force and/or joint torque production that are 
responsive to strength training. Future strength training interventions should therefore 
measure neuromuscular properties post-training, including but not limited to: Muscle size; 
muscle fascicle length and angle; excitatory drive to the agonist muscle; and activation of 
antagonists (i.e. co-activation). These outcomes should accompany any measures of 
functional capacity, strength, and/or passive mechanical outcomes (e.g. muscle fascicle 
stiffness). Future studies incorporating measures of neuromuscular, functional, and 
mechanical outcomes will then be able to determine the mechanisms underpinning the 
response to strength training in individuals with CP and uncover any relationships between 
structural adaptation and muscle function. 
 
 Conclusion 
This systematic review provides only preliminary evidence that skeletal muscle 
morphology and architecture adapts following strength training in children and adolescents 
with CP. A lack of robust RCTs, inadequate intervention description, and variability of 
study designs contribute to the inconsistencies in the limited studies that do exist. A 
greater understanding of the distinct morphological and architectural adaptations following 
strength training in individuals with CP could lead to more effective training programs in 
the fields of rehabilitation and exercise prescription for this population. 
 
 Update of literature since publication  
The literature search for the systematic review was undertaken in November 2015. An 
updated search of the literature was conducted for published data between 2015 and 
2018. No new studies were identified that met the inclusion criteria. Specifically, no new 
studies have reported muscle morphology or architecture outcomes following muscle 
strengthening interventions in individuals with CP. 
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Functional anaerobic and strength training (FAST) in 
individuals with cerebral palsy: Study protocol 
 
Chapter two established limited evidence for muscle morphology and architecture 
adaptation following strength training in children and adolescents with CP, from a small 
number of studies. There have been no previous robustly designed exercise trials in young 
adults with CP using training parameters that meet established guidelines, that have 
measured muscle morphology and architecture outcomes. There is a need for well-
designed exercise interventions in young adults with CP, to assess how muscle properties 
and functional capacity adapts. Details of the functional anaerobic and resistance training 
parameters and progressions according to established guidelines are set out below, as 
well as establishing a-priori outcome measures and the data analysis plan for 
implementation of the intervention. This chapter presents the study protocol for the FAST 
intervention. 
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Abstract  
Introduction: Individuals with cerebral palsy have muscles that are smaller, weaker and 
more resistant to stretch compared to typically developing people. Progressive resistance 
training leads to increases in muscle size and strength. In cerebral palsy, the benefits of 
resistance training alone may not transfer to improve other activities such as walking; 
however, the transfer of strength improvements to improved mobility may be enhanced by 
performing training that involves specific functional tasks or motor skills. This study aims to 
determine the efficacy of combined functional anaerobic and strength training in: 1) 
influencing muscle strength, structure and function, and 2) to determine if any changes in 
muscle strength and structure following training impact on walking ability and gross motor 
functional capacity and performance in the short (following 3 months of training) and 
medium terms (a further 3 months post-training). Methods and analysis: 40 adolescents 
and young adults with cerebral palsy will be recruited to undertake a 12-week training 
program. The training program will consist of 3 x 75 minute sessions per week, made up of 
5 lower limb resistance exercises and 2-3 functional anaerobic exercises per session. The 
calf muscles will be specifically targeted, as they are the most commonly impacted 
muscles in CP and are a key muscle group involved in walking. If, as we believe, muscle 
properties change following combined strength and functional training, there may be long 
term benefits of this type of training in slowing the deterioration of muscle function in 
people with spastic type cerebral palsy. Ethics and dissemination: Ethical approval has 
been obtained from the ethics committees at The University of Queensland (2014000066) 
and Children’s Health Queensland (HREC/15/QRCH/30). Findings will be disseminated by 
publications in peer-reviewed journals, conferences, and local research organisations’ 
media. Trial Registration: Trial registered with the Australian and New Zealand Clinical 
Trials Registry (ACTRN12614001217695)
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3.1 Introduction 
 Cerebral Palsy 
Cerebral palsy is the largest single cause of childhood physical disability with an economic 
burden in Australia of $1.47 billion per year.2 Cerebral palsy is an umbrella term for a 
group of motor impairment disorders caused by a non-progressive lesion in the developing 
child’s brain during pregnancy or shortly after birth.1 Spasticity, a velocity dependent 
increase in muscle tone,99 is the primary sign of spastic type CP that interferes with normal 
muscle growth100 resulting in the development of fixed contractures of the muscle-tendon 
unit which compromise strength and function4 and may result in skeletal deformity5 
requiring surgery. While the brain lesion responsible for CP is static, it results in secondary 
musculoskeletal problems such as reduced joint range of motion, increased joint stiffness, 
and muscle weakness.6,7 These secondary alterations progress with age9 and contribute to 
a gradual loss of functional capacity,10 characterised by deterioration in gait11,12 and 
reduced muscular strength13 throughout adolescence and young adulthood in individuals 
with CP. Treatments aim to reduce the progressive secondary musculoskeletal problems 
in the lower limb and maintain independent mobility and walking into adolescence and 
adulthood.  
 
 Cerebral palsy lower limb neuromuscular adaptations and relationship to 
function 
Architectural adaptations of the lower limb muscles in individuals with CP compared to TD 
individuals include: i) reduced muscle volume,17-19 ii) increased muscle fascicle stiffness,21 
iii) reduced22-24 or similar18,25 muscle fascicle lengths, iv) increased intramuscular fat,27 and 
v) increased Achilles tendon length.28 Alterations to muscle architecture in individuals with 
CP begin to occur within the first five years of life17,29,30 which may progress into 
adulthood.28 Muscle architecture is the primary determinant of muscle function31 and the 
specific musculotendinous adaptations in individuals with CP may contribute to a loss of 
muscle strength7,8,32 and functional ability.33 The decline in force generating capacity of the 
muscle has been directly attributed to a reduced muscle volume.28 Increased muscle 
fascicle stiffness21 may also result in the inability of the muscle fascicles to reach lengths 
favourable for high force production.31 Furthermore, weaker calf muscles with stiffer 
muscle fascicles interacting with a longer Achilles tendon in series, as observed in 
individuals with CP,8,21,28 may result in altered muscle function during walking.34 A higher 
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intramuscular fat content translates to a reduced proportion of contractile tissue within the 
muscle.27 This reduced muscle quality may therefore be a contributing factor to muscle 
weakness and have implications for functional performance in individuals with spastic CP. 
The alterations to the musculotendinous unit may also contribute to the reduced power 
generation during gait35 and diminished anaerobic performance36 in individuals with CP. 
Moderate to high correlations have also been reported between strength and walking 
speed (r=0.61)37 and between strength and activity limitations (r=0.70 – 0.83)4 suggesting 
muscle weakness plays a role in the mobility difficulties associated with spastic CP.  
 
Neural factors underlying reduced muscle force and the resultant joint torque in individuals 
with CP include reduced excitatory drive to the agonist muscle and increased co-activation 
of antagonists.101-103 The production of muscle force requires sufficient activation of 
available motor units. It has been hypothesised that reduced excitatory drive to the 
motoneuron pool due to damaged motor pathways results in an inability to fully activate all 
available motor units in individuals with CP.104 The reduction in maximum activation 
capacity has been shown to account for over 50% of variation in maximum isometric PF 
strength between paretic and non-paretic limbs in individuals with CP suggesting that 
reduced neural drive is a major contributor to muscle weakness.102 Co-activation or co-
contraction is muscle activity that occurs simultaneously in agonists and antagonists 
around a joint and is usually quantified using electromyography. Co-activation is important 
because the net muscle moment at a joint is a product of all muscle forces acting around 
the joint, both agonist and antagonist. The amount of co-activation of antagonistic muscle 
groups during different activities has been reported to increase with CP.102,103 An 
increased co-activation with CP may result in less force being produced to perform the 
task, and increase energy expenditure during movement.105 The neural and muscle 
parameters that influence muscle force generation have collectively been termed 
neuromuscular properties.28,106,107  
 
 Impact of progressive resistance training on muscle structure and function 
Muscular strength and power, maximum voluntary activation level, muscle volume, muscle 
fascicle architecture and the force-length properties of muscle are all responsive to PRT 
and have therefore been targeted in exercise-based interventions in TD individuals.72-77 
Neuromuscular adaptations following PRT have been described in healthy adults that 
provide a link between changes in muscle architecture and functional outcomes such as 
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increases in strength and power.74,76,77 A whole body resistance training study in older 
adults found a 20% increase in isometric maximum voluntary PF torque was accompanied 
by triceps surae muscle volume and activation level increases of 12% and 9% 
respectively.93 Following a concentric resistance training program in healthy young adults, 
Franchi et al74 demonstrated Vastus Lateralis fascicle lengths increased by 5%, along with 
an 8% increase in muscle volume. Longer fascicle lengths and increased voluntary 
activation following resistance training can alter the fascicle length-force relation of the 
muscle.76 This may result in a greater fascicle force being produced at the corresponding 
pre-training muscle fascicle length that would be beneficial for individuals performing tasks 
such as walking and running near their maximum capacities as may be the case for 
individuals with CP. Specifically, the muscle may operate at more optimum fibre lengths 
and velocities for force production resulting in more efficient function during challenging 
tasks such as walking up and downhill.. Emerging evidence that muscle architecture 
adapts specifically to the type of training performed (i.e. concentric v eccentric)74 may 
provide an opportunity to target the specific neuromuscular deficiencies present in spastic 
CP through well designed resistance training programs. Considering the positive muscle 
adaptations following PRT in TD individuals, this form of exercise is a low cost and low risk 
treatment option to individuals with CP that may enhance muscle structure and function. 
 
 Progressive resistance training and translation to function in Cerebral Palsy 
Despite the correlations between strength and mobility in individuals with CP,4,37 evidence 
is scarce regarding the translation of strength improvements to gross functional and 
mobility-related measures such as walking performance.43-45 Resistance training 
interventions in individuals with CP have traditionally focused on enhancing muscle 
strength; hypothesising functional performance would improve as a consequence. There is 
consensus in the literature that PRT is effective in improving muscle strength in children 
with CP without negatively impacting on the level of spasticity.43,46-49 Several RCTs of 
resistance training in individuals with CP have demonstrated increases in muscular 
strength but without a concurrent increase in functional performance43,50-52 leading to 
questions regarding the overall effectiveness of this intervention.53 Without examining the 
underlying neuromuscular properties that PRT can impact on in individuals with CP, these 
studies can only hypothesise as to the mechanisms underlying this incongruity. There is 
also conjecture in the literature regarding the retention of strength improvements following 
a period of detraining post-intervention.43,44,56,108 Potential explanations for the 
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inconsistency in findings include failing to account for the confounding effects of growth, 
natural history, and uncontrolled activity levels during follow-up periods. The retention of 
effect post-intervention in individuals with CP is an important consideration for exercise 
prescription in order to periodise and plan the timing of future therapies.  
 
The National Strength and Conditioning Association (NSCA) provides guidelines on the 
prescription of resistance training in youth.54 The RCT’s conducted by Dodd et al,48 Liao et 
al,51 Lee et al,56 and Scholtes et al44 do not meet the NSCA guidelines outlining the type of 
exercises performed (single and multi-joint) and program duration (8-20 weeks).53 
Similarly, a RCT carried out by Maeland et al52 only performed one exercise (seated leg 
press) in middle-aged adults with CP and found no effect on mobility. Studies by Liao et 
al,51 Lee et al56 and Scholtes et al44 also included participants under the age of 7 years 
which is not in line with the NSCA’s guidelines.54 The mismatch between training program 
design in these studies and the NSCA guidelines provides a potential explanation for the 
ineffectiveness of these studies at influencing functional outcomes in youth with CP.53 A 
more recent RCT conducted by Taylor et al43 in young adults with CP more closely 
matched the NSCA training guidelines (participants aged 18 years, trained twice weekly 
for 12 weeks, 3 sets of 10-12 repetitions per exercise) but participants performed different 
exercises depending on individually identified deficiencies from gait analysis, and no 
measures of neuromuscular properties were performed making it difficult to ascertain 
whether any muscle or neural parameters were altered by the intervention. Nonetheless, 
Taylor et al43 increased the strength of the targeted muscles by 27% compared to the 
control group, but showed no transfer to improvements in measures of mobility.  
 
The lack of translation of strength improvements to functional performance may be related 
to the specificity of training (the training intervention being implemented in a context not 
related to the functional performance being assessed), the confounding effects of multiple 
impairments on function (muscle weakness, stiffness, and coordination may all influence 
function), and unsuitable intervention quality (intensity, duration, frequency, and/or type of 
PRT).53,63,109,110 Individuals with CP may also use compensatory movement strategies that 
prevent the targeted muscle being trained effectively when using multi-joint exercises.53 
 
Anaerobic muscle power refers to the ability of the neuromuscular system to perform 
maximum work within a short time period65 and is reduced in children with CP compared to 
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their TD counterparts.36 Anaerobic training in youth and adolescents with CP has led to 
improvements in muscle strength, anaerobic capacity, and agility.66 Given the difficulty in 
improving functional outcomes following traditional strength training interventions, the 
addition of anaerobic training may lead to increased mobility and agility that is important 
for activities in daily living such as climbing stairs and walking over different terrain.  
 
 Impact of progressive resistance training on muscle properties in cerebral 
palsy 
Extensive attention has been paid to evaluating the effects of resistance training using 
functional, performance, and gross motor outcome measures, without examining the 
muscle itself. The relationship of muscle architecture to muscle function suggests that the 
evaluation of key muscle parameters such as volume, activation level and fascicle 
behaviour should occur following PRT as a means of examining whether the 
neuromuscular properties have been altered. RCTs provide the highest level of scientific 
evidence and no such studies exist regarding the effect of PRT on skeletal muscle 
structure in individuals with CP. Recent prospective investigations have shown that muscle 
volume57 and cross-sectional area58 are increased following resistance training in this 
population, and that muscle architecture may change depending on the type of training 
performed.59 The lack of a control group and presence of confounding variables in these 
studies such as growth, age, and degree of skeletal maturity make the results less robust. 
The impact of PRT on in vivo muscle and tendon function during gait has not been 
investigated. It is possible that PRT may alter the neuromuscular properties of muscle in 
individuals with CP resulting in beneficial effects that may slow the progression of 
musculoskeletal decline in this population. Such neuromuscular alterations that may occur 
in vivo cannot be measured from gross functional outcome measures.  
 
 Purpose  
This current study compares an exercise training model that will combine FAST to a 
control group in a wait-list randomised controlled trial of adolescents and young adults with 
spastic type CP. The FAST program will comprise three 75 minute sessions per week for 
12-weeks delivered in a group circuit training format (total intervention dose = 45 hours). 
We intend to determine if FAST is effective in providing a superior and lasting benefit on 
skeletal muscle properties and functional performance compared to standard care alone. 
As there is conjecture in the literature regarding the benefits of strength training as a 
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physical therapy in individuals with CP, it is important to determine if a more intensive 
program such as the combined FAST model presented here can provide beneficial 
alterations to skeletal muscle resulting in translation to improved gross motor function 
compared to standard care. If the FAST program is effective in altering skeletal muscle 
properties and improving muscle function then this training intervention may yet be an 
effective treatment option for individuals with spastic type CP.    
 
3.2 Methods and analyses 
 Study Design 
A randomised controlled trial will test the efficacy of a 12-week, 3 sessions per week, 
combined progressive resistance and functional anaerobic training program on lower limb 
neuromuscular properties and functional mobility compared to a control group (performing 
daily activity and receiving usual care) in adolescents and young adults with spastic 
hemiplegia or diplegia type CP. The broad aims of this study are to:  
1. Determine whether a 12-week FAST program leads to changes in Medial 
Gastrocnemius (MG), Lateral Gastrocnemius (LG), Soleus (SOL) and Tibialis 
Anterior (TA) neuromuscular properties, muscle fascicle function and functional 
mobility in young adults with spastic type CP compared to young adults with spastic 
type CP not receiving FAST (performing daily activity and receiving usual care). 
2. Examine the retention of any changes in MG, LG, SOL, and TA neuromuscular 
properties, muscle fascicle function and functional mobility due to FAST in young 
adults with spastic type CP 12-weeks following cessation of the FAST program. 
 
The primary hypotheses to be tested are:  
Neuromuscular properties 
H1A Adolescents and young adults with spastic type CP receiving FAST will have a 
significantly increased MG, LG, SOL, and TA muscle volume following a 12-week training 
program compared to adolescents and young adults with spastic type CP performing daily 
activity and receiving usual care.      
 
H1B Adolescents and young adults with spastic type CP receiving FAST will have a 
significantly decreased ankle and muscle fascicle stiffness following a 12-week training 
program compared to adolescents young adults with spastic type CP performing daily 
activity and receiving usual care. 
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The secondary hypotheses to be tested are:  
Muscle fascicle function and gait  
H2A Adolescents and young adults with spastic type CP receiving FAST will have 
significantly less MG muscle fascicle lengthening during stance while walking following a 
12-week training program compared to adolescents and young adults with spastic type CP 
performing daily activity and receiving usual care. 
 
H2B Adolescents and young adults with spastic type CP receiving FAST will have 
significantly increased ankle DF angle at foot contact and during stance while walking 
compared to adolescents and young adults with spastic type CP performing daily activity 
and receiving usual care. 
 
Intramuscular fat content 
H3 Adolescents and young adults with spastic type CP receiving FAST will have 
significantly less MG, LG, SOL, and TA intramuscular fat content following a 12-week 
training program compared to adolescents and young adults with spastic type CP 
performing daily activity and receiving usual care. 
 
Performance  
H4 Adolescents and young adults with spastic type CP receiving FAST will have 
significantly increased muscular strength, power output, agility and walking ability following 
a 12-week training program compared to adolescents and young adults with spastic type 
CP performing daily activity and receiving usual care.   
 
Retention of effect  
H5 Adolescents and young adults with spastic type CP who received FAST will have 
significantly less MG, LG, SOL, and TA muscle volume; greater ankle and muscle fascicle 
stiffness; increased muscle fascicle lengthening and decreased ankle DF angle at foot 
contact and during stance while walking; reduced muscular strength, power output, and 
mobility; and increased MG, LG, SOL, and TA intramuscular fat 12-weeks after the 
intervention compared to immediately post-intervention.  
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 Study sample and recruitment 
Forty individuals aged 15-30 years with spastic type CP will be recruited across South 
East Queensland, Australia. Potential study participants will be identified through 
expression of interest advertising and word of mouth at the following associations: 
Cerebral Palsy League Queensland; Sporting Wheelies and Disabilities; Brisbane 
Paralympic Football Program; and Australian Athletes with Disabilities. We will use the 
Queensland Cerebral Palsy Register (QCPR) as a recruitment frame via a targeted mail 
out with a project information pack that will be conducted by the QCPR staff to potential 
participants who have agreed to be contacted for research projects. Advertisements will 
also be placed in local newspapers and social media (e.g. Facebook information site) as 
well as other online news media. Friends and colleagues of the young adults with spastic 
type CP may also be approached to volunteer for the study. 
 
 Inclusion criteria 
The study will include male and female young adults:  
a) Who are aged between 15 and 30 years; 
b) Who have a confirmed diagnosis of spastic hemiplegia or diplegia type CP; 
c) Who are able to walk independently; 
d) Who are Gross Motor Function Classification System (GMFCS)111 level I or II; 
e) Who have maximum passive ankle DF range of motion of <5° (knee fully extended). 
 
 Exclusion criteria 
The study will exclude participants: 
a) Who have had previous lower limb surgery in the last 2 years and/or Botulinum 
toxin-A injections to the lower extremities within the last 6 months; 
b) Who cannot provide sufficient cooperation and cognitive understanding to 
participate in the intervention exercises; 
c) Who have undertaken lower limb resistance training within the last 6 months. 
 
 Sample size 
Sample size for the overall FAST RCT is based on the study’s primary hypothesis 
comparison between the effect of FAST compared with usual care immediately post-
intervention (12-weeks) on muscle volume assessed using MRI. No RCTs have measured 
lower limb muscle volume as an outcome measure following resistance training in young 
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adults with CP. The sample size for the FAST RCT is calculated from pre-post cohort data 
for MG muscle volume change after lower limb strength training in 13 ambulant children 
with CP.52 An effect size of 0.88 was calculated using the mean difference in MG muscle 
volume post-intervention of 14 mL with an estimated SD of the difference between means 
of 16 mL. An 8-week pilot study of the FAST program in TD individuals revealed a mean 
gastrocnemius muscle volume difference of 11.5 mL post-training with a SD of the 
difference between means of 14 mL; an effect size of 0.82. The data from McNee et al57 
are from a younger sample than those included in this study and participants may not have 
been skeletally mature, resulting in an underestimation of muscle hypertrophy. An 
estimated effect size of 0.85 was used in a one-tailed a-priori power analysis requiring 16 
experimental and 16 control subjects to enable the null hypothesis to be rejected with a 
power of 0.80 and an alpha level set at 0.05. To allow for an estimated 10% attrition rate 
during the intervention, 20 participants will be needed in each group (40 total).   
 
 Randomisation  
Participants who are eligible to participate in the study will receive a baseline assessment, 
and then be randomised to either the FAST (intervention group) or control group 
(performing daily activity and receiving usual care) using a concealed matched-pairs 
randomisation method. Participants will be matched in pairs according to age and sex, to 
minimise group differences at baseline, and a computer generated sequence of random 
numbers will be used to allocate a number “1” or “2” to each member of the pair. 
Treatment allocation will be recorded on a folded piece of paper, placed into sealed, 
opaque envelopes, held by non-study personnel. Allocations will read either: “1: Control, 2: 
Intervention”, or “1: Intervention, 2: Control”. As each pair is randomised, they will be 
allocated the next consecutive envelope opened by non-study personnel until all 
participants have been allocated into the intervention or control group. After the 
randomisation process is complete, study personnel will be informed of group allocation. 
 
 Study procedure 
Participants will attend the neuromechanics and biomechanics laboratories at The 
University of Queensland, Australia, for baseline and follow-up assessments. The 
intervention will take place in a fully equipped tertiary institution gymnasium in Brisbane, 
Australia. Participants allocated to the intervention group will undertake 12-weeks of FAST 
and will commence training within two weeks of the baseline assessments. Participants in 
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the control group will receive no training and will be allowed to continue with usual daily 
activities. Participants in the control group will be offered a 12 week FAST training program 
following completion of the 3 month follow-up assessments. The experimental design and 
outcome measures are reported in Figure 3-1. according to Consort guidelines.112 
 
 
Eligible participants: Young adults 15 to 30 years with 
spastic hemiplegia or diplegia type cerebral palsy, no lower 
limb surgery 2 years prior to baseline period, no Botulinum 
toxin-A injections to lower limb 6 months prior to baseline 
period.  
Screening and classification 
measures:  
GMFCS 
Medical history 
questionnaire 
Screening measures: 
Screening for eligibility criteria 
Not eligible, not 
interested. No 
further contact 
Baseline measures (T1) 0 
weeks: 
Muscle Volume 
Active and passive muscle 
properties 
Maximum isometric strength  
Maximum voluntary activation  
3D Gait Kinematics and 
Kinetics 
Functional strength  
Walking distance (6 min) 
Anaerobic power  
Agility  
Functional mobility 
Baseline (T1) assessments 
(n=40): Matched for age and sex   
Randomisation  
FAST group: 
Combined heavy 
progressive resistance 
exercise and functional 
anaerobic training.   
75 min x 3 days per week x 
12 weeks. 45hrs total 
training time. 
Measures during 
intervention: 
RPE 
Fatigue and injury 
  
Primary Endpoint (T2) 
13 weeks. 
Post intervention outcomes 
(T2 and T3): 
Muscle Volume 
Active and passive muscle 
properties 
Maximum isometric strength  
Maximum voluntary activation  
3D Gait Kinematics and 
Kinetics 
Functional strength  
Walking distance (6 min) 
Anaerobic power  
Agility  
Functional mobility 
Primary Endpoint (T2) 
13 weeks. 
Control group: 
No exercise training.  
Usual daily activity. 
 
Figure 3-1. Study flow diagram of intervention and outcome measures. 
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 Study intervention: Functional anaerobic and strength training (FAST) 
The intervention group will undertake 75 minutes of FAST, 3 times per week, for 12-
weeks, totalling 36 sessions (total FAST dosage = 45 hours). The FAST program will 
target the MG, LG, SOL, and TA muscles as they are the most commonly impacted 
muscles in spastic type CP and play a primary role in body weight support and forward 
propulsion during the stance phase of walking and toe clearance during the swing phase 
of walking.113,114 Functional anaerobic training has been included in this study to address 
the multifactorial nature of motor impairments seen in CP as well as incorporating context 
specific training relatable to the outcomes being assessed (e.g. anaerobic power and 
mobility).  
 
 Training program design 
Participants may train individually or in small groups (<6) to allow strict supervision by two 
experienced trainers with tertiary qualifications in the field of exercise science. A 5 minute 
warm-up and cool-down of the lower limb muscles using a stationary bicycle or treadmill 
will be performed by all participants at the beginning and end of each session respectively. 
The heavy resistance training will be performed first in each session, followed by the 
functional anaerobic training component. Each participant will be familiarised with the 
different exercise stations and taught correct technique prior to commencement of the 
training program. 
 
The heavy resistance training component of each session will consist of 5 resistance 
exercise stations (Figure 3-2). Each participant will commence on an individual station and 
progress through the circuit until they have completed all 5 stations. Participants will 
commence at a random station each week to prevent staleness of the training program 
and to randomise any neuromuscular effects of training order. The resistance exercises 
selected in this study are as follows: seated bent knee calf raise, leg press, seated straight 
knee calf press, TA raise, and standing calf raise. A full description of each exercise is 
presented in Table 3-1 below 
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Figure 3-2. Flow chart outlining the resistance exercise training circuit. Starting exercise 
station for each session may vary between training sessions. Exercise order will be 
preserved. 
Seated bent 
knee calf raise 
Tibialis 
anterior raise 
Seated 
straight knee 
calf press 
Standing calf 
raise 
Seated leg 
press 
57 
 
 
Table 3-1. Description of strength training exercises to be performed in FAST program. 
 Seated calf raise Seated tibialis 
anterior raise 
Seated leg press Standing calf raise Seated straight knee 
calf press 
Muscle(s) 
targeted 
Primary: Soleus 
Secondary: Gastrocnemii 
Tibialis anterior Gluteals, Quadriceps, 
Hamstrings, Triceps 
Surae 
Primary: Gastrocnemii 
Secondary: Soleus 
Primary: Gastrocnemii 
Secondary: Soleus 
Initial 
participant 
positioning  
Seated with hips flexed 
at 90o, knees flexed at 
90o, feet flat on the floor 
approximately 30cm 
apart. Dumbbell held on 
training leg, above the 
knee. Non-training leg 
resting with foot flat on 
the floor. 
Seated with hips 
flexed at 90o, knee 
flexed at 70o, Training 
foot secured in foot 
plate. Non-training leg 
resting with foot flat on 
the base of training 
device. 
Seated with hips flexed 
at 70o, knees flexed at 
70o, feet flat on the foot 
plate approximately 
30cm apart, toes 
pointing slightly 
outwards. 
Standing upright on a 
20cm step, holding a 
hand rail if required. 
Place dumbbell in hand 
on training leg side, heels 
hanging approximately 
10cm off the step. Non-
training leg resting in the 
air above step. 
Seated with hips flexed 
at 70o, training leg knee 
at 0o, foot flat on the 
footplate with the heel 
hanging approximately 
10cm below the 
footplate. Non-training 
leg resting with foot flat 
on the floor. 
Instructions 
to 
participant 
Hold the dumbbell on 
your knee and keep your 
toes on the floor, slowly 
raise your heel up 
towards the sky until you 
can’t go any further. 
Slowly lift the front of 
your foot up, keeping 
your knee bent and 
heel on the footplate 
until you can’t go any 
further. Lower your 
Slowly push the 
footplate forward, 
keeping your knees 
slightly bent, and then 
bring it back towards 
you slowly. 
Keep your knee straight 
and toes on the step, 
slowly raise your heel 
towards the sky until you 
can’t go any further. 
Slowly lower your heel 
Slowly push the footplate 
forward with the front of 
your foot, keeping your 
knee straight, and then 
bring it back towards you 
slowly. 
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Slowly lower your heel 
down to the floor. 
foot back down again 
slowly. 
down again until it hangs 
slightly below the step. 
Movement 
description  
1 repetition: Lift the 
weight by raising the heel 
up using the ball of the 
foot until the ankle is in 
maximum plantar flexion 
before lowering the heel 
to return to the original 
position. 
1 repetition: Lift the 
weight by dorsiflexing 
the foot, keeping the 
heel on the footplate, 
until the ankle is 
maximally dorsiflexed 
before lowering the 
forefoot to return to 
the original position. 
1 repetition: Extend 
both knees equally to 
push the footplate 
forward. Do not lock 
the knees in full 
extension before 
flexing the knees to 
return to the original 
position. 
Keep the back flat 
against the support 
pad for the duration of 
the movement. 
1 repetition: Raise the 
heel up using the ball of 
the foot until the ankle is 
in maximum plantar 
flexion before lowering 
the heel to return to the 
original position. 
1 repetition: Use the ball 
of the foot to plantar flex, 
pushing the footplate 
forward before 
dorsifllexing the ankle to 
return to the original 
position. 
Keep the back flat 
against the support pad 
for the duration of the 
movement. 
Unilateral 
or bilateral 
training 
Unilateral Unilateral Bilateral Unilateral Unilateral 
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The functional anaerobic training component will consist of 2-3 (dependent on training 
period) functional anaerobic exercises per session focusing on power, agility, coordination 
and speed of movement, adapted from Verschuren et al.66 The exercises are designed to 
improve anaerobic capacity and mobility in a task specific context related to everyday 
activities such as stair climbing, bending, changing direction and stepping over obstacles. 
A detailed description of each functional anaerobic exercise is presented in Table 3-2 
below. 
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Table 3-2. Description of functional anaerobic exercises included in FAST program 
adapted from Verschuren et al.66 
Exercise  Equipment Description Targeted fitness 
component 
Step-ups Step or Block  Step up with right leg over the block 
followed by the left. Turn around 
and step back over the block with 
left leg first. Count the number of 
repetitions completed.  
Strength, power, 
coordination  
Beanbag 
run  
4 mats, 12 
beanbags 
Place 4 mats in a row, 1.5m apart. 
Place 4 beanbags on each of the 
first 3 mats. Move a beanbag from 
mat 1 to 2, 2 to 3, and 3 to 4. Run 
back to the start and repeat. Count 
the number of beanbags moved.  
Power, agility, 
coordination 
(bending, turning, 
getting up from the 
floor). 
Lateral 
step-ups 
Step or Block  Step up sideways with right leg first 
over the block. Step back over the 
block with left leg first. Count the 
number of repetitions completed. 
Strength, power 
(Stair climbing, 
avoiding obstacles). 
5m sprint  2 strips of tape Place tape 5m apart. Sprint as fast 
as possible between lines of tape. 
Count the number of sprints 
completed.  
Agility, speed. 
Obstacle 
course 
1 hoop, 
beanbags, 
step, hurdle, 
basket 
Take a beanbag from the hoop, 
over the step, under the hurdle and 
into the basket. Repeat and count 
number of repetitions completed.  
Power, agility, 
speed, coordination 
(bending, turning, 
getting up from the 
floor). 
Shuttle 
sprint 
5 lines of tape 
placed 1.5m 
apart 
Sprint to line 1, return to start. 
Sprint to line 2, return to start, 
continue. Count the number of lines 
touched.  
Power, agility, 
speed, coordination. 
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Up and 
down 
stairs 
3 stairs 
(17.5cm step 
height) 
Move up and down 3 stairs as 
quickly as possible. Count number 
of repetitions completed.  
Strength, power 
(Stair climbing). 
Agility run  Bean bag, 
cones, basket 
Zig-zag between 5 cones placed 
1.5m apart (in and out), and return 
to the start line. Count number of 
repetitions completed.  
Power, agility, 
speed, coordination. 
4 cone 
run 
4 cones of 
different 
colours  
Start in the centre of a 2m x 2m 
square. Trainer calls a colour to run 
to, touch the cone, and back to the 
centre. Trainer then calls another 
colour. Count the number of cones 
touched.  
Power, agility, 
speed, coordination. 
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 Progressive resistance training volume and intensity 
A high training volume and moderate load will follow the principles of PRT for healthy 
young adults115 to achieve the primary training goal of increasing muscle size.116 The 
training program will be periodised, comprise multiple sets, focusing on the 6-12 Repetition 
Maximum (RM) range and take place 3 times per week (at least 24 hours relative rest 
between training sessions) in order to enhance muscle hypertrophy.117 Training weeks 1-4 
are made up of the highest training volume at a moderate load (3 sets of 12 RM) to 
maximise the neural adaptations that primarily occur during the early stages of a 
resistance training program.80 The training program will progress by decreasing the 
number of repetitions per set, completed at a higher load, from weeks 5-12. Table 3-3 
details the progression of training load and volume over the 12-week intervention.  
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Table 3-3. Training progression of resistance exercises to be performed in the FAST 
program. 
Week Speed of 
movement 
Load Sets Repetitions Rest 
1-2 Concentric: 2s 
Eccentric: 2s 
60% 12 
RM 
3 12 90s 
3-4 Concentric: 2s 
Eccentric: 2s 
80% 12 
RM 
3 12 90s 
5-6 Concentric: 1s 
Eccentric: 2s 
100% 8 
RM 
3 8 90s 
7-8 Concentric: 1s 
Eccentric: 2s 
100% 8 
RM 
3 8 90s 
9-10 Concentric: X 
Eccentric: 2s 
100% 6 
RM 
4 6 120s 
11-12 Concentric: X 
Eccentric: 2s 
100% 6 
RM 
4 6 120s 
RM = repetition maximum: Amount of weight that can be moved through the available 
range of motion a designated number of times to fatigue. X = explosive concentric 
movement. Load will be adjusted in 0.25kg increments to maintain defined repetition 
number. 
 
Four exercises (seated bent knee calf raise, seated straight knee calf press, standing calf 
raise, and TA raise) will be trained unilaterally on left and right legs. The leg press exercise 
will be trained as a bilateral movement. This will allow the left and right gastrocnemii, SOL, 
and TA muscles to be trained in isolation and minimises any compensatory movement 
strategies employed by the participants to accomplish the exercise. The multi-joint leg 
press exercise was included to provide a greater training stimulus to the larger muscles 
(quadriceps, hamstrings, gluteals) of the lower limb.  
 
Commercially available weighted pulley systems will be used as the resistance for the leg 
press and seated straight knee calf press with a weight range from 7-250 kg. A custom 
built training device will be attached to a weighted pulley with a weight range from 0.25-50 
kg, to be used as the resistance for the TA raise. A dumbbell, barbell, or weight vest will be 
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used as the resistance for the standing calf raise and seated bent knee calf raise. Custom 
weights will be used to allow 0.25 kg increments to be made to all loads. 
 
Participants who are unable to complete 12RM of the prescribed exercises using the 
lowest weight (seated exercises) or body weight (standing calf raise) will commence 
training using elastic stretch resistance bands. Once participants can complete 12RM 
using the resistance bands, they will progress to a heavier resistance band or change to 
the weight loaded exercise. Hip and knee position will be kept the same regardless of the 
type of load used.  
 
 Functional anaerobic training volume and intensity   
The functional anaerobic exercises will be performed at maximal intensity, comprising 
multiple all-out efforts lasting between 20 and 30s. To satisfy the definition of anaerobic 
exercise, a maximal effort must be made such that the participant is exhausted at the end 
of each exercise period.65 Participants will be instructed to complete as many repetitions 
as possible in the time allowed and the trainers will provide verbal encouragement to 
promote maximal effort. Each session in training weeks 1-4 will comprise three x 20s 
maximum exercise bouts of two functional anaerobic exercises. The functional anaerobic 
training program will progress over the 12-week period by: 1) adding additional exercises, 
2) increasing the repetitions performed, 3) increasing the duration of exercise bouts, and 
4) decreasing recovery time. Table 3-4 details the progression of training volume and 
intensity over the 12-week intervention. 
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Table 3-4. Individual training session design and progression of functional anaerobic exercises. 
Week Session  Exercises Repetitions Duration Intensity Rest  
1 1 
2 
3 
Step-ups; beanbag walk 
Lateral step-ups; 5m sprint  
Up and down stairs; shuttle sprint  
3 
3 
3 
20s 
20s 
20s 
Maximum  
Maximum  
Maximum  
100s 
100s 
100s 
2 1 
2 
3 
Step-ups; obstacle course 
Step ups sideways; Agility run 
Up and down stairs; 4 cone run 
3 
3 
3 
20s 
20s 
20s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s 
3 1 
2 
3 
Step-ups; beanbag walk 
Lateral step-ups; 5m sprint  
Up and down stairs; shuttle sprint 
3 
3 
3 
20s 
20s 
20s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s  
4 1 
2 
3 
Step-ups; obstacle course 
Step ups sideways; Agility run 
Up and down stairs; 4 cone run 
3 
3 
3 
20s 
20s 
20s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s 
5 1 
2 
3 
Step-ups; beanbag walk 
Lateral step-ups; 5m sprint  
Up and down stairs; shuttle sprint 
4 
4 
4 
25s 
25s 
25s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s 
6 1 
2 
3 
Step-ups; obstacle course 
Step ups sideways; Agility run 
Up and down stairs; 4 cone run 
4 
4 
4 
25s 
25s 
25s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s 
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7 1 
2 
3 
Step-ups; beanbag walk 
Lateral step-ups; 5m sprint  
Up and down stairs; shuttle sprint 
4 
4 
4 
25s 
25s 
25s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s 
8 1 
2 
3 
Step-ups; obstacle course 
Step ups sideways; Agility run 
Up and down stairs; 4 cone run 
4 
4 
4 
25s 
25s 
25s 
Maximum 
Maximum 
Maximum 
100s 
100s 
100s 
9 1 
2 
3 
Step-ups; beanbag walk, obstacle course 
Lateral step-ups; 5m sprint, Agility run  
Up and down stairs; shuttle sprint, 4 cone run 
4 
4 
4 
30s 
30s 
30s 
Maximum 
Maximum 
Maximum 
90s 
90s 
90s 
10 1 
2 
3 
Step-ups; obstacle course, 5m sprint 
Step ups sideways; Agility run, shuttle sprint 
Up and down stairs; 4 cone run, beanbag walk 
5 
5 
5 
30s 
30s 
30s 
Maximum 
Maximum 
Maximum 
90s 
90s 
90s 
11 1 
2 
3 
Step-ups; beanbag walk, obstacle course 
Lateral step-ups; 5m sprint, Agility run  
Up and down stairs; shuttle sprint, 4 cone run 
5 
5 
5 
30s 
30s 
30s 
Maximum 
Maximum 
Maximum 
90s 
90s 
90s 
12 1 
2 
3 
Step-ups; obstacle course, 5m sprint 
Step ups sideways; Agility run, shuttle sprint 
Up and down stairs; 4 cone run, beanbag walk 
5 
5 
5 
30s 
30s 
30s 
Maximum 
Maximum 
Maximum 
90s 
90s 
90s 
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 Individual Progression  
Initial 12 RM load will be determined in the first week of training for each participant by 
experienced trainers. Individual progression of load will be monitored in every training 
session to determine the need for progression. Load may be added to an exercise during a 
session or prior to the start of a new session if the participant can complete more than the 
required number of repetitions in all sets of that exercise (i.e. the participant is not 
exercising to fatigue).  
 
 Monitoring and adverse events 
Correct technique will be strictly monitored at all exercise stations and individual feedback, 
instruction and demonstration will be provided by the trainers. Participants will report a 
rating of perceived exertion (RPE) on a Borg scale (6-20) at the completion of every 
training session prior to the cool-down phase.118 Each participant will complete a training 
diary in conjunction with the trainer throughout the intervention duration to document their 
progress, report injuries and fatigue levels, and provide intrinsic motivation to progress 
their training intensity. A short debriefing session will occur at the completion of the training 
session to discuss participants’ general wellbeing, motivation and any concerns they may 
have regarding the training program. Any missed sessions by participants will be recorded 
by the trainers. A missed session may be made-up on a separate day during the same 
training week. 
 
Participant motivation will be enhanced by providing a visual display of personal best 
results for each exercise within the training environment. Individuals will be encouraged to 
improve their personal best performances in each session which will be displayed in 
relative terms using a change score in performance rather than an absolute result to avoid 
any negative perceptions associated with underperforming or competing against their 
peers.  
 
Any injuries or adverse outcomes attributable to the intervention or testing protocol will be 
documented and reported and individuals referred to their treating clinician. The presence 
of a trainer at all exercise sessions will allow close monitoring of the occurrence of injuries 
or adverse events during training and in response to training. The training diaries 
completed by the participants will also provide valuable information about short and long 
term training experiences. Participants will report any leg pain, lower leg stiffness and level 
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of leg fatigue prior to each training session using a visual analogue scale (0-100mm). 
Annual auditing of trial conduct will be completed by study investigators.  
 
3.3 Outcome measures  
Measures will be taken at baseline (pre-training, T1), immediately following training (post-
training, T2), and 12-weeks post-training (retention, T3). Data collection for each 
assessment time point will be scheduled within a two week period. Measures of height, 
weight, leg length, tibia and fibula length, and maximum calf circumference will be taken at 
each assessment.  
 
 Primary Outcomes 
There will be a primary outcome measure for the volume (mL) of the MG, LG, SOL, and 
TA muscles, and the neuromuscular properties of the MG muscle. 
 
a) Muscle Volume  
Magnetic resonance imaging will be used to measure muscle volume of the MG, LG, 
SOL and TA muscles. Magnetic resonance imaging is considered to be the gold 
standard of muscle volume measurement in vivo119,120 and has been validated against 
cadaveric values (r=0.99, SEE=3.9 cm2).119 Participants will lay supine on the MRI 
gantry with the knee fully extended and the ankle held in the anatomically neutral 
position (or maximum DF if anatomically neutral is unattainable). Axial plane MRI scans 
of the lower leg will be acquired using a Siemens MAGNETOM Verio 3.0 Tesla MRI 
scanner (Erlangen, Germany) with 2 x 6 channel body matrix array combined with 24 
channel spine coil. 2-point gradient echo Dixon images will be acquired in 2D with 
TR/TE = 970/13 ms, 140 degree flip angle, 4 mm slice thickness, 240 x 320 acquisition 
matrix, and 350 x 350 mm field of view. The borders of the MG, LG, SOL and TA will be 
manually segmented by deﬁning a piecewise linear boundary in all corresponding axial 
plane images using Stradwin (v4.2, Mechanical Engineering, Cambridge University, UK) 
reconstruction software. Surface rendering for each muscle and muscle volume (ml) 
calculations will be performed using the measurement modules within Stradwin. This 
method has high test-retest reliability measuring MG muscle volumes (ICC 0.99).121 
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b) Neuromuscular properties 
Participant setup and instrumentation  
Participants will be instructed to refrain from any strenuous physical activity in the 48 
hours prior to data collection to minimise possible transient changes in the 
neuromuscular properties of the muscle. Participants will be assessed at the same time 
of day to avoid possible diurnal variation in the follow-up neuromuscular measures. All 
neuromuscular measurements will be made on the MG muscle of the impacted leg, with 
the knee in full extension (0 degrees extension) and repeated with the knee in 90 
degrees flexion. 
 
Full details of the participant setup has been reported previously.21,28 Briefly, 
participants will lay prone on an adjustable plinth with their foot secured to a footplate of 
a Biodex isokinetic dynamometer (System 3, Biodex Medical Systems, Shirley, NY) so 
that the axis of the dynamometer will be aligned with the ankle joint centre via a custom 
adjustable foot strap designed to minimise heel lift. The knee will be secured to the 
plinth using a padded strap to prevent any change in knee angle during the 
measurements. Prior to any testing, the limits of ankle ROM will be established by 
applying a manual torque to the footplate and recording the corresponding ankle angle 
(maximum PF and DF).  
 
A custom LabView program (v12.0f3, National Instruments, Texas, USA) will be used to 
control the dynamometer and acquire ankle joint torque, angle and velocity via a USB 
data acquisition device (NI USB-6259 BNC, National Instruments, Texas, USA) at a 
sampling rate of 1000 Hz. Ultrasound images will be recorded at 80Hz using a PC-
based ultrasound scanner with a 96 element beamformer and a 7MHz linear probe with 
60mm field of view (LV7.5/65/64D, Telemed Echo Blaster 64 EXT-1T, Vilnius, 
Lithuania). EMG data will be recorded at 1000 Hz from differential surface electrodes 
placed over the muscle bellies of the MG, LG, SOL and TA using a four channel 
NeuroLog EMG system (Digitimer Ltd., Welwyn Garden City, UK). Dynamometer, EMG 
and ultrasound data will be synchronised via a 3 volt square wave generated by the 
ultrasound scanner, which will trigger the recording of data in the LabView software. 
 
An ultrasound transducer will be fixed to the skin using elastic wrap above the MG 
muscle belly in the same orientation of the muscle fascicles to measure fascicle length 
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and pennation angle changes.122 Muscle fascicle length will be defined as the straight 
line distance between the superficial and the deep muscular fascia parallel to the lines 
of collagenous tissue visible on the ultrasound image. Changes in muscle fascicle 
length and pennation angle during passive and active lengthening will be automatically 
tracked using an optical flow tracking algorithm.123,124 This method of measuring 
changes in muscle fascicle length has been shown to be accurate and reliable during 
controlled contractions (CMD 0.98).124  
 
i) Passive mechanical properties 
Passive ankle joint torque will be assessed initially in all participants by rotating the foot 
throughout three cycles of their full ROM at 10o s-1. A third-order polynomial will be fitted 
to the average of three cycles in each participant.21 A gravity correction will be applied 
to all torque measurements to account for the gravitational torque acting on the foot and 
footplate. Briefly, a geometric fit of the gravitational moment will be performed on the 
torque signal.21 The gravitational moment will be modelled using a generalised sinusoid 
equation in the region where passive moments are lowest.125 Slack angle (degrees), 
peak ankle torque (Nm), ankle stiffness (Nm deg-1), and change in ankle angle 
(degrees) will all be measured at the ankle joint level. Muscle fascicle slack length 
(mm), change in MG fascicle length (mm), and MG fascicle strain (%) will all be 
measured at the MG fascicle level. MG physiological cross sectional area (PCSA) will in 
turn be computed from the ratio of MG muscle volume to MG fascicle length.126 Detailed 
explanations for the above measures can be found in Barber et al.21 The level of 
spasticity will be assessed by passively dorsiflexing the ankle joint through full range of 
motion (ROM) at a fast velocity (150 o s-1) using an isokinetic dynamometer while 
recording electromyographic (EMG) data simultaneously from the MG, LG, and SOL 
muscles. The ROM in the ankle joint will be assessed using the isokinetic dynamometry 
protocol described above. A consistent torque will be applied to the footplate pre- and 
post-training to measure any change in ROM following the intervention. 
 
ii) Active mechanical properties 
Participants will perform maximum voluntary isometric contractions (MVIC) of the PF 
muscles at five ankle angles corresponding to 5, 25, 50, 75 and 95% of the range 
between maximum PF and maximum DF. A MVIC of the DF muscles will also be 
performed at 50% ROM. Each participant will perform two MVICs at each angle, lasting 
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4s each in duration, with a rest period of 2 min between trials. The trial that produces 
maximum torque will be used for subsequent analysis. Active torque-angle and torque-
fascicle length curves will be adjusted for the effect of gravity and the passive torque 
measured at the same fascicle lengths will be removed to calculate active torque.28 
Torque will be normalised to PCSA in each participant.  
 
 Secondary outcomes 
a) Intramuscular fat content 
Magnetic resonance imaging (MRI) will be used to measure muscle the intramuscular 
fat (IMF) content of the MG, LG, SOL and TA muscles. Participant setup in the MRI 
gantry and image acquisition will be identical to that described above. Separate water 
and fat images will be calculated within the MRI scanner software (syngo MR B19) 
using the known chemical shift between the water and fat signal components. The 
borders of the MG, LG, SOL and TA will be manually segmented on the Dixon water 
images using Osirix127 (v6.0.2, Pixmeo SARL, Geneva, Switzerland) to create regions of 
interest. Intramuscular fat content will be calculated using a ratio of the water and fat 
signal intensities within the region of interest in each muscle. Measures of intramuscular 
fat content using this method have been shown to be reproducible within 0.33% in 
young adults with bilateral CP27 with a high inter-tester coefficient of variation of 
1.43%.128 
 
b) Isometric muscle strength 
Isometric muscle strength of the PF and DF muscles will be measured with a Biodex 
isokinetic dynamometer using the protocol and patient setup described above. The 
maximum peak ankle PF and DF torque obtained from two MVICs at each joint angle 
will be used for the analysis.  
 
c) Anaerobic power 
Anaerobic power output of the participants will be assessed using the Muscle Power 
Sprint Test (MPST).129 Following a warm-up of 5-10 minutes (cycle ergometer), 
participants will be required to complete six 15m runs as quickly as possible with 10s 
rest between sprints. Power output can be calculated as the product of body mass and 
distance^2, divided by time^3.129 Participants will be familiarised with the distance and 
rest time of the test by walking a practice trial. The test will be performed indoors on a 
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straight, flat, non-slippery surface, and sprint times will be recorded using timing gates. 
The MPST has been validated against the Wingate Anaerobic cycling Test130 and has 
excellent test-retest reliability (ICC 0.98) in children and adolescents with CP.129 
 
d) Agility 
The 10 x 5m Sprint Test is a simple and inexpensive measurement tool that will be used 
to assess an individual’s ability to change direction rapidly without losing balance.129 
Participants will be asked to perform 10 five metre sprints continuously between two 
sets of cones on an indoor, non-slippery surface. Total time to complete the 10 sprints 
will be recorded using timing gates. This test has high test-retest reliability (ICC 0.97) in 
children and adolescents with CP.129 
 
e) Functional strength 
A 30s repetition maximum (RM) test will be used as a functional strength assessment 
involving components of balance, speed, endurance and muscular strength.131  
Participants will complete as many repetitions as possible in 30s of the following 
exercises: (1) lateral step up (performed unilaterally), (2) sit to stand (performed 
bilaterally), and (3) stand from half kneel (performed unilaterally). 180s rest will be given 
between each exercise. The total number of repetitions performed in 30s for each 
exercise will be recorded, summed, and used in the analysis. This form of functional 
strength testing has high inter-tester reliability (ICC 0.91 – 0.96)131 and coefficient of 
variation (CV) ranging from 10.9 – 39.9%.131 
 
f) Walking ability 
The 6-Minute Walk Test (6MWT) will be used to assess the maximum distance 
participants can walk during a 6 minute period. Participants will be verbally instructed to 
walk non-stop around a 30m indoor, flat, non-slippery circular track for 6 minutes as 
quickly as possible (without running). A familiarisation of the test will occur on a 
separate occasion prior to the assessment. An examiner will follow the participant 
during the test for safety purposes. The test will be videoed to calculate total distance 
walked (m) and fastest walking speed (m s-1). The 6MWT has excellent test-retest 
reliability (ICC 0.98)132,133 in children with CP.  
 
A timed stairs test will assess the time taken for participants to go up and down a 5-step 
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set of stairs.48 The test requires participants to walk up 5 stairs as quickly as possible 
(without running), using the handrails if necessary, then turn around on a platform and 
walk down the stairs as quickly as possible. The test will be videoed to calculate the 
time (s) taken to complete the test successfully. Separate times will be calculated for the 
up and down components of the test. 
 
Preferred walking speed (m s-1), cadence (steps min-1), step length (m), 3D gait 
kinematics and kinetics will be computed after the participants walk on a force 
instrument treadmill (AMTI, Arlington, USA). Reflective markers will be attached to the 
pelvis, and upper and lower limbs and position recorded at 200 Hz using an 8-camera, 
three-dimensional motion capture system (Qualysis, Gothenburg, Sweden). To ensure 
participants are comfortable using the treadmill, they will be made aware of the safety 
stop buttons and the handrails. The participants will initially walk at a slow pace while 
holding the handrails and the speed will be increased slowly until a comfortable walking 
speed is achieved. When comfortable using the treadmill, the participant will be asked 
to walk without holding the handrail. Participants will then be required to determine their 
self-selected walking pace by increasing/decreasing the treadmill at 0.2 km.hr-1 
increments each 30-60s until they report the speed is most comfortable without holding 
the hand rails. Data will be collected from participants walking at a self-selected speed 
on flat, an uphill (7%) and downhill gradient (-7%). 10 complete strides will be collected 
from each leg and the average of five complete strides will be used in the analysis for 
each participant. 
 
g) In vivo muscle mechanics during walking 
2D B-mode ultrasound will be used to examine MG muscle function during treadmill 
walking by attaching a flat ultrasound transducer (LV7.5/65/64D, Telemed Echo Blaster 
64 EXT-1T, Vilnius, Lithuania) to the surface of the skin above the MG muscle and 
recording muscle fascicle length changes as described previously.34 Muscle fascicle 
behaviour during walking will be analysed using the semi-automatic process described 
earlier which has been shown to be highly repeatable (CMC 0.88).123 The average of 
five complete strides will be used in the analysis for each participant to ensure the 
overall reliability of muscle fascicle length data.134 Surface EMG will also be collected 
from MG, LG, SOL and TA muscles to assess muscle activation and timing during gait 
(Digitimer Ltd., Welwyn Garden City, UK).  
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 Masking  
Masking of the participant from the intervention is not possible due to the nature of the 
study.  Neuromuscular data will be quantitatively analysed and masked to group allocation. 
The physical performance measurements will be performed by the same researchers who 
will also be providing the training intervention due to practical limitations. However, any 
bias will be overcome by the objective and quantifiable nature of the outcome measures.   
 
 Statistical analyses  
Generalised estimating equations (GEE) for longitudinal analysis135 will be used to 
evaluate differences in continuous data between groups for the two post-baseline 
assessments on an intention-to-treat basis. This method takes into account the 
dependency of repeated measures in the same participant and any missing data. To 
evaluate the effectiveness of the intervention, the interaction term of group and time (group 
x time) will be assessed. Statistical significance will be accepted at p < 0.05 and the 
statistical analysis will be performed using SPSS version 20 (SPSS Inc., Chicago, IL, 
USA). 
 
3.4 Ethics and dissemination 
 Ethical approval and trial registration 
Full ethical approval has been granted by the Medical Research Ethics Committee of The 
University of Queensland (2014000066), and the Children’s Health Queensland Hospital 
and Health Service Human Research Ethics Committee (HREC/15/QRCH/30). The trial 
has been registered with the Australian and New Zealand Clinical Trials Registry: 
(ACTRN12614001217695). Any substantive protocol amendments will be submitted 
formally to the ethics committees of The University of Queensland and Children’s Health 
Queensland, and not implemented until approved. The registered trial details will also be 
updated to reflect any approved amendments to the protocol. Participant information and 
consent forms will be provided by the researcher for all participants involved in the trial. 
These documents have been amended accordingly in order to provide separate 
information sheets and consent form which are suitable for children and teenagers. 
Participants will be given the opportunity to discuss their involvement in the project and 
ask questions. Informed, written consent will be obtained from all participants over the age 
of 18 years before entering the trial. Parents or guardians will provide informed, written 
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consent for participants younger than 18 years, and assent will be obtained from 
participants (if younger than 18 years) before entering the trial.  
 
 Data storage and dissemination of findings 
Individual data will be monitored by study investigators upon completion of testing and 
during the intervention. No data monitoring committee has been established as the study 
is not a drug trial and any adverse events will be identified by study investigators during 
testing and training. Participant information will be stored in locked filing cabinets at the 
study site. All data, reports, and administration forms will be identified by a coded 
identification number to maintain participant confidentiality. The final dataset will only be 
accessed by study investigators. Trial findings will be disseminated by publications in peer-
reviewed journals, conferences, and local research organisations’ newsletters and 
publications. Results will be disseminated regardless of the magnitude or direction of 
effect. Any decision to describe interim results, stop or terminate the trial will be made by 
study investigators.   
 
3.5 Discussion 
This paper presents the study protocol for a randomised controlled trial investigating the 
efficacy of a combined functional anaerobic and strength training program on skeletal 
muscle properties and muscle function in adolescents and young adults with spastic type 
CP. Critical aspects of the training study are presented in detail regarding the training 
frequency, volume, duration, intensity, and individual progression. The type and technique 
of each exercise included in the training program has been standardised and described.  
 
Previous RCTs of strength training interventions in individuals with CP have assessed their 
effectiveness using performance outcome measures such as strength, walking ability and 
gross motor function, with conflicting results.43-45,48,66 To our knowledge, no RCTs have 
measured the effects of resistance training on lower limb skeletal muscle properties and in 
vivo muscle function under controlled movements and during walking in this population. 
Furthermore, it is hypothesised that the addition of functional anaerobic training will 
enhance the transfer of strength gains to functional performance. Understanding the 
neuromuscular adaptations following combined functional anaerobic and strength training 
in individuals with CP might influence the prescription of exercise training in this population 
and help guide future conservative treatment decision-making.
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Functional capacity in adults with cerebral palsy: Lower limb 
muscle strength matters 
 
This chapter investigates how muscle strength and stiffness is related to functional 
capacity in a cross-section of adults with CP. The data reported in this study contains 
baseline data from the FAST study outlined in Chapter 3, as well as additional data 
collected in older adults with CP. Adults with CP have weaker and stiffer muscles than 
their TD counterparts. It is unknown, however, whether these factors play a role in 
reducing overall functional capacity. It is important to establish the limiting factors for 
functional capacity in individuals with CP in order to target these parameters using specific 
exercise programming. Using statistical regression analyses, it is possible to establish the 
relative importance of muscle strength and stiffness to functional capacity outcomes.  
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Abstract 
Objective: To investigate the relationship between lower limb muscle strength, passive 
muscle properties and functional capacity outcomes in adults with cerebral palsy. Design: 
Cross-sectional study. Setting: Tertiary institution biomechanics laboratory. Participants: 
Sample of 33 adults with spastic-type cerebral palsy with a mean age of 25 (range, 15-51) 
years; mean ± SD body mass 70.15 ± 21.35 kg; Gross Motor Function Classification 
System level I n=20, level II n=13. Interventions: Not applicable. Main Outcome 
Measures: Six-minute walk test distance (m); lateral step-up test performance (total 
repetitions); timed up-stairs test performance (s); maximum voluntary isometric strength of 
plantar flexors and dorsiflexors (Nm.kg-1); and passive ankle joint and muscle stiffness. 
Results: Maximum isometric plantar flexion strength independently explained 61% of 
variance in six-minute walk test performance; 57% of variance in lateral step-up test 
performance; and 50% of variance in timed up-stairs test performance. Gross Motor 
Function Classification System level was significantly and independently related to all 
three functional capacity outcomes, and age was retained as a significant independent 
predictor of lateral step-up, and timed up-stairs test performance. Passive medial 
gastrocnemius muscle fascicle stiffness and ankle joint stiffness were not significantly 
related to functional capacity measures in any of the multiple regression models. 
Conclusions: Low isometric plantar flexion strength was the most important independent 
variable related to distance walked on the six-minute walk test, fewer repetitions on the 
lateral step-up test, and slower timed up-stairs test performance. These findings suggest 
lower isometric muscle strength contributes to the decline in functional capacity in adults 
with cerebral palsy. 
79 
 
4.1 Introduction  
Ambulant young adults with CP experience a decline in physical activity, aerobic capacity 
and walking ability into adulthood that is accelerated compared to TD adults, with a 
substantial reduction in mobility occurring before 40 years of age.38,136-139 There is a 
paucity of knowledge about the individual factors that contribute to the decline in function 
in adults with CP, however musculoskeletal adaptations such as muscle weakness8,140 and 
stiffness21,38 likely interact with the natural effects of ageing in some manner to limit 
functional capacity. There is a lack of understanding about how musculoskeletal 
development progresses through adulthood in individuals with CP and whether any decline 
in physical mobility is related to deterioration of muscle.  
 
Recent evidence suggests that a reduction in muscle strength and alterations in muscle 
structure, rather than increased spasticity, are associated with impaired gait function and 
measures of gross mobility,38,141-143 with strength accounting for up to 69% of the variance 
in gross motor function on the Gross Motor Function Measure (GMFM-66) score.37 The 
moderate relationship (adjusted R2 = 21–35%) between isometric lower leg strength and 
mobility capacity in children with CP that is not seen in TD individuals reinforces the 
importance of muscular strength to function in individuals with CP.144 Improvements in 
ankle muscle strength in young children with CP using resistance exercise programs has 
been associated with improvements in the GMFM-66 walking, running, and jumping 
dimension (r=0.84).145 Similarly in adults with CP, improvements in ankle DF function and 
range of movement during gait has been shown following explosive resistance training.146 
Although the adult CP literature is scarce regarding the relationship between PF strength 
and function, taken together, these findings suggest that muscle strength may play a key 
role in effective mobility and functional capacity in adults with CP as they age.  
 
The resistance to passive movement in the absence of muscle activation is defined as 
passive stiffness, which may be due to structural musculoskeletal alterations rather than 
reflex-mediated mechanisms.17,29,30 Adults with CP have significantly increased passive 
ankle and PF muscle stiffness compared to TD adults.38 Furthermore, this increased 
passive stiffness of the ankle muscles, along with muscle weakness, has been related to 
impaired gait function in the adults with CP.38 While these biomechanical parameters have 
been associated at a univariate level to impaired toe-lift, reduced gait-velocity, and active 
range of movement in adults with CP,38 whether they are related to different measures of 
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functional capacity and their relative influence on different functional tasks remains 
unknown. 
 
A number of functional capacity measures have been used to assess walking ability and 
performance of gross motor tasks in individuals with CP.132,144,147,148 The six-minute walk 
test (6MWT) has been used as a measure of walking capacity and endurance in 
individuals with CP,132,148,149 however, it is difficult to determine the impact of 
musculoskeletal adaptations on walking capacity assessed using the 6MWT without 
objectively quantifying strength and muscle properties. Other functional capacity 
assessments related to strength, coordination, power, and speed of movement are the 
lateral step-up (LSU) test and timed up-stairs (TUS) test.43,144 In children with CP, 
isometric strength of the leg muscles has explained 28% and 35% of the variance in LSU 
and TUS test performance respectively.144 How these various tasks are impacted by a 
further reduction in muscle strength and increased passive stiffness with ageing in 
individuals with CP is unknown. 
 
The quantification of the relationships between muscle strength, passive stiffness and 
functional capacity outcomes using multiple regression analysis will increase our 
understanding of the muscular factors underpinning the functional decline in adults with 
CP. The aim of this study was to investigate the relationships between lower limb muscle 
strength, passive stiffness, and functional capacity outcomes in adults with CP.  It is likely 
that functional decline in adults with CP is impacted by the interaction of multiple factors, 
rather than one isolated characteristic (i.e. strength). We hypothesised that lower isometric 
muscle strength, increased passive muscle and ankle joint stiffness, and older age would 
be associated with reduced functional capacity outcomes.  
 
4.2 Methods 
Thirty-three community dwelling adults with spastic-type CP (18 M, 15 F; mean age 25 
years, range 15-51 years; mean ± SD body mass 70.15 ± 21.35 kg) participated in the 
study. Participants were recruited across South East Queensland and Sydney, Australia 
from the Queensland Cerebral Palsy Register; Cerebral Palsy League Queensland; 
Brisbane Paralympic Football Program; Cerebral Palsy Alliance; and expression of interest 
advertising. An estimated effect size of 0.4, and an alpha level of 0.05 was used in an a-
priori sample size calculation with a power of 0.80, determining that 36 subjects were 
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required to include 4 factors into each model. The GMFCS111 levels of participants were 
established during the pre-screening process in an interview, with the following 
classification: Level I, n=18; Level II, n=15. Although developed for children with CP, the 
GMFCS has been used previously to classify the gross motor ability of adults with CP.150 
Thirteen participants had received lower limb orthopaedic surgeries in the past, with 15 
participants also having previously received intramuscular Botulinum toxin-A injections to 
the lower limbs. This study was provided ethical clearance from the Human Research 
Ethics Committees at The University of Queensland (2014000066; 2014000229) and The 
Cerebral Palsy Alliance (2015-09-02). Written and verbal information was provided to all 
participants prior to the study commencing, and signed written consent (or assent if under 
18 years) was obtained. All data were collected between August 2014 and April 2017. 
 
 Functional capacity 
The 6MWT was used to assess walking capacity and endurance measured as the 
maximum distance participants could walk during a 6-minute period on a 30m, flat, non-
slippery track.151 The LSU test was used as a composite measure of functional strength, 
coordination, power, and speed of movement performed on the left and right legs. 
Participants were required to stand with one leg on a 21cm box placed laterally to them, 
and the other leg on the ground. One repetition was recorded if the participant raised their 
standing leg from the start position to within 5 degrees of full extension on the box, and 
participants were instructed to complete as many repetitions as possible in 30s. The 
combined total of left and right leg repetitions was used in the analysis. The TUS test was 
used to assess mobility capacity walking up-stairs as a surrogate measure of a power task 
that occurs regularly in daily life. Participants were assessed on the time taken to ascend a 
six-step set of stairs as quickly as possible (without running), using a handrail if required, 
with the fastest time recorded from three trials used for subsequent analysis. The LSU and 
TUS tests were recorded on a video camera and analysed offline using freely available 
PC-based video analysis software (Kinovea v.0.8.15, France). Functional capacity 
outcomes were chosen a priori, and statistical regression analyses were only conducted 
on these three outcomes. No participants wore ankle-foot orthoses during the functional 
capacity assessments. 
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 Dynamometry and passive movement assessments  
Participants laid prone on an adjustable plinth with their foot secured to a footplate of an 
isokinetic dynamometer (Biodex System 3, NY, USA). Detailed information regarding 
participant setup and instrumentation used in this study have been reported 
elsewhere.21,28,152 Briefly, passive maximum ankle DF range of motion was set in the 
dynamometer using a manually applied torque threshold greater than 20 Nm. Passive 
ankle joint torque and angle were measured during three slow passive trials at 10 deg.s-1 
while electromyography (EMG) and B-mode ultrasound data of medial gastrocnemius 
(MG) muscle fascicles were simultaneously collected (Supplementary file 1). In a small 
subset of participants (n=4) the ankle was rotated in a similar footplate and at a similar 
speed, however, this was undertaken using manual rotation whilst simultaneously 
measuring the torque generated using a torque transducer and footplate angle using an 
accelerometer. 
 
Muscle activity levels were recorded from MG, LG, SOL, and TA using a differential 
surface EMG system (Neurolog, Hertfordshire, UK). Ultrasound images of MG muscle 
fascicles were acquired at 80Hz using a PC-based ultrasound scanner (Telemed Echo 
Blaster 64 EXT-1T) and a linear transducer (LV7.5/65/64D, Telemed Medical Systems, 
Lithuania) fixed to the skin using elastic wrap. Changes in muscle fascicle length and 
pennation angle were measured offline using semi-automated tracking algorithm.123,124,153 
Participants performed two unilateral MVICs of the ankle PF and DF muscles at five 
angles corresponding to 5%, 25%, 50%, 75%, and 95% of the range between maximum 
PF and maximum DF. The trial that produced maximum torque was used for subsequent 
analysis. The passive torque measured at the same joint angle was subtracted from the 
maximum torque recorded during each MVIC to calculate the active torque produced by 
each participant. All torque measurements were corrected for the torque generated by 
gravity acting on both the foot and the footplate, using the geometric fitting method 
described in detailed by Barber et al.21 
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 Passive properties 
Medial gastrocnemius fascicle slack length was defined as the measured fascicle length 
(mm) from the slow passive ankle rotation at an ankle joint PF torque of 1Nm. Fascicle 
stiffness was calculated by fitting an exponential function to the mean muscle fascicle 
versus joint torque curve for passive ankle rotations. The stiffness value (k) is the 
coefficient obtained from the resultant exponential fit. Ankle slack angle (degrees) and 
ankle joint stiffness was calculated using the same procedure, fitting an exponential 
equation to the mean ankle angle versus joint torque curve (Supplementary file 2).  
 
 Statistical analysis  
Descriptive statistics are presented as means (SD) for normally distributed continuous 
variables, median (range) for non-parametric continuous variables, and as frequency (%) 
for categorical variables. Differences in outcome measures between GMFCS levels were 
assessed using a Student’s T test, or the Mann-Whitney U test if the variable was non-
parametric. The LSU and TUS test data was log transformed prior to regression analyses 
to account for their skewed distribution. Independent variables included age, sex, GMFCS, 
PF and DF MVIC, CP subtype (unilateral or bilateral), MG muscle fascicle and ankle joint 
passive stiffness, MG muscle fascicle slack length and ankle joint slack angle. The three 
functional capacity outcome measures were used as dependent variables. Multivariate 
regression of each functional capacity outcome was performed in a two-step process. 
Firstly, univariate associations between each of the functional capacity measures and 
independent variables were established. All independent variables with a univariate linear 
regression significance level of P ≤ 0.20 were retained. Secondly, variables that were 
retained from the univariate analyses were entered into a series of multiple linear 
regression models on a stepwise basis in order of the strength of their association. Cook's 
distance value was used to diagnose and remove outliers. All regression models were 
assessed for multicollinearity, heteroscedasticity and normality of residuals. There were no 
missing data.  
 
4.3 Results 
The personal demographics and characteristics categorised by GMFCS level are 
presented in Table 4-1. 
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Table 4-1. Participant demographics categorised by GMFCS level. 
Characteristic  Overall (n=33) GMFCS I (n=18) GMFCS II (n=15) 
Age, years, (range) 25 (15 – 51) 24 (15 – 41) 27 (17 – 51)  
Sex: M/F 18/15 10/8 8/7 
Height, cm 166.67 (12.68) 170.85 (10.00) 164.15 (12.53) 
Weight, kg 70.15 (21.35) 72.85 (19.12) 69.41 (26.10) 
Maximum passive DF angle (degrees)  
(median, range) 
15.45 (-21.99 – 
28.86) 
18.58 (1.61 – 28.86) 14.75 (-21.99 – 25.90) 
Lower limb involvement, n (%)    
 Unilateral 20 (61) 13 (72) 7 (47) 
 Bilateral 13 (39) 5 (27) 8 (53) 
Previous lower limb surgery, n (%)    
 Muscle-tendon lengthening  9 (27) 3 (17) 6 (40) 
 Osteotomy  3 (9) 0 (0) 3 (20) 
Previous intramuscular botulinum toxin-A injection, n (%) 15 (45) 8 (44) 7 (47) 
Use of mobility aid during functional capacity assessments, n 
(%) 
5 (15) 0 (0) 5 (33) 
Data are mean (SD) unless otherwise stated.  
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Descriptive statistics of the independent and dependent variables categorised by GMFCS 
level are presented in Table 4-2. There were significant differences between GMFCS 
levels across all three functional capacity measures, with GMFCS level II walking less on 
the 6MWT, performing less repetitions on the LSU test, and taking longer to ascend six 
stairs compared to participants who were GMFCS level I. All participants were able to 
complete the assessment tasks and no participant reported musculoskeletal pain during 
assessments.
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Table 4-2. Descriptive statistics of outcome measures categorised by GMFCS level. 
Outcome Overall (n=33) GMFCS I (n=18) GMFCS II (n=15) 
6MWT distance (m)  465.10 (155.40) 564.78 (112.98) 345.48 (107.65) 
LSU repetitions (n), median (range)  27.0 (4.0 – 74) 51.0 (22.0 – 74.0) 18.0 (4.0 – 38.0) 
TUS (s), median (range) 3.77 (2.30 – 16.78) 3.20 (2.30 – 4.93) 7.57 (3.0 – 16.78) 
MVIC (Nm.kg-1)    
 PF 0.81 (0.51) 1.01 (0.52) 0.57 (0.40)* 
 DF 0.15 (0.09) 0.18 (0.08) 0.11 (0.09)* 
Ankle joint stiffness (k) 0.10 (0.03) 0.09 (0.03) 0.11 (0.03) 
MG fascicle stiffness (k)  0.75 (0.88) 0.55 (0.49) 1.00 (1.16) 
Ankle joint slack angle (PF, deg) 17.44 (13.02) 19.94 (12.73) 15.15 (13.42) 
MG fascicle slack length (mm) 44.15 (12.10) 47.28 (10.32) 40.38 (13.34) 
Data are mean (SD) unless otherwise stated. *Significantly different to GMFCS Level I at p<0.05; Significantly different to GMFCS Level 
I at p<0.001. 
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 Six-minute walk test  
At a univariate level, there were associations between normalised PF and DF MVIC, MG 
slack length, height, age, limb involvement, and 6MWT distance that were significant at 
p<0.20 (Table 4-3). The final multiple linear regression model retained normalised PF 
MVIC, and GMFCS level (Table 4-4), F(2, 28) = 50.53, p<0.001, adjusted R2 = 0.77. No 
other independent variables were significant (p≤0.05) in the multiple linear regression 
model.  
 
Table 4-3. Univariate analysis of relationships between independent and dependent 
variables. Significant correlations (r) at p<0.05 are indicated in bold. 
 
Six-minute walk 
test distance (m) 
Lateral step-up 
test (total 
repetitions) 
Timed up-
stairs test (s) 
Age (years) -0.41 -0.58 0.56 
Height (m) 0.41 0.27 -0.23 
Weight (kg) -0.01 -0.05 0.03 
PF MVIC (Nm.kg-1) 0.65 0.71 -0.73 
DF MVIC (Nm.kg-1) 0.39 0.45 -0.53 
Ankle stiffness (k)  -0.20 -0.27 0.37 
MG fascicle stiffness (k) -0.32 -0.39 0.40 
Ankle slack angle (deg)  -0.30 -0.46 0.46 
MG fascicle slack length (mm)  0.39 0.38 -0.49 
For the timed up-stairs test, a negative correlation indicates a faster time. 
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Table 4-4. Results of multiple regression models. Adjusted R2 values indicate the cumulative R2 value for the regression model as each 
independent variable was entered in a stepwise process. 
Dependent variable N 
Independent variables 
entered stepwise into final 
model 
Regression 
coefficient ± SE p Value Adjusted R2  
Six-minute walk test 32 (1 outlier removed) PF MVIC (Nm.kg-1) 
GMFCS level 
164.34 ± 29.45 
-148.65 ± 29.75 
<0.001 
<0.001 
0.61 
0.77 
Lateral step-up test 
(Log transformed)  
30 (3 outliers 
removed) 
PF MVIC (Nm.kg-1) 
GMFCS level 
Age 
0.27 ± 0.08 
-0.23 ± 0.06 
-0.011 ± 0.004 
0.002 
0.001 
0.007 
0.57 
0.68 
0.76 
Timed up-stairs test 
(Log transformed) 
32 (1 outlier removed) PF MVIC (Nm.kg-1) 
GMFCS level 
Age 
-0.17 ± 0.05 
0.18 ± 0.05 
0.008 ± 0.003 
0.003 
0.001 
0.007 
0.50 
0.64 
0.72 
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 Lateral step-up test 
Univariate linear regression revealed that normalised PF and DF MVIC, MG fascicle 
stiffness, ankle joint slack angle and MG slack length, age, and limb involvement were 
associated (p<0.2) with LSU performance (log transformed) (Table 4-3). Normalised PF 
MVIC, GMFCS level, and age were retained in the final regression model (Table 4-4), F(3, 
26) = 29.36, p<0.001, adjusted R2 = 0.76. No other independent variables were significant 
(p≤0.05) in the multiple linear regression model.  
 
 Timed up-stairs 
Univariate analysis showed normalised PF and DF MVIC, ankle joint and MG fascicle 
stiffness, ankle joint slack angle and MG fascicle slack length, age and limb involvement to 
be significantly associated (p≤0.2) with TUS test performance (log transformed) (Table 4-
3). Normalised PF MVIC, GMFCS level, and age were retained in the final model (Table 4-
4), F(3, 28) = 27.06, p<0.001, adjusted R2 = 0.72. No other independent variables were 
significant (p≤0.05) in the multiple linear regression model. 
 
4.4 Discussion 
The multiple linear regression models developed in this study provide insight into potential 
underlying factors associated with walking ability and functional capacity in adults with CP. 
The main finding of this study was that maximum isometric PF strength explained 50 – 
61% of the variance in 6MWT, LSU test and TUS test performance of adults with CP. 
Maximum isometric PF strength explained more of the variance in walking capacity 
(6MWT, 61%) and LSU test performance (57%) compared to the TUS test (50%) 
indicating the relative importance of the calf muscles to walking ability in adults with CP. 
Maximum isometric PF strength of adults with CP in this study (0.81 ± 0.51 Nm.kg-1) was 
approximately 50% less than what has been found in TD young adults (1.50 ± 0.37 Nm.kg-
1), and approximately 35% less than TD adults aged over 70 years (1.19 ± 0.36 Nm.kg-
1).154 The relative reduction in muscle strength compared to TD adults is consistent with 
the literature describing muscle weakness in individuals with CP compared to their TD 
counterparts.8,28,144,155 Although not determined in this study, a loss of muscle volume,20 
altered muscle quality,27 and changes in activation properties102 may explain the relative 
muscle weakness compared to TD individuals. 
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The overall mean distance walked for adults with CP in this study on the 6MWT was 
465.10 ± 155.40 m, which is in agreement with previously reported 6MWT distances in 
adults with CP of similar functional classification.43,149 Typically developed older men and 
women aged between 55 and 70 years have been shown to walk greater distances on the 
6MWT,156 which may indicate an accelerated decline in walking capacity in the relatively 
younger adults with CP in this study (mean age 25 years) compared to older TD adults. Of 
our independent variables, maximum isometric PF strength, and GMFCS level were 
retained in the final regression model explaining a combined 77% of the variance in 6MWT 
distance. The significant relationship between PF strength and 6MWT in this study when 
controlling for GMFCS level, supports the evidence indicating the importance of the calf 
muscles in generating the power needed for an effective push-off during gait.157 This 
finding explains slightly more variance in 6MWT performance than has been shown in 
children and adolescents with CP, where ankle PF and hip flexor strength explained 
approximately 50% of the variance in 6MWT distance.141 
 
Our findings contradict a recent study assessing predictors of 6MWT performance in 
adults with CP (mean age 39 ± 12 years), where no relationship was found between lower 
limb muscle strength and 6MWT performance.149 The robustness of this finding is limited, 
however, due to muscle strength being measured using a subjective manual muscle 
testing method without objectively quantifying joint torque. Our model also incorporated 
GMFCS level as an independent variable that was significantly associated with 6MWT 
distance in the final model. This finding may be considered intuitive as adults with CP who 
have higher gross motor function walk significantly greater distances on the 6MWT.149 Age 
has been previously reported as a significant independent predictor of 6MWT distance in 
TD older adults.158 Age, however, was not a significant independent predictor of 6MWT in 
this study. This finding is in agreement with the limited 6MWT literature in adults with CP, 
where no effect of age was found in a sample with a greater mean age (mean, SD 39 ± 12 
years).149 The exclusion of age from our final 6MWT regression model may have been due 
to the relatively young to middle-age distribution of the participants, along with the 
presence of more important predictor variables.  
 
Maximum isometric PF strength explained the most variance in LSU test performance 
(adjusted R2=57%) and TUS test (adjusted R2=50%). For the LSU and TUS tests, GMFCS 
and age were also significantly and independently associated with test outcomes. There 
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was, however, less variance explained by PF strength for the TUS regression model than 
for the 6MWT and LSU test. Explanations for this include the potential use of the handrail 
for balance ascending stairs, as well as the likelihood for different neuromuscular demands 
and contribution of PF strength required in the TUS test. There was more variance 
explained by maximum PF strength in our sample of older adults for the LSU and TUS 
tests than has been shown in children with CP (28 – 35%).141,144 There is potentially 
greater deterioration in other physiological variables with ageing in individuals with CP, 
such as reduced rate of force development,38 reduced muscle activation capacity102 and 
increased co-contraction,102 culminating in a greater influence of muscle strength on these 
functional capacity outcomes compared to younger individuals.  
 
Clinically, joint stiffness (contracture) and muscle weakness are considered detrimental to 
functional capacity in individuals with CP. Even though MG muscle fascicle stiffness was 
higher in the GMFCS II group compared to GMFCS level I group, there was no significant 
relationship between passive muscle stiffness and any of the functional capacity outcomes 
in the multiple regression analyses. While passive stiffness has been shown to be 
moderately correlated to reduced toe-lift during gait (r=-0.48),38 compensatory movement 
strategies (altered kinematics) may be used by the individual to maintain walking and 
overall functional capacity.  
 
The significant relationship between PF strength and functional capacity outcomes found 
in this study indicates the potential for interventions targeting muscle weakness that may 
lead to improved function. Muscle weakness in adults with CP highlighted in this study 
indicates the need for early intervention to prevent the rapid decline in muscle health 
(muscle volume, quality, and function) that may occur before 30 years of age in adults with 
CP. To date, however, there is a lack of evidence linking an increase in lower limb strength 
following strength training interventions to improved functional capacity in adults with 
CP.43,159 The paucity of studies that have implemented robust PRT programs in individuals 
with CP, as well as the lack of objective neuromuscular outcome measures following the 
interventions, makes it difficult to draw conclusions regarding the effectiveness of strength 
training in this population.160 Given the high multimorbidity rates in middle-aged adults with 
CP, even without improvements in functional capacity following muscle strengthening 
interventions, there may be benefits to overall health wellbeing by maintaining muscle 
mass and strength across the lifespan.161 The design of robust exercise training 
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interventions in skeletally mature individuals with CP,152 with objective neuromuscular and 
functional outcome measures, show the most potential to further our understanding of the 
link between neuromuscular adaptation and functional capacity in this population.  
 
 Study Limitations  
It is not possible to establish a cause and effect relationship using a regression approach. 
The generalisability of the findings in this study are limited to the independent variables 
that were measured and included in the regression analyses in adults with CP classified as 
GMFCS level I or II. It is plausible that other potential predictors of neuromuscular 
performance, such as activation capacity, play a role in the diminished functional capacity 
in adults with CP that were not captured in this study. The LSU and TUS tests also contain 
elements of strength endurance, balance, coordination and power that were not measured 
in isolation in this study. Due to the plasticity of the human musculoskeletal system, 
alternative strategies and mechanisms might contribute to accomplishing functional 
capacity outcomes, overcoming any detriment in isolated torque generating capacity and 
increased passive stiffness. Musculoskeletal pain may impact functional capacity 
outcomes in some individuals with CP, and quantification of pain levels may be considered 
for inclusion in future studies. Nine participants had previous lower limb muscle-tendon 
surgery that may have influenced isometric strength and functional capacity outcomes not 
specifically accounted for in the regression analyses. Due to the time since surgery (5-40 
years); age of participants; and heterogeneity of surgical procedures, it was not possible to 
determine the impact of the prior surgical interventions on the outcome measures in this 
study. 
 
 Conclusions  
The results from this study further our understanding of how the deterioration of muscle 
strength is independently associated with functional decline in adulthood for people with 
CP. We therefore suggest that the relationship between muscle deterioration and 
functional decline with ageing in CP is primarily driven by a loss of muscle strength that 
can be measured objectively. Appropriately designed interventions to enhance muscle 
strength, such as PRT, might slow the decline in functional capacity and improve overall 
muscle health in individuals with CP as they age. 
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4.5 Supplementary files  
 Supplementary file 1 
 
Figure 4-1. Representative data of (A) ankle joint angle, (B) ankle joint torque, and (C) 
normalised EMG during a passive ankle rotation from PF to DF in the dynamometer. Black 
line, MG EMG; red line, LG EMG; blue line, SOL EMG; grey line, TA EMG. 
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 Supplementary file 2 
 
Figure 4-2. Representative data of (A) ankle joint torque versus ankle joint angle, and (B) 
ankle joint torque versus MG muscle fascicle length during a passive ankle rotation from 
PF to DF in the dynamometer. Red line, trial 1; blue line, trial 2; black dashed line, mean of 
all trials; grey dashed line, exponential fit of the mean curve.
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Effect of the FAST intervention on muscle size, strength and 
functional capacity 
 
In the previous chapter, it was established that muscle strength is important to functional 
capacity, whereas no relationship was found for muscle or joint stiffness. This finding, 
however, is an association and as such does not prove causal relationship between 
strength and functional capacity. This study thereby set out to investigate the causal 
relationships between the FAST intervention and muscle structure, strength, and functional 
capacity. This chapter specifically reports on the impact of the FAST intervention on lower 
limb muscle volumes, joint and muscle stiffness, muscle strength, and functional capacity. 
This is the first study to report muscle hypertrophy following FAST training in young adults 
with CP.  
 
 
 
 
 
 
Bibliographic details of published manuscript 
Gillett JG, Lichtwark GA, Boyd RN, Barber LA. Functional anaerobic and strength training 
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Abstract  
Purpose: To investigate the efficacy of a 12-week combined functional anaerobic and 
strength training program on neuromuscular properties and functional capacity in young 
adults with spastic-type cerebral palsy. Methods: 17 young adults (21±4 years, 9 males, 
Gross Motor Function Classification System level I=11, II=6) were randomised to 12 
weeks, 3 sessions per week, of high intensity functional anaerobic and progressive 
resistance training of the lower limbs (n=8), or a waitlist control group (n=9). Pre- and post-
training plantar flexor and tibialis anterior muscle volumes and composition, passive and 
active plantar flexor muscle properties, and functional capacity outcomes were assessed. 
Results: The training group had higher values compared to the control group (adjusted 
mean difference) at 12-weeks for: more- and less-impaired total plantar flexor and tibialis 
anterior muscle volumes; maximum isometric plantar flexion strength; muscle power sprint 
test peak power; agility shuttle time; composite functional strength score; and six-minute 
walk test distance. The change in total plantar flexor muscle volume was associated with 
the change in plantar flexor muscle strength. There were relationships between the 
change in plantar flexor muscle strength and change in functional capacity outcomes 
(functional strength; six-minute walk test). Conclusions: Combined functional anaerobic 
and strength training increased muscle size, strength and functional capacity in young 
adults with cerebral palsy. The addition of anaerobic training to progressive resistance 
training programs assists in the transfer to improved functional capacity. 
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5.1 Introduction  
Absolute muscle size and the rate of muscle growth are reduced in individuals with 
CP.19,98,162 The gap between growth rates in TD individuals and those with CP also widens 
with age.98,162 This impaired muscle growth and adaptation has been described as a 
potential mechanism for the development of skeletal muscle deformity in children with 
CP.30 Muscle size is a major determinant of muscle strength. Reduced muscle size may 
therefore be a large contributor to the hallmark characteristics of muscle weakness8 and 
reduced functional ability163 seen in this population. Adolescents and young adults with CP 
also have reduced lower limb muscle volumes relative to total body mass compared to 
their TD counterparts.164 This normalized muscle mass deficit may lead to difficulties 
performing activities that require force and power generation from the lower limbs. The 
reduced muscle mass at a young age in individuals with CP has recently been compared 
to sarcopenia among older TD adults.165 This may lead to an accelerated decline in 
muscular strength reserve and diminished oxidative capacity of muscle tissue that has a 
detrimental impact on metabolic health. 
 
Further musculotendinous adaptations such as reduced muscle quality (less force-
generating contractile tissue relative to non-contractile tissue),27 and increased joint and 
muscle fascicle stiffness21 may also result in the inability of the muscle fascicles to reach 
lengths favourable for high force production. Importantly, muscle size and fascicle 
architecture, along with strength and power have been shown to be responsive to PRT in 
TD individuals.74,91,166 
 
Improvements in strength have been demonstrated for both TD and individuals with CP 
following PRT.43,46,91,159,160 Multiple studies have reported limited evidence for subsequent 
improvements in functional capacity and translation to improved physical activity 
performance in individuals with CP.43,45,108,159 The lack of strength transfer to functional 
capacity improvements in previous strength training studies may be due to a lack of 
specificity of training modes; insufficient training loads to illicit adaptation; a lack of use of 
PRT guidelines; and the confounding effects of multiple impairments in individuals with CP 
such as muscle weakness, stiffness, and altered motor control, that may all influence 
function.53,167 
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The addition of functional training exercises to traditional PRT programs may lead to 
increased functional capacity according to the principle of specificity of training. Two well 
designed studies have reported improvements in functional capacity following specific 
anaerobic training in children and adolescents with CP.66,67 Isolated resistance training 
does not train the skills or movements required to perform functional tasks which may 
explain the incongruence between strength and functional adaptations following isolated 
resistance training interventions.43,45 
 
As most muscle strengthening interventions in individuals with CP have focused on 
improving strength and mobility, the outcome measures have been predominantly gross 
motor and functional capacity measures without examining the muscle itself. 81,159 Key 
morphological and architectural parameters such as muscle size, have been extensively 
evaluated following PRT interventions in the TD population that provide a link between 
changes in muscle structure and functional outcomes such as increases in strength and 
power.74,77 Skeletal muscle hypertrophy in TD adults has been reported across a wide 
variety of resistance training interventions, age ranges, muscle groups, and sexes.168,169 
While the evidence is strong for positive muscle adaptation following PRT in TD 
individuals,169,170 a recent systematic review found only preliminary evidence for improved 
muscle morphology and architecture in children and adolescents with CP.160 
 
To the best of our knowledge, there have been no studies published in adults with CP that 
have measured muscle morphology, architecture, or muscle quality changes after 
resistance training interventions. The hypertrophic response to resistance training could be 
better understood by testing the efficacy of PRT interventions in more skeletally mature 
individuals with CP, alongside a control group measured at identical time points. It remains 
unknown whether muscle in skeletally-mature individuals with CP can adapt similarly to TD 
muscle following PRT, and whether any morphological adaptations are related to strength 
and functional outcomes. Measuring muscle quality and muscle stiffness changes would 
also assist in understanding the structural mechanisms underpinning any functional 
capacity or strength improvements following training.  
 
The purpose of this study was to test the efficacy of a high intensity combined progressive 
resistance and anaerobic training intervention in individuals with CP aged 15 – 30 years. 
We hypothesised that combined functional anaerobic and strength training would result in 
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increased lower leg muscle volume, reduced muscle fascicle stiffness, and improvements 
in strength and functional capacity. 
 
5.2 Methods  
A waitlist randomised controlled trial was conducted to test the efﬁcacy of a 12-week, 3 
sessions per week, combined progressive resistance and functional anaerobic training 
program on lower limb neuromuscular properties and functional capacity compared to a 
waitlist control group.  
 
 Participants  
Participants were recruited across South East Queensland, Australia from the Queensland 
Cerebral Palsy Register; Queensland Paediatric Rehabilitation Service; Cerebral Palsy 
League Queensland; Brisbane Paralympic Football Program; and expression of interest 
advertising from July 2015 to August 2017. Written informed consent (assent if 15-18 
years) was obtained from participants and a parent or guardian (if participant <18 years). 
The study was approved by the Human Research Ethics Committees at The University of 
Queensland (2014000066); Children’s Health Queensland Hospital and Health Service 
(HREC/15/QRCH/30); and the Cerebral Palsy League of Queensland (CPL-2016-001). 
This study was registered with the Australian New Zealand Clinical Trials Registry 
(ANZCTR: 12614001217695). Male and female participants were included who: 1) were 
aged between 15 – 30 years; 2) were diagnosed as unilateral or bilateral spastic type CP; 
3) were able to walk independently; 4) were classified as levels I-II, using the GMFCS111; 
and 5) had a maximum passive ankle DF range of <5 degrees (knee fully extended).  
 
 Design and procedure  
Following baseline assessments, participants were stratified according to age in either 15-
18 years or 18-30 years band widths, and sex. Once stratified, participants were then 
randomised into either the immediate intervention group or waitlist control group using a 
computer-generated list of random numbers in concealed envelopes opened by non-study 
personnel. Participants assigned to the intervention group began training within 2 weeks of 
the baseline assessments. The control group received no resistance or anaerobic training 
and were allowed to continue with usual daily activities. Both groups were reassessed 
within 3 days of completing the 12-week intervention or control period. Data were collected 
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in the Centre for Sensorimotor Performance at The University of Queensland, Australia, for 
both baseline and follow-up assessments. The intervention took place in a fully equipped 
tertiary institution gymnasium in Brisbane, Australia. Blinding for all measures was not 
possible as participants and trainers were aware of group allocation. Assessors were not 
blinded to group allocation. Adherence to the training program was recorded by the trainer 
at the end of each completed prescribed training session in participant training diaries. The 
full study protocol has been published.152 
 
 Sample size  
As no previous randomised trials have measured lower limb muscle volumes following 
resistance training in young adults with CP, pilot data from TD individuals was used to 
determine the sample size for this study. An 8-week pilot study of our training program in 
10 TD individuals revealed a mean medial gastrocnemius muscle volume difference of 
11.5 mL post-training with an SD of the difference between means of 14.0 mL. An 
estimated effect size of 0.85 calculated from this pilot data was used in an a-priori power 
analysis determining that 16 experimental and 16 control subjects were required to confirm 
the null hypothesis with a power of 0.80 and an alpha level set at 0.05. To allow for an 
estimated 10% attrition rate during the intervention, 20 participants were required for each 
group. 
 
 Intervention 
A detailed description of the content and progression of the training intervention has been 
published in the study protocol.152 Participants randomised to the training group undertook 
three training sessions per week, for 12-weeks, totalling 36 sessions. The PRT component 
was performed first in each session, followed by the functional anaerobic exercises. 
Participants trained individually or in groups of no more than three, to allow strict 
supervision and adherence to the prescribed exercise and rest periods. The PRT 
component of each session consisted of five lower limb resistance exercise stations as 
follows: seated bent knee calf raise, leg press, seated straight knee calf press, seated TA 
raise, and standing calf raise. The resistance training program was periodised, comprising 
multiple sets of between 6 – 12 repetitions. Training sets and repetitions progressed 
according to the training program every four weeks and training load was adjusted during 
any session based on participants completing the required number of sets and repetitions 
to task failure.152 The functional anaerobic training component consisted of 2-3 functional 
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anaerobic exercises per session completed at maximal intensity that were adapted from a 
functional training study in children with CP, related to everyday activities such as stair 
climbing, bending, changing direction and stepping over obstacles,66 The number of 
anaerobic exercises per session; repetitions performed; and work to rest ratio progressed 
every 4 weeks.152 
 
 Primary outcome 
Full details of the outcome measures and instrumentation have been published in the 
study protocol.152 Muscle volumes were measured using magnetic resonance imaging pre- 
and post-intervention. Axial plane scans of the lower leg were acquired using a Siemens 
3.0 Tesla magnetic resonance imaging scanner (MAGNETOM Verio, Erlangen, Germany) 
with 2 x 6 channel body matrix array combined with 24 channel spine coil. 2-point gradient 
echo Dixon images were acquired in 2D with TR/TE = 970/13 ms, 140-degree flip angle, 
4mm slice thickness, 240 x 320 acquisition matrix, and 350 x 350 mm field of view. The 
borders of the individual muscles were manually segmented offline using Stradwin (V.4.2, 
Mechanical Engineering, Cambridge University, United Kingdom) reconstruction software, 
surface rendered, and then muscle volume (mL) calculations were performed using the 
measurement modules. This method has high test-retest reliability measuring medial 
gastrocnemius muscle volumes (ICC=0.99).121 
 
 Secondary outcomes 
Ankle and medial gastrocnemius fascicle active and passive mechanical properties were 
assessed during controlled movements using integrated dynamometry, surface 
electromyography, and B-mode ultrasound imaging.21 These outcomes were measured on 
the impaired limb in participants with unilateral CP, and the more-impaired limb in 
participants who had bilateral CP based on participant report. If the more impaired limb 
could not be determined, the right side was used. Two MVICs of the PF muscles were 
performed at five angles corresponding to 5%, 25%, 50%, 75%, and 95% of the range 
between maximum PF and maximum DF. A maximum voluntary isometric contraction of 
the DF muscles was also performed at 50% of the participants range of movement. The 
post-intervention MVICs in each participant were performed at the same ankle angles 
used to test their MVIC at baseline. Absolute (N·m) and normalized (N·m·mL-1, to PF and 
DF volume) maximum torque across this range was used for subsequent analysis. 
Changes in muscle fascicle length and pennation angle with changes in joint angle or 
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during contraction were assessed using ultrasound imaging and a semi-automated 
tracking algorithm.123,124,153 
 
Fascicle slack length was defined as the measured fascicle length (mm) from a slow 
passive ankle rotation (10 deg·s-1) at an ankle joint PF torque of 1N·m in all participants. 
Fascicle stiffness was calculated by fitting an exponential function to the muscle fascicle 
versus joint torque curve for three successive passive ankle rotations. The stiffness value 
is the coefficient obtained from the resultant exponential fit. Ankle slack angle (deg) and 
ankle joint stiffness was calculated using the same procedure, fitting an exponential 
equation to the ankle angle versus joint torque curve. A higher exponential coefficient 
corresponds to stiffer muscle fascicles or ankle joint. 
 
Intramuscular fat content of the medial gastrocnemius muscle was calculated from two-
point gradient echo Dixon magnetic resonance images27 in a subsample of participants 
(n=6 intervention; n=3 control). Erroneous Dixon image acquisition due to technical issues 
with the implemented protocol resulted in unusable data in 8 participants. The ratio of the 
water and fat signal intensities within the regions of interest along the midquartile of the 
muscle were used to quantify average intramuscular fat using the following equation: 
𝐴𝑓  = ∑ (
𝐼𝑓
𝐼𝑓+ 𝐼𝑤 
)  X 100
𝑛
𝑖=1
      [1] 
 
Where Af is the average percentage fat, If is the pixel intensity in fat-saturated images, and 
Iw is the pixel intensity in water-saturated images.  
 
The Muscle Power Sprint Test was used to estimate anaerobic power output.129 
Participants completed six 15m runs as quickly as possible with 10s rest between sprints. 
An individual’s ability to change direction rapidly without losing balance was assessed 
using the 10x5m sprint test.129 Participants performed ten 5m sprints continuously between 
two sets of cones. A 30s repetition maximum test was used as a functional strength 
assessment involving components of balance, speed, coordination, endurance and 
muscular strength.131 Participants completed as many repetitions as possible in 30s of the 
following exercises: 1) lateral step-up, 2) sit-to-stand, and 3) stand from half-kneel. The 
total number of repetitions performed in 30s for each exercise was summed and used in 
the analysis. The six-minute walk test was used to assess the maximum distance 
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participants could walk during a six-minute period on a 30m, indoor, flat, non-slippery 
track. A timed stairs test assessed the time taken for participants to ascend and descend a 
five-step set of stairs as quickly as possible (without running). The clinimetric properties of 
these outcome measures are reported in the full study protocol.152 Other secondary 
outcome measures were collected,152 however these are not reported in this paper as they 
do not contribute to the specific study aims and hypotheses. Assessments made at 12-
weeks post-intervention are not reported in this study. 
 
 Statistical Analysis  
Continuous data were examined with the Shapiro–Wilk test for normality. General linear 
models were used to compare the differences between groups for primary and secondary 
outcome variables at 12 weeks, with group allocation (waitlist, 0; intervention, 1; serving as 
the main effect within the model).  Baseline values, age, and sex were used as covariates 
in the regression models. Assumptions of the model were met, including homoscedasticity 
and linearity, and residuals found to be normal. Data are given as mean (SD), and alpha 
was set at 0.05 for primary analyses. Results are presented as between group differences 
with 95% Confidence Intervals (CI). The relationship between changes in muscle volume, 
strength, and functional capacity outcomes were assessed using linear regression. Data 
analysis was performed using SPSS (v.24, IBM Corporation, NY, USA). Analyses were 
conducted on the basis of intention to treat. Missing values were imputed as last 
observation carried forward.  
 
5.3 Results 
Study recruitment, allocation and follow-up are reported according to CONSORT 
guidelines in Figure 5-1. Participants who proceeded to baseline assessments were 
adolescents and young adults (n=18) with spastic-type CP (8 unilateral; 9 males; mean 
age 20.7 ± 4.1 years, range 15-28 years). One participant was excluded during the 
baseline assessments due to an inability to follow instructions resulting in a total sample 
size of 17 participants who progressed to the intervention phase.  
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Figure 5-1. CONSORT study flow diagram. Abbreviations: QCPR – Queensland Cerebral 
Palsy Register; QPRS – Queensland Paediatric Rehabilitation Service.
Assessed for eligibility (n=179) 
QCPR database (n=110) 
QPRS database (n=74) 
Other contact (n=5) 
Excluded (n=171) 
 Not meeting inclusion 
criteria (n=48) 
 Declined (n=21) 
 Did not respond (102) 
 Other reasons (n=0) 
Baseline (T1) 
assessments 
(n=18) 
Randomised (n=17) 
Excluded after T1 (n=1, 
inability to follow 
instructions) 
Allocated to intervention (n=8) 
 Received allocated 
intervention (n=8) 
 Did not receive allocated 
intervention (n=0) 
Age strata: 15 – 18 years 
(n=2); 18 – 28 (n=6) 
 
Allocated to waitlist (n=9) 
 Received allocated 
intervention (n=9) 
 Did not receive allocated 
intervention (n=0) 
 Age strata: 16 – 18 years 
(n=2); 18 – 27 years (n=7) 
 
Primary endpoint 
(T2)  
Lost to follow up (n=0)  
Discontinued intervention (n=0) 
 
  
Lost to follow up (n=1, interstate 
relocation) 
Discontinued intervention (n=0) 
  
Analysed (n=8) 
  
Analysed (n=9) 
  
Social media 
recruitment (n=10) 
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The personal demographics and characteristics at baseline are presented in Table 5-1.  
 
Table 5-1. Participant demographics and baseline characteristics. 
Characteristics  Intervention group (n= 8) Control group (n= 9) 
Age at enrolment, y:mo 20y6mo (4y8mo) 21y8mo (4y3mo) 
Sex: M/F 4/4 5/4 
Height, cm  163.3 (15.7) 170.3 (7.3) 
Weight, kg 67.7 (17.0) 68.4 (13.9) 
Lower limb involvement, n (%)   
 Unilateral 5 (62.5) 3 (33.3) 
 Bilateral 3 (37.5) 6 (66.7) 
GMFCS, n (%)   
 Level I  6 (75) 5 (55.6) 
 Level II 2 (25) 4 (44.4) 
Previous lower limb surgery,a n (%)    
 Yes 4 (50) 3 (33.3) 
Data are mean (SD). a Surgery types: muscle-tendon lengthening (n=7), osteotomy (n=2).  
 
In the intervention group, 8 participants started training and were assessed at 12 weeks 
(100% retention); in the waitlist control group, 8 participants were assessed at 12 weeks 
(88% retention), with one participant lost to follow-up due to relocation. Sensitivity analysis 
was performed by removing the one control participant with missing follow-up data from 
the post-intervention analysis to determine if their removal changed any of the results. The 
removal of their data did not influence the mean difference or statistical significance for 
any outcome measure.   
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On average, participants completed 33.7 (out of 36, 95% adherence) training sessions 
over the 12-week period. The mean total dose of the 12-week training intervention was 
38.9 hours, comprising 28.5 hours of PRT (73%) and 10.5 hours of functional anaerobic 
training (27%). There were two instances of minor musculoskeletal pain recorded during 
the intervention. One participant reported lateral ankle pain during the last two weeks of 
the training period that did not require medical treatment. The other participant reported 
lower back and knee pain during the last two weeks of the intervention which was treated 
by their physician. In both instances training continued, however individual exercises were 
modified by reducing the resistance training load and progressing once pain had ceased. 
Unadjusted baseline and 12-week follow-up data are presented in Table 5-2.  
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Table 5-2. Outcomes at baseline (T1) and follow-up (T2) assessments (immediately following intervention) for muscle morphology and 
architecture; maximum isometric strength; and functional capacity measures by group allocation. 
 
Outcomes 
T1 (baseline) mean (SD) T2 (12-weeks) mean (SD) 
Intervention (n=8) Control (n=9) Intervention (n=8) Control (n=9) 
Muscle volume (mL)     
More impaired limb     
 MG 115.50 (48.85) 145.12 (53.75) 125.54 (58.49) 140.63 (47.50) 
 LG 62.81 (19.07) 87.93 (29.49) 69.60 (28.75) 83.94 (27.85) 
 SOL 248.37 (151.73) 313.37 (76.99) 263.39 (165.11) 306.47 (73.54) 
 Total PF (summed MG, LG, SOL) 425.91 (205.76) 545.71 (150.33) 458.53 (227.86) 531.04 (136.50)  
 TA 56.20 (21.51) 70.43 (19.74) 60.84 (25.38) 69.72 (22.81) 
Less impaired limb      
 MG 161.77 (79.91) 172.41 (59.38) 179.70 (93.18) 168.84 (56.27) 
 LG 80.56 (39.24) 92.94 (31.24) 90.53 (43.99) 89.38 (27.91) 
 SOL 286.25 (121.32) 342.84 (78.50) 309.92 (146.43) 336.45 (77.05) 
 Total PF (summed MG, LG, SOL) 528.58 (229.95) 608.27 (102.94) 580.15 (274.14) 594.67 (151.71) 
 TA 76.66 (35.53) 88.18 (29.94) 80.60 (35.96) 86.76 (29.12) 
More impaired limb MG intramuscular fat (%)b 19.02 (12.51) 21.96 (12.97) 18.52 (13.72) 23.85 (8.18) 
Less impaired limb MG intramuscular fat (%)b 18.45 (12.83) 20.87 (11.63) 17.84 (12.39) 21.83 (8.66) 
Passive fascicle stiffness (k)  0.56 (0.44) 0.42 (0.19) 0.44 (0.15) 0.35 (0.16) 
Passive ankle stiffness (k) 0.09 (0.02) 0.08 (0.02) 0.08 (0.01) 0.08 (0.01) 
Ankle slack angle (PF deg)  16.30 (11.97) 22.47 (11.21) 22.79 (6.95) 21.34 (11.24) 
Fascicle slack length (mm) 45.83 (7.05) 51.23 (6.64) 46.50 (10.12) 48.47 (6.36) 
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Isometric strength (N·m)     
 PF 67.39 (32.42) 90.51 (26.41) 84.32 (26.28) 80.90 (33.10) 
 DF 9.28 (4.47) 13.69 (7.73) 11.56 (4.61) 12.76 (6.93) 
Normalised isometric strength (N·m·mL-1)     
 PF 0.17 (0.01) 0.17 (0.03) 0.20 (0.05) 0.16 (0.05) 
 DF 0.18 (0.10) 0.19 (0.10) 0.21 (0.12) 0.19 (0.09) 
Ankle angle at maximum isometric PF strength (deg) -17.38 (5.60) -16.11 (5.49) -17.38 (5.60) -16.11 (5.49) 
Ankle angle at maximum isometric DF strength (deg) 10.06 (4.50) 8.67 (10.44) 10.06 (4.50) 8.67 (10.44) 
Power     
 Peak MPST (W) 304.07 (289.53) 389.19 (268.55) 330.08 (289.26) 381.08 (260.70) 
 Mean MPST (W) 242.43 (221.59) 344.41 (240.93) 272.29 (231.92) 340.23 (241.32) 
Agility      
 10x5m Shuttle (s) 28.86 (10.93) 24.77 (8.98) 25.00 (8.08) 24.42 (8.92) 
Functional strength      
 30sRM Total Score (repetitions) 69.00 (37.99) 83.78 (34.35) 103.63 (40.97) 86.44 (37.30) 
Timed stairs      
 Time up-stairs (s) 4.38 (2.13) 3.24 (0.43) 3.30 (0.85) 3.10 (0.41) 
 Time down-stairs (s) 5.48 (4.50) 2.99 (0.56) 3.88 (2.72) 2.86 (0.61) 
Walking ability      
 6MWT distance (m) 500.35 (145.09) 543.46 (139.90) 530.91 (124.67) 521.41 (133.36) 
MG, medial gastrocnemius; MPST, muscle power sprint test; LG, lateral gastrocnemius; SOL, soleus; total PF, summed muscle volume 
of medial gastrocnemius, lateral gastrocnemius and soleus; TA, tibialis anterior; Functional strength, summed score of 30s repetition 
maximum for lateral step-up, lunge, and sit-to-stand; 6MWT, six-minute walk test; 30sRM, 30-second repetition maximum.; negative 
ankle angle represents dorsiflexion; b Usable data for intervention group (n=6), control group (n=3).  
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Adjusted mean differences between groups at 12-weeks are presented in Table 5-3.  
 
Table 5-3. Difference between intervention and control groups immediately following 
intervention (T2) for primary and secondary outcome measures adjusted for baseline 
values, age, and sex. 
 
Outcome measure 
 
Mean difference (95% CI) 
 
p 
Muscle volume (mL)    
More impaired limb MG  13.21 (0.96 – 25.45) 0.037 
More impaired limb LG  12.96 (2.48– 23.49) 0.020 
More impaired limb SOL  25.50 (13.66 – 37.34) 0.001 
More impaired limb total PF  48.77 (22.54 – 75.01) 0.002 
More impaired limb TA  7.76 (3.19 – 12.33) 0.003 
Less impaired limb MG  20.46 (9.04 – 31.89) 0.002 
Less impaired limb LG  12.98 (1.67 – 24.28) 0.028 
Less impaired limb SOL  36.44 (13.96 – 58.93) 0.004 
Less impaired limb total PF  69.89 (29.28 – 110.51) 0.003 
Less impaired limb TA  5.12 (0.67 – 9.57) 0.028 
Intramuscular fat (%)b     
More-impaired limb MG  -2.31 (-10.30 – 5.69) 0.468 
Less-impaired limb MG -1.97 (-8.13 – 4.18) 0.424 
Passive properties     
Passive fascicle stiffness (k)  0.07 (-0.08 – 0.22) 0.336 
Passive ankle stiffness (k) -0.01 (-0.02 – 0.01) 0.653 
Fascicle slack length (mm) 3.17 (-2.67 – 9.00) 0.260 
Ankle slack angle (deg)  -4.71 (-14.24 – 4.82) 0.303 
Strength and functional capacity    
Isometric PF strength (N·m) 22.47 (3.36 – 41.57) 0.025 
Isometric DF strength (N·m) 2.53 (-0.44– 5.51) 0.088 
Normalised isometric PF strength (N·m·mL-1) 0.05 (0.01 – 0.09)  0.031 
Normalised isometric DF strength (N·m·mL-1) 0.03 (-0.03 – 0.09)  0.266 
Functional strength (total repetitions) 32 (21 – 43) <0.001 
MPST peak power (W) 31.25 (4.49 – 58.01) 0.026 
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MPST mean power (W) 34.85 (-5.63 – 75.33) 0.085 
10x5m Agility Shuttle (s) -2.83 (-5.02 – -0.64) 0.016 
6MWT (m) 47.65 (16.16 – 79.14) 0.006 
Timed Up-Stairs (s) -0.25 (-0.62 – 0.12) 0.167 
Timed Down-Stairs (s) -0.44 (-1.20 – 0.32) 0.229 
Abbreviations not listed in thesis: Total PF, summed muscle volume of medial 
gastrocnemius, lateral gastrocnemius and soleus; Functional strength, summed score of 
30s repetition maximum for lateral step-up, lunge, and sit-to-stand; negative time (s) 
indicates an improvement; b Usable data for intervention group (n=6), control group (n=3). 
 
At 12-weeks, PF and TA muscle volumes of the more- and less-impaired limbs were 
significantly greater in the training group than the control group. The proportion of medial 
gastrocnemius intramuscular fat content was not significantly different for the usable data 
in the intervention group (n=6) compared to the control group (n=3) at 12-weeks. There 
were no statistical differences in passive muscle or ankle joint properties between the 
training and control groups at 12-weeks.  
 
Absolute and normalized maximum isometric PF strength was greater in the training group 
than the control group at 12-weeks (Table 5-3). Peak anaerobic power, functional strength, 
agility, and walking distance were greater in the intervention group compared to the control 
group at 12-weeks (Table 5-3).  
 
The change in total PF muscle volume was associated with the change in isometric PF 
strength (R2=0.47, p=0.002). There were relationships between the change in isometric PF 
strength and changes in composite functional strength score (R2=0.32, p=0.018), and the 
six-minute walk test distance (R2=0.28, p=0.028). 
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5.4 Discussion 
A randomised controlled trial of a 12-week combined progressive resistance and functional 
anaerobic training program in young adults with CP demonstrated a significant increase in 
PF and TA muscle volumes, along with a concurrent increase in strength and functional 
capacity. To our knowledge, this is the first study to report increases in muscle size 
following PRT in young adults with CP that were significantly related to functional capacity 
and muscle strength improvements. These findings support the importance of appropriate 
exercise intervention design to improve neuromuscular impairments and functional 
capacity in individuals with CP.66,67 
 
The magnitude of hypertrophy shown within the training group (7.5 – 9.6% across PF 
muscles) was of a similar magnitude to lower limb muscle hypertrophy in TD adults that 
has been reported following PRT.74,169 The hypertrophy seen in this study is less, however, 
than previously reported muscle volume increases of 23-24% in the medial and lateral 
gastrocnemii following targeted PF strength training in children with CP.108 The large 
amount of hypertrophy reported in a pre-post intervention study by McNee et al108 may be 
explained by lower baseline muscle volumes from their younger sample (age range 6 – 16 
years), as well as natural muscle growth over the 10 week intervention period, resulting in 
a larger absolute increase in muscle size than that reported in this study.  
 
The external training stimulus is responsible for promoting the complex post-exercise 
physiological cascade, shifting muscle protein balance to favour synthesis over 
degradation, that ultimately leads to a hypertrophic response (increased contractile tissue 
size).171,172 Skeletal muscle hypertrophy has been proposed as the primary mechanism 
underpinning the growth of contractile tissue volume following PRT in humans.170 
Achieving recruitment of the greatest number of available muscle fibres and exposing 
them to the exercise stimulus appears to be important for attaining skeletal muscle 
hypertrophy in TD individuals.168 In the present study, there was more hypertrophy in the 
PF of the less-impaired limb compared to more-impaired limb. Designing appropriate PRT 
parameters in individuals with CP may therefore be imperative when targeting specific 
muscles, where range of movement may be reduced impacting the amount and range of 
tension that can be developed in the muscles. Individuals classified at lower GMFCS 
levels (III-V), with a greater muscle contracture, reduced range of motion, bony deformity, 
or reduced motor control may not be able to recruit a large enough number of muscle 
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fibres, as well as expose the recruited muscle fibres to the exercise stimulus (loaded 
controlled contraction) to initiate a hypertrophic response. The conventional dynamic PRT 
implemented in this study, in high functioning individuals with CP (GMFCS levels I-II), 
followed prescribed guidelines set down by international strength and conditioning 
associations that have produced significant skeletal muscle hypertrophy in TD 
individuals.168 
 
The upregulation of satellite cell activity has been proposed as a key mechanism 
underpinning skeletal muscle growth during development.173 There is conjecture in the 
literature as to whether or not satellite cell addition is required for skeletal muscle 
hypertrophy.174 Recent evidence suggests children with CP muscle contracture (GMFCS 
levels II-V) have a reduced number of satellite cells.3 Reduced satellite cell number has 
therefore been proposed to account for the reduced muscle growth in individuals with CP, 
as well as a diminished ability to strengthen these muscles.173 In addition, there is 
evidence of competing signalling pathways of muscle hypertrophy from altered 
transcriptional profiles analysed using muscle biopsies from wrist muscles in six children 
with CP with severe contracture.41 The heterogeneous presentation of CP poses the 
question as to whether a reduction in satellite cell activity and altered myogenic signalling 
pathways occurs in all muscles of individuals with the disorder, who may be of varying 
functional classification (GMFCS levels I-V), or only in the most severely impacted 
muscles (muscular contracture). The measurement of cellular mechanisms was beyond 
the scope of this study, making it difficult to know whether the skeletal muscle hypertrophy 
and muscle strengthening were mediated by an increase in satellite cell activity, or via 
other mechanisms. Further research is needed to determine the cellular mechanisms for 
muscle adaptation following training interventions in individuals with CP.  
 
Intramuscular fat content did not change following training. An increase in contractile 
tissue after training may therefore have been accompanied by concurrent increases in 
non-contractile tissue resulting in similar muscle compartment tissue composition at 12-
weeks. An absolute increase in contractile tissue, however, would still have a positive 
impact on the force-generating capacity of the muscle. Any increase in non-contractile 
tissue that may have occurred didn’t result in stiffer muscle fascicles, as the passive 
medial gastrocnemius muscle fascicle stiffness didn’t increase following training. This 
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finding must be interpreted with caution due to the limited number of Dixon images that 
could be used in the analysis. 
 
Maximum isometric PF strength increased after training within the training group by 25%. 
Furthermore, the change in total PF muscle volume was significantly associated with the 
change in PF strength (R2=0.47), indicating a positive relationship exists between PF 
muscle hypertrophy and strength in people with CP. When PF strength was normalized to 
total PF muscle volume, there was still a significant difference between groups at 12-
weeks, suggesting that the strength increase of the training group was not explained by 
morphological changes alone. A plausible explanation for this is the neural changes that 
occur alongside muscular adaptation following PRT leading to improved motor learning 
and control.80 Similar increases in strength (27%) have been reported in young adults with 
CP (GMFCS levels II-III) following a robustly designed lower limb PRT intervention.43 
 
The young adults in the training group showed improvements from baseline to 12-weeks in 
anaerobic capacity (peak power, 8.3%), functional strength (30s repetition maximum test, 
50.2%), agility (13.4%), and walking capacity (six-minute walk test, 6.1%). In this study, 
functional anaerobic exercises were conducted based on a previous 8-month functional 
training program in younger individuals with CP (aged 7-18 years), which showed 
improvements in anaerobic capacity (25%) and functional strength (20-23%).66 A recent 
functional power training study performed in even younger children with CP (aged 4-10 
years), used similar exercises with the addition of external load, and found 83% 
improvement in anaerobic capacity measured using the muscle power sprint test.67 The 
functional anaerobic training in our study made up less than 30% of the total training 
program volume, which may explain the reduced gains in anaerobic capacity, but greater 
functional strength improvements seen in our group of young adults with CP compared to 
previous studies.66,67 The participants in our study were also of greater mean age 
compared to previous interventions, and of high functional classification (GMFCS level 
I=11; level II=6), potentially reducing the capacity for improvement in functional tasks due 
to their higher pre-training level.  
 
The improved walking capacity on the six-minute walk test in the training group after 
training compared to the control group (MD 47.65m) is similar to the proposed 
improvement (50m) required to be of clinical and functional importance to adults with CP.52 
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This finding provides evidence of a beneficial transfer to a functional capacity task that was 
not specifically trained. An increased rate of force development in the DF muscles, as well 
as greater range of ankle joint movement during gait has been reported previously 
following PRT in adults with CP, supporting the notion that PRT of the lower extremity 
muscles can improve gait outcomes in this population.146 
 
The change in PF strength in young adults with CP in this study was significantly 
associated with changes in their functional strength test score (R2=0.32) and six-minute 
walk test distance (R2=0.28). This finding indicates that an increase in PF strength 
underpinned a significant proportion of the improvement in functional capacity outcomes. 
This finding supports recent evidence that muscle strength is an important predictor of 
lower limb functional capacity tasks in adults with CP.163 A further explanation of the 
improvements in functional capacity measures was the specificity of our training program. 
The functional anaerobic training included activities such as step-ups, shuttle running, stair 
climbing and agility drills that were designed to improve anaerobic capacity in a context 
related to everyday activities. Part of the improvements in functional capacity outcomes 
were likely due to performing training tasks that closely resembled the outcome measures.   
 
 Limitations  
A potential limitation was that we were unable to definitively separate the contribution of 
PRT and anaerobic training components to the changes in outcome measures. The PRT 
component, however, made up more than 70% of the total training volume, so it was the 
likely contributor to the muscle hypertrophy and strength improvements of the lower leg 
muscles in this study. The target sample size was not met despite an extensive 
recruitment strategy being implemented over two years. The recruitment strategy utilised 
local CP register databases; targeted mail-outs; social media advertising; and 
rehabilitation hospitals. The study was constrained by a single-site for the intervention, 
which limited our recruitment to participants within geographical locations able to access 
the training facility. The study also had a limited timeframe for completion resulting in 
recruitment being halted prior to the targeted sample size being reached. Despite the 
smaller sample size, this intervention was feasible in high functioning young adults with CP 
and found differences in muscle volumes, strength and functional capacity between groups 
at 12-weeks. Additional limitations include the imbalance between groups in terms of lower 
limb involvement and GMFCS level, and the lack of assessor blinding for outcome 
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measures. Future research is required with larger sample sizes in adults with CP, across 
wider functional classification levels, to further investigate the neuromuscular responses to 
PRT in this population.   
 
 Implications 
From a clinical perspective, functional strength and measures of functional capacity 
improved after training, which provides strong evidence for the inclusion of functional 
anaerobic exercises in PRT interventions for individuals with CP. This type of training is 
relatively inexpensive, accessible in the community, and provides a potential avenue to 
address the muscle size deficit seen in adolescents and young adults with CP. 
117 
 
Contribution to the authorship of the following submitted 
manuscript incorporated as Chapter 6:  
Gillett JG, Lichtwark GA, Carty CP, Boyd RN, Barber LA. The effect of combined functional 
anaerobic and strength training on treadmill gait kinematics and kinetics in ambulatory 
young adults with cerebral palsy. Submitted to Gait & Posture.  
 
Contributor Statement of contribution 
Jarred Gillett (Candidate) Conception and design (70%) 
Conducted experiments (85%) 
Data and statistical analysis (70%) 
Data interpretation (70%) 
Wrote and edited paper (75%) 
Glen Lichtwark  Conception and design (10%) 
Conducted experiments (10%) 
Data and statistical analysis (10%) 
Data interpretation (5%) 
Wrote and edited paper (5%) 
Christopher Carty  Data and statistical analysis (10%) 
Data interpretation (5%) 
Wrote and edited paper (5%) 
Roslyn Boyd  Conception and design (10%) 
Data interpretation (5%) 
Wrote and edited paper (5%) 
Lee Barber Conception and design (10%) 
Conducted experiments (5%) 
Data and statistical analysis (10%) 
Data interpretation (15%) 
Wrote and edited paper (10%) 
6  
118 
 
Effect of the FAST intervention on treadmill gait kinematics 
and kinetics 
 
The FAST training program increased plantar flexor and tibialis anterior muscle sizes, 
strength and functional capacity as reported in Chapter 5. Part of the improvements in 
functional capacity may have been due to improved gait kinematics, kinetics and temporal-
spatial parameters. It may also be important to establish whether the increase in muscle 
size and strength is transferred to improved gait via increased ankle power generation or 
improved ankle dorsiflexion during the swing and stance phases. This chapter describes 
the gait outcomes following the FAST intervention.  
 
 
 
 
 
 
 
 
This manuscript is under review in the peer-reviewed scientific journal, Gait & Posture. 
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Abstract 
Leg muscle weakness is a major impairment for individuals with cerebral palsy and is 
related to reduced functional capacity. Evidence is limited regarding the translation of 
strength improvements following conventional resistance training to improved gait 
outcomes. The purpose of this study was to evaluate the secondary effects of a combined 
functional anaerobic and strength training intervention on gait kinematics and kinetics in 
individuals with cerebral palsy aged 15 – 30 years. 17 young adults (21±4 years, 9 males, 
GMFCS I=11, II=6) were randomised to 12 weeks, 3 sessions per week, of high intensity 
functional anaerobic and progressive resistance training of the lower limbs (n=8), or a 
waitlist control group (n=9). Pre- and post-training outcomes included maximum ankle 
dorsiflexion angle at foot contact and during stance, gait profile score, ankle and hip power 
generation during late stance, and the ratio of ankle to hip power generation. There were 
no between-group differences at 12-weeks for any kinematic or kinetic outcome variable. 
Within-group analysis revealed an increase in peak ankle power during late stance (0.31 ± 
0.28 W.kg-1, p=0.043) and ankle to hip power ratio (0.43 ± 0.37, p=0.034) following 
training in the intervention group. The training intervention led to increased overground 
walking capacity, agility and sprint power, compared to the control group, without any 
between-group differences in gait kinematics or kinetics. Improvements in overground 
measures of functional capacity in high functioning young adults with cerebral palsy 
occurred in the absence of changes in treadmill gait kinematics and kinetics. 
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6.1 Introduction  
Effective walking may be compromised in individuals with CP due to both altered ability to 
coordinate muscle contractions, as well as adaptations in the musculoskeletal system that 
occur secondary to the brain lesion that causes CP. Secondary musculoskeletal 
adaptations include reduced leg muscle volumes,20 increased muscle and ankle joint 
stiffness,21 reduced muscle activation,101 muscle weakness,163 contracture,175 and bony 
deformity.176 Combined with an already compromised motor control, these adaptations 
commonly result in equinus177 and crouch178 gait patterns depending on their relative 
contributions and whether the individual has unilateral or bilateral limb involvement.  
 
Force contributions from the PF muscles are particularly important for body weight support 
during stance, and propulsion during push-off. In children with CP, the alterations to the PF 
muscle-tendon units (MTU) may therefore contribute to reduced ankle joint power 
generation during gait.35,179 As individuals with CP develop, the PF muscle growth 
trajectory is reduced compared to aged matched TD peers,162 and the muscle size deficit 
increases relative to total body mass into adulthood,164 which may pose a further challenge 
for lower limb power generation during gait. The maximum isometric strength of the PF 
muscles have been recently shown to explain 61% of the variance in 6MWT performance 
in adults with CP.163 In another experimental study on adults with CP, impaired gait 
function was associated with reduced rapid force generation and increased passive 
stiffness of ankle muscles.38 Taken together, these findings support the importance of 
muscular strength for maintaining mobility in this population, suggesting that interventions 
targeting neuromuscular properties of the ankle PF might be beneficial for improving gait 
function.  
 
Despite these findings, and those from other cross-sectional studies reporting positive 
correlations between strength and mobility in individuals with CP,4,37,163 there is a paucity 
of evidence regarding the translation of strength improvements following resistance 
training to mobility-related measures such as walking performance.43,45,57,159  One recent 
quasi-controlled study implemented a lower limb explosive PRT program in adults with CP 
and reported increased rate of force development in ankle DF muscles, as well as an 
increase in ankle DF during toe clearance and at foot contact.146 There were no post-
training differences found however, in functional capacity measures (6MWT; 10m walk 
test; timed up and down stairs test) between the training and control groups. Individuals 
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with CP have difficulties with co-ordination and motor control, therefore, providing 
resistance training as an isolated intervention may not enhance motor learning or translate 
to improvements in walking ability.63 
 
We have previously published a combined FAST protocol designed to improve lower limb 
muscle properties and functional capacity in adolescents and young adults with CP.152 The 
resistance training component of the FAST intervention specifically targeted the PF 
muscles. Participants in the 12-week FAST intervention group increased lower limb 
muscle size, isometric strength and functional capacity (6MWT; agility; muscle power 
sprint test) compared to the control group after training.180 It remains unknown whether 
muscle morphological or functional capacity improvements were related to any changes in 
overall gait quality or individual gait parameters. Therefore, the purpose of this study was 
to evaluate the secondary effects of the FAST intervention152 on gait kinematics and 
kinetics in individuals with CP aged 15 – 30 years. We hypothesised that combined 
functional anaerobic and strength training would result in increased ankle DF at foot 
contact and during stance, improved gait profile scores, and increased ankle power during 
late stance, compared to a control group receiving no training. 
 
6.2 Methods  
A waitlist randomised controlled trial was conducted to test the efﬁcacy of a 12-week, 3 
sessions per week, combined progressive resistance and functional anaerobic training 
program on lower limb gait kinematics and kinetics compared to a waitlist control group. 
This study presents secondary gait outcome data from a published trial.152,180 
 
 Participants  
Male and female participants aged 15 – 30 years were recruited who had a diagnosis of 
unilateral or bilateral spastic type CP; able to walk independently; and classified as level I 
or II, using the GMFCS.111 Recruitment occurred from July 2015 to August 2017 via the 
Queensland Cerebral Palsy Register; Queensland Paediatric Rehabilitation Service; 
Cerebral Palsy League Queensland; Brisbane Paralympic Football Program; and 
expression of interest advertising. Written informed consent (assent if 15-18 years) was 
obtained from all participants and the study was approved by institutional ethics 
committees (UQHREC 2014000066; HREC/15/QRCH/30; CPL-2016-001).  
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 Design and setting 
Participants were stratified according to age in either 15-18 years or 18-30 years band 
widths, and sex, following the baseline measures. Once stratified, participants were then 
randomised into either the immediate intervention group or waitlist control group using a 
computer-generated list of random numbers in concealed envelopes opened by non-study 
personnel. The control group received no prescribed training and were allowed to continue 
with usual daily activities. The intervention took place at a tertiary institution gymnasium, 
and commenced within 2 weeks of randomisation to the intervention group. Both groups 
were reassessed within 3 days of completing the 12-week intervention or control period. A 
training diary was completed for all participants to monitor adherence and session 
performance.   
 
 Intervention  
A detailed description of the acute program variables and exercises performed in the 
FAST intervention can be found in the published study protocol.152 Briefly, participants 
randomised to the intervention group undertook three supervised training sessions per 
week, for 12-weeks. Each session comprised PRT and functional anaerobic exercises. 
The PRT component was performed first in each session, followed by the functional 
anaerobic exercises. The PRT specifically targeted the PF muscles and TA, comprising 
the following exercises: seated bent knee calf raise, leg press, seated straight knee calf 
press, seated TA raise, and standing calf raise. The PRT was periodised, comprising 
multiple sets of between 6 – 12 repetitions. The number of sets and set structure 
progressed every four weeks and training load could be adjusted during any session. Two 
or three (depending on training period) functional anaerobic exercises were performed per 
session, completed at maximal intensity lasting between 20 and 30 seconds per bout. 
These exercises were related to everyday activities such as stair climbing, bending, 
changing direction and stepping over obstacles.66 The number of anaerobic exercises per 
session; repetitions performed; and work to rest ratio progressed every 4 weeks.152 
 
 Gait analysis protocol  
Participants walked at a self-selected walking speed in enclosed footwear on a force 
instrumented, tandem (fore-aft split belt) treadmill (AMTI, USA) while 3D kinematics and 
kinetics were simultaneously acquired. Participants self-selected walking pace was 
determined for both baseline and follow-up assessments by increasing or decreasing the 
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treadmill belt speed at 0.2 km.hr-1 increments each 30 – 60s until they reported the speed 
that was most comfortable. A minimum of ten strides were collected for each individual, 
with the average of all available complete strides used in the analysis for each participant. 
All discrete measurements were made on the impaired leg in individuals with unilateral CP, 
and on the most impaired leg in individuals with bilateral CP. Full details of the outcome 
measures and instrumentation have been published in the study protocol.152 
 
 Data collection and processing 
Three-dimensional motion capture data was collected at 200 Hz using an 8-camera motion 
capture system (Oqus, Qualisys, Sweden). Thirty-two reflective markers (12 mm) were 
attached to specific anatomical locations on the pelvis (anterior and posterior superior iliac 
spines), thigh (greater trochanter, 3-marker cluster), knee (medial and lateral femoral 
condyles), shank (3-marker cluster), ankle (medial and lateral malleoli) and foot (first 
metatarsal head, fifth metatarsal head, calcaneus), and used to calculate ankle, knee and 
hip joint angles. 
   
Ground reaction forces (GRF) were collected at 2000 Hz from the front and rear force 
plates mounted beneath the treadmill, synchronised to the marker trajectory data. Marker 
trajectory and GRF data were filtered with a bidirectional second-order low-pass 
Butterworth digital filter with a 15 Hz cut-off frequency. A modified Gait2392 model181 was 
scaled using marker locations from a static calibration trial for each participant, in 
conjunction with standard scaling procedures using OpenSim software (v3.2).182 Joint 
angles and moments were computed using inverse kinematics and dynamics analyses in 
OpenSim (v3.2).182 Instantaneous joint powers for the ankle, knee, and hip were calculated 
by multiplying the net joint moments by joint velocities. Joint moments and powers were 
normalised to each individual’s body weight.  
 
Primary outcomes specified a-priori in the study protocol were walking speed (m.s-1), stride 
length (m), and maximum ankle DF at foot contact and during the stance phase. The gait 
profile score (GPS)(o)183 was calculated to assess overall gait quality before and after the 
intervention. Each individual gait variable score that made up the GPS was calculated as 
the root mean square (RMS) difference between the median of all available gait cycles 
from the CP participants, and that of a reference group of ten TD young adults (aged 24 ± 
4 years; height 178.8 ± 6.6 cm; weight 80.3 ± 12.0 kg) collected using an identical protocol 
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and instrumentation. A minimum change in GPS of 1.6o was used to determine a 
meaningful change in gait 184. Other secondary outcomes included peak positive ankle 
power in late stance (W.kg-1), peak positive hip power in late stance (W.kg-1), and the ratio 
of peak ankle to peak hip power during late stance. Custom Matlab (The Mathworks, USA) 
scripts were written to perform all analyses following the inverse dynamics procedures.   
 
 Data analysis  
Primary outcome measures were compared between the intervention and control groups 
at 12-weeks using general linear models with group allocation serving as the main effect 
within the model. Covariates in the regression models were baseline values, age, and sex. 
Alpha was set at 0.05 for primary analyses. Within-group analysis was performed on the 
secondary outcome measures using paired t-tests. All available data was included in the 
analysis using the intention to treat principle. The carry forward method was not applied for 
the specific variables where data was missing to avoid introducing bias to the analysis with 
a small sample size.185 Statistical analysis was conducted using SPSS (v.24, IBM 
Corporation, USA). 
 
6.3 Results  
A flow diagram of study recruitment, allocation and follow-up is reported according to 
CONSORT guidelines in Figure 6-1.  
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Figure 6-1. CONSORT study flow diagram. Abbreviations: QCPR, Queensland Cerebral 
Palsy Register; QPRS, Queensland Paediatric Rehabilitation Service.   
Assessed for eligibility (n=179) 
QCPR database (n=110) 
QPRS database (n=74) 
Other contact (n=5) 
Excluded (n=171) 
 Not meeting inclusion 
criteria (n=48) 
 Declined (n=21) 
 Did not respond (102) 
 Other reasons (n=0) 
Baseline (T1) 
assessments (n=18) 
Randomised (n=17) 
Excluded after T1 (n=1, 
inability to follow 
instructions) 
Allocated to intervention (n=8) 
 Received allocated 
intervention (n=8) 
 Did not receive allocated 
intervention (n=0) 
 Age strata: 15 – 18 years 
(n=2); 18 – 28 (n=6) 
 
Allocated to waitlist (n=9) 
 Received allocated 
intervention (n=9) 
 Did not receive allocated 
intervention (n=0) 
 Age strata: 16 – 18 years 
(n=2); 18 – 27 years (n=7) 
 
Primary endpoint 
(T2)  
Lost to follow up (n=1; technical 
issue with data collection) 
 
  
Lost to follow up (n=2; 1 interstate 
relocation, 1 data not collected 
within timeframe) 
  
Analysed (n=7) 
  
Analysed (n=7) 
  
Social media 
recruitment (n=10) 
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There were missing data at follow-up for two participants in the control group (one 
relocated during the control period; one did not complete assessment within specified 
timeframe). There was missing data from two participants in the intervention group (valid 
kinetic data could not be obtained for one participant due an inability to walk on the 
treadmill appropriately; missing pre-training data for one participant due to technical data 
collection issues). This resulted in a total sample size of seven intervention and seven 
control participants for kinematic analysis, and six intervention and seven control 
participants for kinetic data analysis. The personal demographics and characteristics at 
baseline are presented in Table 6-1. 
 
Table 6-1. Participant demographics and characteristics at baseline. 
Characteristics  Intervention group (n= 7) Control group (n= 9) 
Age at enrolment, y:mo 21y3mo (4y8mo) 21y8mo (4y3mo) 
Sex: M/F 3/4 5/4 
Height, cm  162.16 (16.18) 170.3 (7.3) 
Weight, kg 67.7 (17.0) 68.4 (13.9) 
Lower limb involvement, n (%)   
 Unilateral 4 (57) 3 (33) 
 Bilateral 3 (43) 6 (67) 
GMFCS, n (%)   
 Level I  5 (71) 5 (56) 
 Level II 2 (29) 4 (44) 
Previous lower limb surgery,a n (%)    
 Yes 3 (43) 3 (33) 
Data are mean ± SD unless otherwise stated. M, male; F, female; GMFCS, Gross Motor 
Function Classification System; a Surgery types: muscle-tendon lengthening (n=6), 
osteotomy (n=2).  
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Details of training adherence and adverse events for the intervention have been reported 
elsewhere.180 Briefly, participants randomised to the intervention group completed 95% of 
all training sessions over the 12-week period. Total training time was 38.9 hours, made up 
of 28.5 hours of PRT and 10.5 hours of functional anaerobic training. There were two 
separate instances of minor musculoskeletal pain reported during the intervention. In both 
cases, training was modified by reducing the load lifted and progressing once the pain had 
ceased.  
 
Representative baseline and follow-up ankle angle, moment and power data for one 
subject with unilateral involvement (GMFCS level I) compared to the TD group average 
are shown in Figure 6-2. Unadjusted baseline and 12-week follow-up data are presented in 
Table 6-2. At 12-weeks, there were no difference between the intervention and control 
groups in walking speed (mean difference 0.05 m.s-1, 95% CI -0.03 – 1.24), stride length 
(mean difference 0.02m, 95% CI -0.13 – 1.71), ankle angle at foot contact (0.260, 95% CI -
4.468 – 5.20), and maximum ankle angle during stance (0.30 0, 95% CI -6.96 – 7.57).  
There were also no differences between groups for secondary outcomes including GPS 
(1.090, 95% -0.65 – 2.84), peak ankle power during late stance (0.47 W.Kg-1, 95% CI -0.01 
– 0.96), peak hip power during late stance (0.17 W.Kg-1, 95% CI -0.02 – 0.35), and the 
ratio of peak ankle to hip power during late stance (-0.14, 95% CI -1.27 – 0.98).
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Figure 6-2. Representative data from one CP participant (unilateral involvement, GMFCS 
Level I) before (dashed black line) and after (solid black line) the intervention compared to 
the TD group average ± 1SD (grey shaded area).
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Table 6-2. Outcomes at baseline (T1) and follow-up (T2) assessments (immediately following intervention) by group allocation; difference 
within groups; and difference between groups adjusted for age, sex and baseline values.  
 
T1 (baseline), mean (SD) T2 (12-weeks), mean (SD) Within-group difference, mean (SD) 
Between-group 
difference,  
mean (95% CI) 
Outcome 
measure 
Int (n=7) Con (n=9) Int (n=7) Con (n=7) Int T2-T1 p Con T2-T1 P Int T2 – Con T2 p 
Walking 
speed 
(m.s-1) 
0.79 (0.35) 0.80 (0.22) 0.80 (0.22) 0.83 (0.21) 0.06 (0.07) 0.063 0.03 (0.04) 0.134 0.05 
(-0.03 – 
1.24) 
0.229 
Stride 
length (m) 
1.03 (0.33) 1.03 (0.30) 1.03 (0.22) 1.04 (0.22) 0.00 (0.17) 0.931 0.01 (0.06) 0.675 0.02 
(-0.13 – 
1.71) 
0.739 
Ankle 
angle at 
foot 
contact 
(PF, deg) 
-6.05 (6.64) -7.04 (3.51) -7.05 (3.51) -7.91 (5.44) -0.63 (4.06) 0.694 -0.87 (4.00) 0.586 0.26 
(-4.68 – 
5.20) 
0.908 
Maximum 
ankle 
angle 
during 
stance 
(DF, deg) 
7.28 (3.04) 9.17 (2.96) 8.30 (2.96) 9.07 (6.04) 1.02 (5.00) 0.609 -0.10 (5.10) 0.959 0.30 
(-6.96 – 
7.57) 
0.927 
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GPS (deg) 9.61 (3.99) 6.76 (2.06) 10.51 (4.16) 6.74 (1.76) 0.90 (1.35) 0.129 -0.02 (0.88) 0.965 1.09 
(-0.65 – 
2.84)  
0.190 
Peak 
ankle 
power 
during late 
stance 
(W.Kg-1) 
1.12 (0.81) 1.23 (0.79) 1.43 (0.88) 1.05 (0.48) 0.31 (0.28) 0.043 -0.18 (0.46) 0.336 0.47 
(-0.01 – 
0.96) 
0.055 
Peak hip 
power 
during late 
stance 
(W.Kg-1) 
0.82 (0.44) 0.70 (0.54) 0.76 (0.31) 0.53 (0.28) -0.06 (0.21) 0.522 -0.17 (0.29) 0.155 0.17 
(-0.02 – 
0.35) 
0.071 
Ankle to 
hip power 
ratio 
1.29 (0.28) 2.00 (0.57) 1.72 (0.55) 2.09 (0.47) 0.43 (0.37) 0.034 0.09 (0.76) 0.775 -0.14 
(-1.27 – 
0.98) 
0.774 
Con, control group; Int, intervention group. 
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Within-group analyses revealed an increase in peak ankle power generation during late 
stance in the intervention group after training (post-pre difference 0.31 ± 0.28 W.Kg-1, 
p=0.043). There was no difference after training in peak hip power generation during late 
stance, which caused a concurrent increase in the ratio of ankle to hip power generation 
within the intervention group (post – pre difference 0.43 ± 0.37, p=0.034). Individual 
baseline and follow-up kinetic data for participants randomised to the intervention group 
are shown in Figure 6-3.  
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Figure 6-3. Individual baseline and follow-up data points from individuals randomised to 
the intervention group for peak ankle power during late stance (A), peak hip power during 
late stance (B), and the ratio of peak ankle to peak hip power during late stance (C). 
Abbreviations: B, bilateral involvement; GMFCS, Gross Motor Function Classification 
System; U, unilateral involvement.  
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6.4 Discussion  
This study examined the effect of a 12-week combined functional anaerobic and strength 
training intervention on treadmill gait kinematics and kinetics at self-selected walking 
speed in young adults with CP. Our hypotheses that the intervention group would have 
increased ankle DF at foot contact and during stance, increased ankle power during late 
stance, and an improved GPS following training compared to a control group receiving no 
training were not supported. There were no changes in participants’ preferred treadmill 
walking speed or stride length after training.  
 
The FAST intervention was designed to address the muscle size, muscle weakness, and 
anaerobic capacity deficits, without any specific treadmill gait training. The training 
stimulus was successful at addressing the primary training goal,180 but may not have been 
sufficient or specific enough to change treadmill gait kinematics or kinetics at preferred 
walking speed.60 If improving treadmill gait kinematics is the primary training goal, then the 
components of the training intervention should be designed specifically for that outcome. 
 
The lack of change in ankle kinematics and GPS after training compared to the control 
group is consistent with findings by Taylor et al,43 who reported no change in GPS or 
preferred walking speed following a well-designed PRT intervention targeting individual 
lower limb strength deficits in adolescents and young adults with CP. Our FAST 
intervention specifically trained the distal lower limb muscles, including the TA,180 that may 
have been expected to translate to improved ankle DF function, however, there was no 
improvement in ankle kinematics during walking. The finding that GPS did not change 
following training is an important result to show that individuals with CP can perform high 
intensity anaerobic training and heavy PRT without a deterioration in their gait. 
 
In contrast to our findings, Kirk et al146 reported increased ankle DF during toe lift, at foot 
contact, and during stance following explosive PRT in adults with CP. The increased rate 
of force development of the ankle DF muscles reported following the 12-week training 
program could account for the improved ankle joint kinematics during gait.146 The main 
difference between Kirk et al’s146 PRT intervention design compared to our study and that 
of Taylor et al,43 was that participants were required to lift with “full intentional acceleration” 
(explosive) during the concentric phase of each repetition. Participants in our FAST 
training intervention were required to lift explosively for the final four weeks of the program, 
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however this may have been insufficient training volume to induce adaptations similar to 
those reported by Kirk et al.146 
 
The improved ankle joint kinematics following explosive PRT reported by Kirk et al,146 did 
not however translate to any improvements in overground functional capacity measures. 
The mechanisms for improving functional capacity may therefore be multiple in origin, and 
not related to discrete changes in preferred-speed walking kinematics or kinetics. The 
FAST intervention did improve overground 6MWT performance in the training group 
compared to the control group,180 and hence while treadmill gait kinematics did not differ 
between groups after training in our study, overground walking capacity did.  
 
Participants’ walking speeds on the treadmill were approximately 45% slower than their 
average walking speeds during the overground baseline 6MWT,180 and approximately 30% 
slower than previously reported preferred walking speeds on a treadmill in typically 
developing young adults.186 It is possible that the treadmill familiarisation time was 
insufficient prior to gait analysis which may have resulted in participants’ selecting a slower 
than typical walking speed. Walking at slower speeds requires less ankle power 
generation during late stance, and may be achieved with no change in gait kinematics.187 
Strength improvements in the PF may therefore not be reflected at slower walking speeds 
where ankle power generation requirements are less, suggesting that the evaluation of a 
range of walking speeds around typical may be useful in future studies.  
 
There were no between-group differences in late stance ankle power, hip power, or ankle 
to hip power ratio after 12-weeks of training. There was, however, a within-group increase 
in ankle power during late stance in the intervention group. Of the available kinetic data, 
four participants who were GMFCS Level I showed increases in their ankle push-off power 
following training, whereas the two participants who were GMFCS Level II, who both had 
bilateral involvement, showed minimal change post-training (Figure 3). There may have 
been differential adaptations to the FAST intervention based on the severity of motor 
impairment and limb involvement, however, subgroup analysis in this study was not 
plausible due to low participant numbers. Future investigations with larger sample sizes 
are required to answer these important differential adaptation questions.  
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 Limitations 
Improvements in functional capacity outcomes measured in the same sample have been 
reported in our previous study180 indicating that controlled treadmill gait analysis may not 
detect meaningful differences in functional capacity for individuals already of a high 
functional level. There was a mix of bilateral and unilateral limb involvement within our 
study’s sample, as well as different treatments and therapies reported during participants’ 
development. These factors likely increased the heterogeneity of the sample and may 
have resulted in different effects on ankle, knee and hip kinematics, as well as how the 
individuals adapted to the FAST intervention. The target sample size was not met despite 
an extensive recruitment strategy being implemented over two years and so this study 
may be underpowered to detect differences in gait outcomes between groups. The study 
was constrained by a single-site for the intervention, which limited our recruitment to 
participants within geographical locations able to access the training facility. The study 
also had a limited timeframe for completion resulting in recruitment being halted prior to 
the targeted sample size being reached. Further research using larger sample sizes to 
examine gait outcomes following this type of training in young adults with CP is required to 
validate the results. 
 
 Conclusion 
The combined FAST program did not lead to objective improvements in treadmill gait 
kinematics or kinetics at a preferred walking speed in the intervention group compared to 
control participants. We hypothesise that the FAST intervention was not task-specific to 
treadmill walking at a preferred speed. The discrepancy in treadmill gait outcomes and 
improvements in overground functional capacity180 requires further exploration and 
suggests that treadmill-based gait outcomes at preferred walking speed may not be 
related to measures of overground functional capacity in young adults with CP.
7 
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Discussion and conclusion 
 
The final chapter of this thesis summarises the key findings from the systematic review 
and experimental studies undertaken; provides clinical and practical implications of this 
research; discusses the limitations and generalisability of the findings; and identifies future 
avenues for study.   
 
The overall aim of this thesis was to examine the effect of combined functional anaerobic 
and strength training on muscle properties, functional capacity, and gait in adolescents 
and young adults with CP. Specifically, this thesis investigated the relationships between 
muscle strength, stiffness, and functional capacity, and the impact of the FAST 
intervention on these outcomes. In addition, the effects of the FAST intervention on 
treadmill gait kinematics and kinetics have been presented.  
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7.1 Key findings 
i) Preliminary evidence from systematically reviewed literature that muscle size and 
fascicle length may be enhanced following strength training interventions in 
children and adolescents with CP 
Prior to the design of the FAST intervention, a systematic review was undertaken to 
determine the impact of strength training on skeletal muscle morphology and architecture 
in children and adolescents with spastic type CP (Chapter 2). The systematic review 
identified preliminary evidence of small to large effects on muscle adaptation (hypertrophy 
and architecture) following muscle strengthening interventions in children and adolescents 
with CP. At the time of conducting the systematic review, and following an updated 
literature search in 2018, no studies have been identified that have measured muscle 
morphology or architectural properties in adults with CP after muscle strengthening 
interventions. Due to the small number of studies included in the review, and the 
heterogeneity of study design and outcome measures, no firm conclusions could be 
drawn. The findings of the review, however, were important for highlighting limitations in 
the current evidence base and informing the design of the FAST intervention.  
 
The FAST intervention protocol was reported in Chapter 3. A waitlist randomised 
controlled trial, stratified by age and sex, was chosen to provide strong methodological 
design, overcoming a major limitation of pre-post cohort designs in prior studies. The 
protocol was implemented in adolescents and young adults, to minimise the confounding 
effect of natural growth in a younger sample, and the outcome measures included 
objective muscle morphology and architectural parameters, alongside functional capacity 
and gait assessments. The PRT program targeted the calf muscles which are important for 
gait function and commonly impaired in individuals with CP. Acute training variables of the 
PRT program met established guidelines,55,115 and the addition of functional anaerobic 
training addressed the principle of specificity to target functional capacity improvements.  
 
ii) Plantar flexion strength is positively related to walking capacity in adults with CP 
In Chapter 4, cross-sectional analyses of 33 adults with CP (aged 15 – 55 years) 
investigated relationships between muscle strength, stiffness, and functional capacity. The 
main finding from this study was that adults with CP have reduced PF muscle strength that 
is independently associated with functional capacity outcomes, when controlling for 
GMFCS level and age. Specifically, maximum isometric PF strength explained 50 – 61% 
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of the variance in 6MWT, LSU test and TUS test performance of adults with CP. Maximum 
isometric PF strength explained more of the variance in walking capacity (6MWT, 61%) 
and LSU test performance (57%) compared to the TUS test (50%) indicating the relative 
importance of the calf muscles to walking ability. Maximum isometric PF strength of adults 
with CP in this study (0.81 ± 0.51 Nm.kg-1) was approximately 50% less than what has 
been found in TD young adults (1.50 ± 0.37 Nm.kg-1), and approximately 35% less than 
TD adults aged over 70 years (1.19 ± 0.36 Nm.kg-1).154 Passive muscle and joint stiffness 
was not related to PF strength or functional capacity outcomes, suggesting that muscle 
strength is more important than passive stiffness for maintaining mobility in adults with CP, 
and should be targeted in specific exercise interventions.  
 
iii) The functional anaerobic and strength training intervention increased muscle 
size, strength, and functional capacity in high functioning young adults with CP 
Chapter 5 provided new evidence that lower limb muscle in young adults with CP can 
undergo hypertrophy following a combined FAST intervention. Overall, the FAST program 
was an effective intervention for young adults with CP to improve muscle size, strength, 
and functional capacity. The increase in muscle size was likely caused by the PRT 
component of the FAST intervention, and the improvements in functional capacity were 
most likely due to the contribution from the anaerobic training component. When PF 
strength was normalised to total PF muscle volume, there was still a mean difference in 
strength between groups after training, suggesting that the strength increase of the training 
group was not explained by morphological changes alone. A plausible explanation for this 
is the neural changes that occur alongside muscular adaptation following PRT leading to 
improved motor learning and control.80,188 Improvements in functional capacity are likely to 
be due to the specificity of training functional tasks in maximum anaerobic efforts during 
the FAST program. This is the first randomised trial of concurrent PRT and anaerobic 
training in young adults with CP to reveal beneficial adaptations in muscle morphology, as 
well as improvements in functional capacity. 
 
iv) The functional anaerobic and strength training intervention did not alter treadmill 
gait kinematics or kinetics  
The effects of the FAST intervention on treadmill gait kinematics and kinetics were 
reported in Chapter 6. There were no between-group differences (intervention compared 
to control) at 12-weeks for ankle DF angle at foot contact, maximum ankle DF during 
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stance, overall gait quality assessed using the gait profile score, ankle power generation 
during late stance, and the ratio of ankle to hip power generation during late stance. 
Within-group analysis revealed an increase in peak ankle power during late stance (0.31 ± 
0.28 W.kg-1, p=0.043) and ankle to hip power ratio (0.43 ± 0.37, p=0.034) following 
training in the intervention group. As treadmill walking was not a trained activity during the 
intervention and the treadmill walking assessment was performed at a self-selected 
comfortable walking speed, the FAST intervention may not have been specific enough to 
improve treadmill gait kinematics. The improvements in overground functional capacity 
reported in Chapter 5 occurred in the absence of improvements in measured treadmill gait 
kinematics. This discrepancy in overground functional capacity versus treadmill gait 
outcomes requires further exploration, and suggests that treadmill-based gait outcomes at 
preferred walking speed may not be related to the improvements in functional capacity 
following training. 
 
7.2 Clinical implications  
The effectiveness of any intervention depends on the outcome of interest, and how it is 
measured. There has been debate in the recent literature about the overall effectiveness 
of resistance exercise for people with CP. The options to measure its effectiveness range 
from qualitative self-report information about quality of life and participation, through to 
quantitative measurements of muscle structure and biochemistry. How someone views the 
importance of different outcome measures will determine their perception of the 
effectiveness of the intervention. It appears that conventional resistance exercise in 
individuals with CP doesn’t lead to improved walking or mobility-related measures. Based 
on these functional measures in isolation, resistance exercise may be perceived to be non-
effective in a clinical setting. Resistance exercise may lead to an increase in muscle mass, 
however, that would have many beneficial effects on overall health and muscle strength. If 
the success of resistance exercise for individuals with CP is solely judged on functional 
outcomes, then we may be missing many pieces of the puzzle regarding the potential 
benefits of this mode of exercise. The inherent heterogeneity of CP also suggests that the 
most important outcome measure may be specific to the individual’s impairments.  
 
It is known with a large degree of certainty that performing PRT leads to increases in 
muscle mass in TD individuals. The long-term negative effects of PRT on health outcomes 
appear almost non-existent in the TD and CP literature. This doctoral program has 
140 
 
provided the first evidence that muscle hypertrophy following combined FAST is possible 
in adolescents and young adults with CP. This field of research, investigating the effects of 
exercise interventions on muscle morphology and architecture in individuals with CP, is in 
its infancy. As the systematic review in Chapter 2 reported, there are very few studies that 
have measured these outcomes following muscle strengthening interventions. There is no 
other voluntary exercise intervention that has been shown to increase muscle mass to the 
extent that PRT has. It would be logical therefore, to consider PRT as a primary 
intervention for individuals with CP, who have up to 50% smaller leg muscle volumes than 
TD individuals.105  
 
Many treatments performed in children with CP to improve gait are likely to further weaken 
the muscles involved in the treatment. Orthopaedic interventions are commonly used to 
treat muscle contractures and bony deformities of the lower limbs in children with CP that 
may lead to improved gait kinematics.189 Surgical interventions, however, do not address 
muscle weakness and motor control deficits. The substantial rest and rehabilitation period 
following surgery may lead to a further loss of muscle mass that has not yet been 
investigated. Another common treatment for children with CP is intramuscular BoNT-A 
injections that are designed to improve walking and functional capacity. Recent studies 
however, have found maintenance of, with no overall improvement in gait quality,190,191 and 
evidence from animal studies have shown damage to the microstructure of muscle tissue 
following BoNT-A injections.192 While these interventions are designed with the intention of 
improving gait and function for children with CP, they may be having unintended 
consequences that furthers the deficit in muscle strength. Muscle strengthening and 
hypertrophic interventions may therefore be more important for children with CP who are 
undergoing neuromuscular or orthopaedic treatments. A higher level of muscular strength 
is beneficial, as it is associated with reduced risk of all-cause mortality.193 In adults with 
CP, calf muscle strength was shown to be positively related to walking capacity, with 
higher levels of strength associated with the further distances walked on a 6MWT (Chapter 
4). Reaching adulthood with higher levels of muscular strength and muscle mass is likely 
to be important for maintaining the minimum strength capacity needed to perform tasks of 
daily living such as ascending stairs or standing from a chair. 
 
The first CP-specific resistance exercise guidelines were published in 2016, and describe 
acute training variables thought to be most effective to increase muscle strength that can 
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be used in future interventions to guide exercise prescription.55 Cerebral palsy is 
heterogeneous by definition. Therefore, in a clinical setting, training programs should be 
tailored within the context of each individual’s impairments, focused on the outcomes that 
may be most beneficial to the individual. In this way, different training modes shouldn’t be 
seen as effective or not effective in isolation, but rather complementary based on the goals 
of, and for, each individual. The known physiological adaptations to different training 
modes should also be taken into consideration when prescribing exercise for individuals 
with CP. The inclusion of task specific training that directly addresses functional deficits 
may be required to induce changes in functional capacity. 
 
7.3 Practical recommendations 
 Acute variables for PRT programs (e.g. sets, repetitions, load, movement timing, 
program duration) should meet established guidelines, but may be adjusted for the 
individual if required, and be context specific.  
 Performing maximum effort anaerobic exercise training may be useful to address 
specific functional capacity outcomes.  
 Resistance exercise should be a regular component of exercise programs for 
ambulatory individuals with CP.  
 Each component of an exercise program (e.g. resistance exercise, anaerobic 
exercise, gait training) shouldn’t be seen as an either-or choice, rather they are 
likely to have complementary effects.  
 
Practical considerations   
 Conventional PRT programs may have the largest effect in high functioning 
individuals with CP (GMFCS levels I and II) compared to lower functioning 
individuals (GMFCS levels III-V) due to the need for voluntary control of movement, 
available range of motion, and providing sufficient mechanical stimulus to the 
targeted muscles to initiate a hypertrophic cascade. 
 Exercise training programs should be designed with the outcome measures in mind. 
If a training program doesn’t improve one outcome measure, it doesn’t necessarily 
mean that it hasn’t had an effect on other outcomes.  
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7.4 Future research and potential limitations 
Due to the combined modes of resistance and anaerobic exercise in the FAST 
intervention, we were unable to definitively separate the contribution of PRT and anaerobic 
training components to the changes in outcome measures. The PRT component, however, 
made up around 70% of the total training time, so it was the likely contributor to the muscle 
hypertrophy and strength improvements of the lower leg muscles in this study. Pragmatic 
decisions were made regarding the modes of training performed, and the number of 
intervention and control groups. This was done to maximise the potential impact of the 
intervention on the outcomes of interest from a limited pool of potential participants. 
Combining the functional anaerobic and resistance training modes overcame the key 
limitation of previous research that had conducted resistance training or anaerobic training 
in isolation. If the study had access to a larger sample, participants could have been 
randomised into either, 1) resistance training; 2) combined functional anaerobic and 
resistance training, or 3) a control group. Future multi-site trials could utilise this design to 
assist our understanding of the contribution the different exercise modes on the muscular 
and functional outcome measures.  
 
The FAST program may be interpreted as a concurrent training methodology – performing 
two distinct modes of exercise during the 12-week training period. Concurrent training in 
TD individuals may attenuate the hypertrophic adaptations compared to PRT alone,194-196 
although this response appears more pronounced in well-trained individuals than in 
untrained individuals.197 The majority of these studies are based on concurrent aerobic 
training and PRT, as opposed to the functional anaerobic exercises performed 
concurrently in our study. High intensity interval training (HIIT) more closely resembles the 
physiological demands of the 20-30s maximum efforts required in the FAST program. A 
recent systematic review and meta-analysis of concurrent HIIT and resistance training in 
TD individuals reported similar changes in muscle hypertrophy and strength compared to 
PRT alone.198 Due to the relative contribution of PRT to total training time in our training 
program (70%); the short duration of the anaerobic exercises; and the untrained status of 
our participants at baseline; it is unlikely that the concurrent training mode attenuated the 
hypertrophic response. 
 
This thesis did not examine the potential influence of the FAST intervention on neural 
factors that underlie a proportion of the reduced muscle force and/or joint torque 
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production in individuals with CP. These factors include reduced excitatory drive to the 
agonist muscle101,102 and increased activation of antagonists (i.e. greater co-
activation).102,103 The production of maximal force requires maximal activation of available 
motor units. It has been hypothesised that reduced excitatory drive to the motoneuron pool 
due to damaged motor pathways results in an inability to fully activate all available motor 
units in individuals with CP.104 The reduction in maximum activation capacity has been 
shown to account for over 50% of variation in maximum isometric PF strength between 
paretic and non-paretic limbs in individuals with CP suggesting that reduced neural drive is 
a major contributor to muscle weakness.102 It would be useful in future exercise 
interventions to examine the neural adaptations to exercise training interventions to 
determine the effects on maximum activation capacity, co-activation, neural drive, and 
synchronisation between muscles.   
 
Cellular and extracellular tissue composition within the muscle compartment is different in 
CP muscle with contracture compared to TD muscle.199 These include a reduction in the 
number of satellite cells,3 altered extracellular matrix,26,39,40, and longer in vivo sarcomere 
lengths.26 Satellite cell differences appear to compromise muscle growth during childhood 
in CP,173 however, contradictory evidence exists regarding the role of satellite cells in 
hypertrophy following a stimulus such as resistance training.174 The measurement of 
cellular properties was beyond the scope of this doctoral program, making it difficult to 
know whether the skeletal muscle hypertrophy and muscle strengthening were mediated 
by an increase in satellite cell activity, or via other mechanisms. The question remains as 
to whether all muscles within the same individual, or between individuals with varying 
motor impairments, have similar cellular and extracellular tissue composition. If there are 
differences in cellular structure, then there may be differences in the adaptive capacity of 
muscle following different exercise modes.  
 
There was a small difference in the total PF muscle hypertrophy found between the more-
impaired (7.7% increase) and the less-impaired (9.8% increase) limbs within the training 
group. Even though whole muscle compartments underwent hypertrophy following the 
FAST intervention, we cannot be certain that the hypertrophy was myofibrillar growth 
alone, or extracellular matrix and connective tissue expansion, or a combination of both 
that led to the greater overall muscle volume. We analysed a subgroup of participants 
using Dixon MRI techniques to assess the intramuscular fat content within the muscle 
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compartment before and after training which revealed no difference between the training 
and control groups at 12-weeks. This suggests that the overall muscle compartment 
hypertrophy may have been achieved via increased proportions of both contractile and 
non-contractile tissue. Future work should investigate the cellular and biochemical 
adaptations to exercise interventions (e.g. using muscle biopsy analyses) concurrently with 
whole muscle morphology and architecture measures in individuals with CP. Studies 
designed to investigate the differential hypertrophic adaptations in more-impaired and less-
impaired limbs in unilateral and bilateral CP, and across different muscle groups, will assist 
in understanding potential differences in adaptive capacity across the spectrum of motor 
impairment levels in people with CP.  
 
The findings following the FAST intervention are generalisable to high functioning young 
adults with CP, classified as GMFCS levels I or II. Participants had to be able to perform 
controlled muscle contractions under external load to provide mechanical stimulus to the 
targeted muscles. Individuals classified at lower GMFCS levels (III-V), with greater muscle 
contracture, reduced range of motion, bony deformity, or reduced motor control may not 
be able to recruit a large enough number of muscle fibres, as well as expose the recruited 
muscle fibres to the exercise stimulus (loaded controlled contraction) to initiate a 
hypertrophic response. Emerging assistive exercise modes such as functional electrical 
stimulation show promise for improving muscular strength and function in individuals 
whose impairments may limit their ability to perform volitional exercise at intensities 
required to stimulate neuromuscular adaptation.200  
 
There were some minor variations to the original published protocol (Chapter 3) compared 
to the version included in this thesis. The original protocol was broad ranging and included 
all proposed outcome measures at the time of study design. This thesis was focused on 
the specific muscular and mobility adaptations to the FAST intervention. As such, 
participation and quality of life outcome measures reported in the original protocol were not 
included in this thesis. The data analyses in this thesis varied slightly from the original 
protocol due to the practical implications of the sample size, study design, and reviewer 
feedback not envisaged at the time of protocol publication. For example, sensitivity 
analyses were conducted for different approaches to dealing with missing data (i.e. carry-
forward compared to deletion methods) that were not specified in the original protocol. 
Data relating to muscle fascicle dynamics during gait, voluntary activation, as well as 3-
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month follow-up data were collected but are not reported in this thesis for pragmatic 
reasons and to maintain the coherence of the thesis. It is envisaged that this data will be 
submitted for publication in future studies. 
 
The target sample size for the FAST intervention was not reached. When designing the 
study, it was believed that the target sample size of 40 was feasible within the timeframe 
for the project. The recruitment strategy was extensive and utilised local CP registers; 
targeted mail-outs; social media advertising, and rehabilitation hospitals. This study was 
conducted at a single-site, which constrained recruitment to geographical boundaries with 
access to the training facility, and had a limited timeframe for completion. To the best of 
our knowledge, no studies exist in adults with CP that have measured muscle volume 
changes following muscle strengthening interventions. The FAST study sample size was 
therefore calculated using one prior pre-post training study in children with CP that 
assessed PF muscle volumes before and after training,57 along with an 8-week pilot 
intervention of our training program in TD young adults. While these studies provided a 
guide to calculate a sample size, it cannot be said that muscle in young adults with CP 
would adapt the same way. Further research will benefit from using sample sizes guided 
by statistical power analyses from the FAST study findings using larger sample sizes to 
investigate morphological, functional capacity, and gait outcomes following training 
interventions in individuals with CP. Future studies should consider multi-site trials to 
increase participant numbers due to the challenges of participant recruitment that were 
encountered. The recent introduction of the National Disability Insurance Scheme across 
Australia may provide an avenue of funding for individuals with CP to access appropriate 
exercise training. Exercise interventions conducted by tertiary institutions may be able to 
become approved service providers under this scheme that would increase the 
attractiveness for people with CP to participate in future exercise training studies and 
assist with recruitment challenges. 
 
7.5 Conclusion 
This thesis presents the first evidence that skeletal muscle hypertrophy is possible in 
adolescents and young adults with CP following a FAST intervention assessed using MRI. 
The FAST study used maximal effort anaerobic exercises to address the limitations of 
previous conventional resistance training studies finding limited transfer of strength gains 
to functional capacity post-training. The study design was strengthened by the use of a 
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control group to improve confidence in the assessment of changes in morphological and 
architectural properties over time. Muscular strength and functional capacity increased at 
12-weeks in the training group compared to control participants. Muscular strength was 
positively related to functional capacity in a cross-section of adults with CP. Passive 
muscle and ankle joint stiffness were not related to any functional outcomes indicating the 
relative importance of muscular strength to maintaining mobility in adults with CP. There 
were no between-group differences in treadmill gait kinematics or kinetics assessed at 
preferred walking speed following the FAST intervention. The clinical implications of 
increasing strength and muscle mass in the CP population are far reaching and requires 
further exploration. It will be important to examine how the cellular, morphological and 
architectural properties of muscle adapt in response to different exercise interventions and 
what impact these adaptations have on the long-term mobility and health in individuals 
with CP as they age.
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